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Abstract 
This work describes the identification of a Schizosaccharomycespombe homologue 
of the Saccharomyces cerevisiae CDC37 gene. Homologues have been previously 
identified in a variety of organisms, including Drosophila, chicken, mouse, rat and 
human. The S.pombe gene has been named cdc3 7 and encodes a protein with a 
predicted molecular weight of 52 kDa. The protein shows extremely high sequence 
similarity with Cdc37p from S.cerevisiae for the first 40 amino acids at the N-
terminus but, as with the homologues from other species, this similarity is 
considerably less over the remainder of the protein. 
Deletion of cdc3 7 results in a lethal phenotype, establishing that the gene is 
essential for viability. The null mutant could survive when cdc3 7+ was expressed 
from the thiamine-regulatable low strength expression vector pREP8 1; when 
expression was repressed, the cells showed a variety of phenotypes, becoming 
swollen, misshapen and/or elongated. The diversity of phenotypes observed 
suggests that Cdc37 has several biological roles. Elongation of S.pombe cells 
indicates a cell cycle defect and measurements of cell length during Cdc37 depletion 
confirmed significant elongation in zicdc37 cells when cdc37+ expression from the 
plasmid pREP8 1 was repressed. FACS and cytological analysis indicated that cell 
cycle defects occurred in both the G2 and mitotic phase of the cell cycle. 
Genetic analysis carried out to investigate the mechanism of cell cycle arrest suggests 
that Cdc37 may be involved with the Cdc2/Cdc13 complex, which controls entry 
into mitosis from the G2 phase. cdc3 7+ was strongly overexpressed in wild-type 
cells from the high strength expression vector pREP 1 with no effect. However, in 
strains carrying either of two cdcl 3 alleles, strong cdc3 7+ overexpression severely 
reduced the restrictive temperature. A similar but more modest effect was seen in 
strains carrying various cdc21s  alleles. Preliminary biochemical studies were also 
carried out, which showed that the Cdc2 protein level was lower than normal in cells 
depleted for Cdc37. 
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1.1 The eukaryotic cell cycle 
1.1.1 Introduction 
The cell cycle is the process by which a cell reproduces and divides into two 
daughter cells. It comprises two critical phases; S phase, during which chromosomal 
DNA is replicated and mitosis (M phase) where the replicated genome is distributed 
equally between the two daughter cells. Separating these two phases are GI (after M 
phase and before S phase) and G2 (after S phase and before M phase). The order 
and integrity of cell cycle events must be maintained to ensure the production of 
viable progeny. 
Cells can exit from the cell cycle from either GI or G2. In multicellular eukaryotic 
organisms, most of the cells that are no longer growing and proliferating are arrested 
at a stationary phase known as GO. Such cells have left the cycle after division at a 
certain point in GI, known as the restriction point (Pardee, 1974). Cells that do not 
leave the mitotic cell cycle at this point are committed to progress through the 
remainder of the cell cycle. 
In yeast, the restriction point is broadly equivalent to a transition point in G 1, 
known as Start (Hartwell, 1974). At Start, cells commit to one of three fates: 
progression through the mitotic cell cycle, entry into a sexual cycle or arrest in 
stationary phase in which viability can be maintained for a long period. 
1.1.2 Regulation of the cell cycle 
The cell cycle is a highly ordered and regulated biological process, coordinating cell 
growth and cell division. Most types of cell grow between each cell division (an 
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exception being early embryonic cells) and lack of coordination of growth and 
division would lead to cells becoming progressively smaller or larger (Murray and 
Kirschner, 1991). In yeasts, this control is achieved by having a critical size 
requirement for passing through certain cell cycle stages. In the budding yeast, 
Saccharomyces cerevisiae, small daughter cells must grow for a longer time before 
they pass Start (Hartwell and Unger, 1977). The fission yeast, Schizosaccharomyces 
pombe, also has a similar size requirement but this control is active in G2 so that cells 
must achieve a certain size before progressing through mitosis and cell division 
(Nurse, 1975; Nurse and Fantes, 1981; Fantes, 1989). 
Regulation of the cell cycle also includes coordination of various cell cycle events. 
For example, cells must ensure that mitosis does not begin until DNA replication is 
completed. If these two events are not coordinated, the result could be aneuploid or 
polyploid daughter cells. A number of cell cycle checkpoints have now been 
identified and are the subject of much research. These include the S-M replication, 
G2-M DNA damage and spindle assembly checkpoints (Sheldrick and Carr, 1993). 
These checkpoints are often signal transduction cascades which feed into the normal 
cell cycle progression machinery leading to arrest so that the problem can be 
addressed. An example of this is the response to DNA damage: if DNA damage is 
detected, cells arrest in G2 until the damage is repaired at which point they re-enter 
the cell cycle. 
1.1.3 Cell cycle control by cyclin dependent kinases (CDKs) 
The machinery that underlies the cell cycle regulatory processes includes a highly 
conserved family of proteins known as the cyclin-dependent kinases (CDKs). By 
definition, the activity of CDKs at specific stages of the cell cycle is absolutely 
dependent on their association with cyclin regulatory subunits. However, CDKs are 
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also regulated both positively and negatively by phosphorylation of key residues and 
negatively controlled by the binding of CDK inhibitors. Although this section 
contains a general description of CDKs and their regulation, it mainly focuses on 
their role in the G2IM transition which is most relevant to this project (Nigg, 1995). 
The founding members of the CDK family are the homologous 34 kDa protein 
kinases Cdc28 in S.cerevisiae (Hartwell, 1974) and Cdc2 in S.pombe (Nurse et al., 
1976). Each has been shown, through genetic analysis, to have key roles in regulating 
cell cycle progress at both the GuS and G2/M transitions. Homologues of this 
kinase, called the p34 2 family, were then identified in other species and it has since 
become clear that all eukaryotic cells contain a form of this kinase, which regulates 
various checkpoints in the cell cycle. 
Unlike in the yeasts, where there is only one p34 cdc2  kinase predominantly regulating 
cdc all transitions, there are multiple mammalian homologues of p34 2, all thought to 
play distinct roles in regulation of the cell cycle. The gene encoding the first human 
homologue of p34' 2 discovered, Cdc2 (also known as Cdkl), regulates the G2IM 
transition (Th'ng etal., 1990; Hamaguchi etal., 1992) and was cloned by 
complementation using 'a fission yeast cdc2ts  strain (Lee and Nurse, 1987). The need 
for function of Cdkl at the GuS transition as with S.cerevisiae Cdc28 and S.pombe 
Cdc2 is not conserved in the mammalian cell cycle. Another 6 CDKs have been 
identified in mammalian cells, named Cdk2-7, and with the exception of CdkS, all are 
involved in regulating various transitions within the cell cycle (Nigg, 1995). For the 
rest of this section, the name Cdc2 will be used to describe the homologues 
S.cerevisiae Cdc28, S.pombe Cdc2 and mammalian Cdkl in the role they play in the 
G2/M transition. 
As previously mentioned, the activity of CDKs is absolutely dependent on 
association with their cyclin partners (Morgan, 1995). Cyclins were first 
characterised as proteins that accumulate periodically during the rapid synchronous 
early divisions of sea urchin embryos (Evans et al., 1983). Most cyclins can be 
categorised depending on their structure and on the stage of the cell cycle at which 
they are required. The five major classes in higher cells are known as cyclins A, B, C, 
D, H. Some of these cyclins and CDKs undergo combinational interactions, in that a 
given cyclin may associate with multiple CDK partners and vice versa. Due to the 
universal function of Cdc2 in S. cerevisiae and S.pombe, it is the specific cyclin bound 
that determines at which stage of the cell cycle the CDK is required. In all 
eukaryotes, cyclin B binds to Cdc2 to form a complex that is required for initiation of 
M phase. 
Reversible phosphorylation of specific residues on Cdc2 also contribute to the 
regulation of Cdc2/Cyclin B kinase activity. These modifications are executed in a 
cell cycle dependent manner. Cdc2 is activated via phosphorylation of a specific Thr 
residue in the activation loop of the CDK catalytic domain by CDK-activating 
kinases (CAK5). This residue is Thr167 in S.pombe, which is equivalent to Thrl6l 
in human (Gould and Nurse, 1989; Krek and Nigg, 1991). This phosphorylation 
event is required for Cdc2 kinase activity (Gould et al., 1991). In contrast, 
phosphorylation of Tyr l 5 negatively regulates Cdc2 kinase activity in S.pombe. 
Tyrl 5 phosphorylation maintains Cdc2/Cyclin B in an inactive form throughout the 
S and G2 phases and removal of this inhibitory phosphate is absolutely required for 
activation of Cdc2 kinase activity and entry into mitosis (Gould and Nurse, 1989). 
Inhibitory phosphorylation of Tyr l 5 is conserved in vertebrates, however, there is 
an additional inhibitory phosphorylation on the adjacent residue Thr14 (Krek and 
Nigg, 1991; Norbury et al., 1991). 
1.2 S.pombe as a model organism 
The fission yeast, S.pombe, is a unicellular ascomycete fungus. S.pombe cells are rod 
shaped, 3.5 pm in diameter and between 7 p.m and 14 p.m in length depending on cell 
cycle position. The cells grow by apical extension and divide by medial fission. 
Following the birth of a new cell, growth occurs only at the old end of the cell, which 
existed in the previous cycle; the new end starts to grow at a defined stage termed 
"New End Take Off (NETO, Mitchison and Nurse, 1985). S.pombe cell division by 
medial fission is more typical of higher eukaryotes than the budding of S.cerevisiae. 
Two features make S.pombe an excellent model for studying the eukaryotic cell cycle. 
Firstly, the cells grow only by length extension, making it possible to determine at 
which stage a cell was in the cell cycle simply by measuring its length (Mitchison, 
1957; Mitchison, 1990). Secondly, S.pombe is amenable to both classical and 
molecular genetic analysis (Gutz et al., 1974; Moreno et al., 1991; Alfa et al., 1993). 
S.pombe cells grow under relatively simple conditions. For laboratory purposes, 
S.pombe are grown in either complex or minimal medium at 20°C to 36 °C (Moreno et 
al., 1991). The generation time varies with strain, medium and temperature. Under 
favourable conditions, S.pombe cells reproduce asexually by means of the mitotic cell 
cycle, whereas starvation induces one of several alternative developmental fates (Fig 
1.1). Essentially, haploid cells are of two mating types, known as h and h, and if 
cells of a single mating type are present, then upon starvation they will exit the 
mitotic cell cycle at GI or G2 and accumulate in stationary phase. If cells of both 
mating types are present, they will transiently arrest in GI and then conjugate to 
form a diploid zygote. Under continued nutrient limitation, such zygotes usually 
undergo meiosis directly, forming an ascus containing four haploid spores that lie 
dormant until nutrient conditions improve. However, if newly formed diploid 
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Fig 1.1 The life cycle of Schizosaccharomyces pombe 
Shown is a schematic diagram representing the life cycle of S.pombe. Normally, cells 
reproduce by means of the haploid mitotic cell cycle (top left). However, if cells are 
deprived of nutrients they will exit the cell cycle and enter stationary phase (top) or 
undergo conjugation to form diploid zygotes (upper centre). If starvation continues, 
the zygotes will undergo meiosis and sporulation, forming an ascus containing four 
haploid spores which lie dormant until nutrient conditions improve (lower centre and 
left). However, if newly formed diploid zygotes are resupplied with nutrients, they 
will resume the mitotic cell cycle as a diploid (lower right). This figure is reproduced 
from Macneill and Fantes, 1993. 
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zygotes are supplied with adequate nutrients, some will resume the mitotic cell cycle 
and divide vegatively as a diploid (Egel and Egel-Mitani, 1974). 
The S.pombe genome is —14 Mb, approximately the same as the budding yeast 
S. cerevisiae. However, unlike S. cerevisiae, the genome is contained in just three 
chromosomes. An international project, coordinated by the Sanger Centre in 
Cambridge, commenced in 1995 to sequence the entire S.pombe genome and is almost 
complete. The data generated from this work can be easily searched from the Sanger 
Centre website: 
http://www.sanger.ac.uk/Projects/S_pombe/  
This resource has proved to be extremely important for this project and allowed the 
identification and subsequent isolation of the gene described in this work. 
1.3 Regulation of the cell cycle in S.pombe 
1.3.1 The mitotic cell cycle in S.pombe 
The mitotic cell cycle of S.pombe (Fig 1.2) is typically eukaryotic, with discrete GI, 
S, G2 and M phases (Fantes, 1989). G1 is very short in S.pombe; DNA replication 
has already taken place by the time of cell division and the daughter cells are already 
in G2 at separation (Nasmyth and Nurse, 1979). Conversely, G2 occupies —70% of 
the cell cycle, with most growth taking place during this phase. Entry into mitosis is 
marked by chromosome condensation and rapid microtubule rearrangement, where 
the cytoplasmic microtubule array disappears and a short spindle is formed. In 
contrast to higher eukaryotes, the nuclear envelope remains intact during mitosis, 
which is also true for S. cerevisiae (Nurse, 1985). After mitosis, the cell forms a 
septum across its centre and separation occurs when the septum is cleaved. 






Fig 1.2 The mitotic cell cycle of S.pombe 
Shown is a schematic representation of the cell cycle in S.pombe. It is typically 
eukaryotic with discrete Gi, S, G2 and M phases. G2 is by far the longest phase, 
occupying about 70% of the cell cycle, whilst the duration of each of the Gi, S and 
M phases is about 10% of the cycle. In S.pombe, septation and cytokinesis occur 
simultaneously with S phase so the newly created daughter cells have already 
undergone DNA replication. 
The GI and G2 phases of the cell cycle contain major control points concerned with 
regulating the onset of S phase and mitosis. The G2 phase includes the main growth 
control, ensuring that mitosis and cell division occur only when the cell has reached a 
critical size (Nurse, 1990). The transition from G2 to mitosis also requires the prior 
completion of DNA replication. Cells that are blocked at the DNA replication stage 
will not enter mitosis (Enoch, 1990; Sheidrick and Carr, 1993). 
Cell cycle controls also exist in GI. An important GI control mediates the 
requirement for the completion of mitosis before S phase can commence; cells 
blocked in G2 cannot undergo S phase (Moreno and Nurse, 1994). As mentioned 
earlier, there is an elaborate system of checkpoints and controls that are the subject 
of much ongoing work, however, these will not be discussed in great detail in this 
thesis (Murray, 1992; Woollard and Nurse, 1995; Russell, 1998). 
1.3.2 Cell cycle mutants and cell cycle regulatory genes 
The study of the cell cycle in S.pombe has been largely based on the analysis of 
mutants, which can be classed into three broad categories which are discussed below: 
mutants which are blocked at a specific stage of the cell cycle (mainly cdc mutants); 
mutants that are defective in coordination of cell growth and cell division; mutants 
that are unable to maintain the dependency between cell cycle events. A fourth 
category of mutants exist which overlaps somewhat with the three previously 
mentioned, where the mutants are identified due to their genetical interaction with 
already established cell cycle mutants. 
Most S.pombe mutants that arrest at specific stages of the cell cycle are known as 
cdc (cell division cycle) mutants and typically display a cell elongation phenotype 
(Fantes, 1989; Macneill and Fantes, 1994). Since cdc phenotypes are lethal, 
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conditional mutants have been isolated and are usually temperature sensitive (ts), 
where the cdc phenotype is only visible at certain 'restrictive' temperatures (usually 
~:35°C). The stage of the cell cycle at which the arrest takes place allows cdc 
mutants to be further classified and include genes required for passage through Start, 
DNA replication, entry into mitosis and septation (Fantes, 1989; Carr et al., 1989). 
As mentioned previously (section 1.3.1), the predominant cell cycle control in 
S.pombe exists at the 02 to M transition and controls entry into mitosis. Mutants 
that alter the timing of entry into mitosis therefore affect the coordination of cell size 
and cell cycle stage. Advancing the timing of entry into mitosis shortens 02, the 
phase where most cell growth takes place and results in cells which are shorter than 
wild-type cells, called the 'wee' phenotype (Nurse, 1975). This can be achieved by 
mutants of Cdc2 that lose the normal regulation mechanisms (Nurse and Thuriaux, 
1980; Fantes, 198 1) or by mutations of genes which regulate Cdc2 kinase activity 
(see section 1.3.3). 
Mutations which cause disruption of the normal dependencies of cell cycle events on 
the completion of earlier events can lead to a variety of lethal phenotypes. These 
include defects allowing cytokinesis to proceed in the absence of nuclear division, 
leading to cells with aberrant septation or 'cut' phenotypes (Yanagida, 1998) and 
cells containing polyploid nuclei which indicate that extra rounds of DNA replication 
have taken place without an intervening mitosis (Broek etal., 1991, Moreno and 
Nurse, 1994). 
1.3.3 Regulation of entry into mitosis 
S.pombe has proved an excellent model organism for investigating the mechanisms 
controlling entry into mitosis. A mechanistic model has now been firmly established 
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and homologues have been identified in higher eukaryotes for many of the 
components of this model (Fig 1.3). 
At the G2 to M transition point, Cdc2 is complexed with Cdcl3, a B-type cyclin 
(Booher and Beach, 1987; Booher and Beach, 1988). This complex begins to 
accumulate during G  and S phase and is most abundant when required to initiate 
mitosis. Cdcl3 is absolutely required for Cdc2 kinase activity in G2 and for entry 
into mitosis. Once the Cdc2-Cdcl3 complex has formed, it is regulated by 
phosphorylation of specific residues of Cdc2 (Draetta and Beach, 1988; Gould and 
Nurse, 1989). 
As previously mentioned (section 1.1.3), phosphorylation of Thr167 by a CDK 
activating kinase (CAK) is required for tight cyclin binding and activation of Cdc2 
kinase activity. To date, it appears that S.pombe contains two partially redundant 
CAKs: the Mcs6-Mcs2 complex and Cskl (Lee et al., 1999). Inactivation of both 
these CAKs prevents Cdc2 activation and causes cell cycle arrest. In S.pombe it is 
still not certain which protein dephosphorylates Thri 67, though the phosphatase 
Ppa2 has become the most likely candidate. Deletion of ppa2 causes cells to divide 
at a reduced cell size (semi-wee phenotype), whilst overexpression causes a delay in 
G2, resulting in elongated cells (Kinoshita et al., 1993). These observations are 
consistent with Ppa2 being a negative regulator of entry into mitosis. However, at 
present the genetic interactions of ppa2 with other cell cycle genes are not 
conclusive and cannot determine which of the mitotic control gene products serves as 
a substrate for Ppa2 activity. 
Two genes, wee]' and mikt, have been identified as negative regulators of Cdc2-
Cdc 13 kinase activity which act by phosphorylating residue Tyrl 5 of Cdc2 (Russell 
and Nurse, 1987a; Lundgren et al., 1991). The wee[ gene product belongs to an 
unusual class of protein kinase capable of phosphorylating both serine and tyrosine 
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Fig 1.3 The control of entry into mitosis by the Cdc2/Cdc13 complex 
The timing of entry into mitosis is controlled by the Cdc2/Cdc 13 complex and the 
pathways which regulate it. A. The association of Cdc2 with Cdc 13 is absolutely 
dependent on the activating phosphorylation of Thrl67 (red P) of Cdc2 by CDK 
activating kinases (CAKs). The inhibitory phosphorylation of Tyr] 5 (orange P) by 
Wed I (and MikI) ensure that Cdc2 remains inactive. B. Upon phosphorylation of 
Thr167, Cdc2 forms a complex with the cyclin, Cdcl3. C. Removal of the TyrlS 
phosphorylation by Cdc25 (and Pyp3) convert the inactive complex into its active 
state, allowing entry into mitosis. 
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residues (Featherstone and Russell, 1991, Parker and Piwnica-Worms, 1992). The 
mikT gene shares extensive sequence homology with weet (Lundgren et al., 1991). 
The wee] gene is a dosage dependent inhibitor of mitosis and loss of wee] function 
advances mitosis resulting in the short 'wee' phenotype (Russell and Nurse, 1987b). 
Loss of mikt function has no effect on cell length in otherwise wild-type cells. 
Although neither weet nor mikt is essential, loss of both activities leads to rapid 
dephosphorylation of Tyrl 5 and to mitotic catastrophe that is lethal (Lundgren et 
al., 1991). This suggests that Weel and Miki share an overlapping function, which 
is required for phosphorylation of the Tyr l 5 residue of Cdc2 but that Wee 1 plays 
the major role. 
The phosphorylation of the Tyr15 residue of Cdc2 by Weel and Miki must be 
reversed to activate the Cdc2/Cdc13 complex and this is carried out by Cdc25 and to 
a lesser extent, Pyp3. The cdc25 gene product has been identified as a dosage 
dependent activator of mitosis, acting in opposition to Wee 1 (Russell and Nurse, 
1986). Both cdc25 mRNA and Cdc25 protein levels fluctuate during the mitotic cell 
cycle, reaching a maximum at the G2 to mitosis transition point (Moreno etal., 1990; 
Ducommun et al., 1990). cdc25 is essential for cell cycle progression and cells 
lacking cdc25 function arrest in G2 but only in the presence of functional weet 
(Fantes, 1979; Russell and Nurse, 1986; Russell and Nurse, 1987b). Both genetic 
(Gould and Nurse, 1989; Gould et al., 1990) and in vitro biochemical evidence (Millar 
etal., 1991) suggest that the cdc25 gene product induces mitosis by 
dephosphorylating the Tyr l 5 residue of Cdc2 , thereby activating Cdc2 kinase 
activity. Pyp3 is another protein tyrosine phosphatase which also contributes to 
this Tyr 15 dephosphorylation (Millar et al., 1992). Pyp3 function is not essential in 
otherwise wild-type cells but does cause a mitotic delay that is enhanced in cells 
which are partially defective in Cdc25 function (Millar et al., 1992). However,pyp3 
is essential in a cdc25 weel double mutant, suggesting that Cdc25 and Pyp3 also 
share an overlapping function but that Cdc25 plays the major role. 
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In order for a cell to enter mitosis and progress through the cell cycle, Cdc25 must be 
activated, and Wee  and Miki must be inhibited. This is achieved by 
phosphorylation of these three proteins by multiple kinases, probably including 
Cdc2 itself as in S.cerevisiae (Patra et al., 1999). The nim1/cdr1 gene (Russell and 
Nurse, 1987a; Young and Fantes, 1987) encodes a protein kinase that can 
phosphorylate and inhibit the Wee  protein in vitro (Wu and Russell, 1993; Coleman 
etal., 1993; Parker etal., 1993). In vivo, the levels ofNiml/Cdrl kinase activity 
correlate directly with levels of Wee  phosphorylation (Wu and Russell, 1993). 
Cdc25, Weel and Miki are also targets of checkpoint kinases that prevent mitosis in 
response to upstream signals. Cdsl, a protein kinase involved in the S-M DNA 
replication checkpoint, is believed to phosphorylate and activate Wee 1, thus delaying 
the onset of mitosis in response to incomplete DNA replication (Boddy et al., 1998). 
There is also evidence that Cdsl phosphorylates and inhibits Cdc25, another 
measure towards delaying the onset of mitosis (Furnari etal., 1999). Chkl is kinase 
involved in the G2-M DNA damage checkpoint and has been shown to 
phosphorylate and inhibit Cdc25 in vitro and in vivo, delaying entry into mitosis in 
response to DNA damage (Furnari et al., 1999). 
1.4 The heat shock response and the role of heat shock proteins as 
molecular chaperones 
When cultured cells or whole organisms are exposed to elevated temperature, they 
increase the synthesis of several highly conserved proteins known as heat shock 
proteins (Hsps). As well as heat-shock, these Hsps are also produced in response to 
a wide variety of other stresses such as exposure to radiation or toxic chemicals 
(Ritossa, 1996; Lindquist, 1986). This heat shock response is universal; it has been 
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observed in every organism where it has been investigated and is found in nearly 
every cell and tissue type of multicellular organisms (Lindquist, 1986). 
Heat stress and the other stresses which increase Hsp synthesis result in a much 
higher than usual intracellular concentration of proteins in denatured conformations, 
which require 'molecular chaperones' to assist them in refolding properly back into 
their normal native conformations. Most Hsps are now known to act as molecular 
chaperones even under normal conditions and their mechanism of action has been 
subject to intense investigation (Gething and Sambrook, 1992; Morimoto, 1994; 
Hart!, 1996). They have been shown to play diverse roles in successful folding, 
assembly, intracellular localisation and regulation of many proteins, even in 
unstressed cells (Gething, 1997). 
The genes encoding Hsps are highly conserved and have been identified in every 
species in which they have been examined. Most of these genes and their products 
can be assigned to families based on the basis of sequence similarity and typical 
molecular weight (Gething, 1997). These families include the HsplOO, Hsp90, 
Hsp70, Hsp60, Hsp40, Hsp25 and small Hsp families. The Hsps recognise and bind 
to target proteins that are in non-native conformations, whether due to denaturation 
induced by stress or because they have not yet been fully synthesised. Binding 
and/or release of the target proteins is often regulated by association and/or 
hydrolysis of nucleotides. Typically, Hsps function as complexes with several other 
chaperones or in association with partners known as cochaperones. The Hsps that 
have been best studied are Hsp40, Hsp60, Hsp70 and Hsp90. The most interesting 
Hsp with regard to this project is Hsp90 and is described in the next section. 
However, brief descriptions of the roles of the other Hsps are included here. 
Hsp70 is the most highly conserved of the Hsps and therefore has been investigated 
most thoroughly. All known Hsp70s have Hsp40 cochaperones and together assist a 
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large variety of protein folding processes in almost all cellular compartments (Bukau 
and Horwich, 1998). They play an essential role in the folding of newly translated 
proteins, targetting proteins and assisting their translocation across organellar 
membranes, disassembling oligomeric protein structures, facilitating proteolytic 
degradation of unstable proteins and controlling the biological acivity of folded 
regulatory proteins (Morimoto et al., 1994; Hart!, 1996). In Hsp70 assisted folding 
reactions, substrates undergo repeated cycles of binding and release, causing local 
conformational changes in the substrate, thus preventing aggregation and facilitating 
folding to its native state (Szabo et al., 1994; Buchberger et al., 1996). Hsp40 is 
believed to target Hsp70 to its destination and also stimulate ATP hydrolysis. 
Hsp60s, or the chaperonins as they are also known, function as a collective of 
double-ring assemblies that promote folding of proteins into their native state (Bukau 
and Horwich, 1998). The huge complexes (-1 MDa) are made up of back to back 
rings of identical or closely related rotationally symmetric subunits of -60 kDa. 
Chaperonins play an essential role in all cells, assisting a large variety of newly 
synthesised and newly translocated proteins to reach their native forms by binding 
them and facilitating their folding inside a large central channel within each ring (Ellis, 
1996; Fenton etal., 1997). 
All known stresses, if sufficiently intense, induce Hsp expression (Feder and 
Hofmann, 1999) and their increase in expression is termed the stress response. A 
common aspect of these inducing stresses is that they result in proteins having non-
native conformations (Somero, 1995), which is consistent with the function of Hsps 
as molecular chaperones, binding only proteins that are in non-native conformations. 
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1.5 The Hsp90-based chaperone system 
1.5.1 The ubiquitous protein chaperone, Hsp90 
Hsp90 is a highly conserved stress protein and is expressed in the cytoplasm of all 
eukaryotic cells, though very small amounts are present in the nucleus as well 
(Parsell and Lindquist, 1993). It is highly abundant in unstressed eukaryotic cells, 
accounting for —I% of cytosolic protein but in response to stress, Hsp90 protein 
levels increase up to ten-fold (Welch and Feramisco, 1982). It is essential in both 
yeast (Borkovich, 1989) and Drosophila (Cutforth and Rubin, 1994). Hsp90 purifies 
as a dimer and dimerisation is required for its function in vivo (Minami etal., 1994). 
In vitro, Hsp90 alone functions as a molecular chaperone that facilitates the folding 
of a number of proteins (Jakob and Buchner, 1994), however, this ability to assist in 
protein folding is probably only part of its function in vivo as a component of the 
Hsp90-based chaperone system. Several transcription factors and protein kinases 
involved in signal transduction have been recovered from cells in association with 
Hsp90. In many cases, the association with this protein chaperone is essential for 
the proper functioning of the signalling pathway. 
1.5.2 The subcomplexes of Hsp90 
There are several Hsp90 cochaperones that have been identified and they appear to 
be organised into discrete subcomplexes (Fig 1.4). To date, four different Hsp90 
subcomplexes have been described and are believed to have distinct roles (Caplan, 
1999). It is thought that the subcomplex which Hsp90 forms, directly affects the 
downstream function of Hsp90. Both the 'Hop' complex and the 'p23' complex 
(Fig 1.4) are associated with maturation of steroid hormone receptors (SHRs), though 
the exact mechanisms have yet to be determined. The Hsp90/Cdc37 complex is 





Fig 1.4 The cochaperones and subcomplexes of Hsp90 
Shown are the known cochaperones of Hsp90 to date and the subcomplexes they 
form. Complex A, called the 'Hop' complex (Caplan, 1999) and complex B, called 
the 'p23' complex (Caplan, 1999), are both involved in the maturation of steroid 
hormone receptors. Complex C, containing p5 O 37 , is involved in the folding and 
activity of various protein kinases, whilst the function of complex D is at present 
unknown. This figure is reproduced and modified from Caplan, 1999. 
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thought not be involved with SHRs but with the correct folding of protein kinases. 
The function of the fourth complex found in S.cerevisiae containing Cpr7 and Cnsl 
is not well understood but Cpr7 has been shown to play a role in the maturation of 
glucocorticoid receptors (Pauli and Mahowald, 1990). 
Hsp90 binds to several of its cochaperones at its C-terminal dimerisation domain 
(Young et al., 1998; Carrello, 1999). All of the cochaperones that bind in this region, 
except Cdc3 7, contain tetratricopeptide repeat sequences (TPR) that mediate their 
association in a competitive manner with Hsp90 (OwensGrillo etal., 1996). 
Although Cdc37 does not contain TPR sequences, it also appears to competitively 
bind Hsp90 at a site adjacent to, although distinct from, the binding site for TPR-
containing proteins (Silverstein et al., 1998). This competitivity between 
cochaperones is unlikely to be the only factor in complex assembly, as this might 
also depend on the nucleotide state of Hsp90 and the presence of other 
cochaperones. 
1.5.3 Steroid hormone receptors and Hsp90 
Steroid hormone receptors (SHRs) are soluble intracellular proteins that shuttle 
between the cytosol and the nucleus. SHRs are the best studied in vivo substrates of 
Hsp90 (Pratt and Toft, 1997). This interaction occurs only in the absence of steroid 
hormones; the addition of hormones causes dissociation of the Hsp90/SHR complex 
and dimerisation of the receptors, allowing them to enter the nucleus and bind 
specific DNA sequences, thus regulating transcription (Louvion etal., 1996). 
Genetic experiments in a heterologous system have demonstrated that Hsp90 is 
required to maintain receptors in an inactive but activatable state in the absence of 
hormone (Xu and Lindquist, 1993; Bohen and Yamamoto, 1994). 
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Both the 'Hop' complex and the 'p23' complex have been found to be associated 
with SHRs but the exact mechanisms are not clearly understood. Sequential passage 
through at least both of these two Hsp90 multicomponent complexes are necessary 
to keep SHRs competent for hormone binding and subsequent activation (Caplan, 
1999). The unstable 'Hop' complex is believed to bind the SHR initially and then 
subsequently, the stable mature complex Hsp90/SHR/p23 complex is formed. The 
intermediate stages of this transition are unclear. 
1.5.4 Protein kinases and Hsp90 
Hsp90 has been found in complexes with a number of protein kinases including 
several CDKs (Hunter and Poon, 1997). In most of the complexes formed between 
protein kinases and Hsp90, a cochaperone, p50, has also been found to be present. 
It has recently been shown that p50 is actually a mammalian homologue of Cdc37 
(Perdew et al., 1997), however, this was unknown at the time most of the work 
described in this section was carried out. 
Several independent lines of evidence link an Hsp90/p50 complex with kinases of 
unrelated signalling pathways, including two examples which are discussed here. 
These studies have shown that this complex is found associated with newly 
synthesised and inactive forms of Src homologues (Brugge etal., 1981; Brugge, 1986) 
and Raf-1 (Stancato et al., 1993) in fibroblasts. However, active forms of Raf-1 and 
src homologues found at the cell membrane lack this chaperone complex. 
v-Src is a membrane-associated protein-tyrosine kinase encoded by Rous sarcoma 
virus (RSV) and had been shown previously to associate with a Hsp90/p50 complex 
in chicken fibroblasts (Brugge et al., 1981; Brugge, 1986; Oppermann etal., 1981). 
Ectopic expression of v-Src in wild-type S. cerevisiae causes rapid cell death with 
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associated disruption of the cell cycle, due to abnormal protein phosphorylation on 
tyrosine residues (Boschelli et al., 1993). However, mutations in CDC37 suppress 
the lethality resulting from v-Src expression, apparently through kinase 
destabilisation (Dey et al., 1996). In chicken fibroblasts, newly synthesised v-Src 
remains complexed with Cdc37 and Hsp90 in the cytoplasm until it is translocated to 
the cytoplasmic membranes (Courtneidge and Bishop, 1982; Brugge et al., 1983). 
When bound to Hsp90/Cdc37 complexes, v-Src was shown to be 
hypophosphorylated and lack protein kinase activity. However, after dissociation 
from the complex, v-Src was shown to be phosphorylated on tyrosine and serine 
residues, to have protein kinase activity and to be associated with membrane 
fractions. 
It is interesting, however, that Hsp90/Cdc37 complexes have not been found with the 
v-Src cellular homologue, c-Src. There are two very different reasons as to why this 
could be: either because the interaction of Hsp90/Cdc37 complexes with v-Src could 
represent a nonphysiological relationship or possibly because mutant protein kinases 
contain a larger fraction of misfolded protein and therefore are better targets for 
Hsp90/Cdc37 association. The Hsp90/Cdc37 complex has also been detected in 
association with three other oncogenic protein-tyrosine kinases, v-Yes (Adkins et al., 
1982), v-Fps (Lipsich et al., 1982) and v-Fgr (Ziemiecki, 1986). 
Raf-1 is another protein kinase that interacts with the Hsp90/Cdc37 complex 
(Stancato et al., 1993; Wartmann and Davis, 1994). It is a serine/threonine protein 
kinase which is normally involved in activating the MAP kinase kinase, Mek, thus 
playing an important role in mitogenic signal transduction. It has also been shown to 
be directly activated by the potent oncoprotein Ras (Ahn, 1993). Unlike the case of 
c-Src, both v-Raf and its cellular analogue c-Raf have been demonstrated to interact 
stably with Hsp90/Cdc37 complexes (Stancato et al., 1993; Wartmann and Davis, 
1994). Raf activation by Ras involves the translocation of the Raf/Hsp90/Cdc37 
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complex to the cell membrane and only membrane-bound Raf exhibits protein kinase 
activity (Wartmann and Davis, 1994). This work also showed that although it is 
predominantly cytosolic, c-Raf also undergoes trafficking to the plasma membrane, 
and only after translocation to membrane sites is its kinase activity stimulated. 
1.6 Cdc37 and its role in the cell cycle with CDKs 
1.6.1 The identification of Cdc37p in S.cerevisiae 
CDC3 7 is an essential gene in S. cerevisiae and is required for passage through the 
GI phase of the cell cycle (Gerber etal., 1995). It was first identified through a 
screen which selected for temperature-sensitive mutations that cause cell cycle arrest 
in G  at Start (Reed, 1980b), the point at which the cell becomes committed to the 
cell division cycle (Hereford and Hartwell, 1974; Johnston etal., 1977; Hartwell and 
Unger, 1977). Cells also arrest in Gl if treated with mating pheromone, or are 
starved of nitrogen, allowing exit from the mitotic cell cycle. Four genes were 
identified in which mutations caused this characteristic arrest at Start: CDC28, 
CDC36, CDC37 and CDC39 (Breter etal., 1983; Ferguson etal., 1986). Mutations 
in CDC36 and CDC39 result in constitutive activation of the mating pheromone 
pathway which in turn leads to GI arrest (Neiman et al., 1990). In contrast, CDC28 
is known to be directly involved in the cell cycle (Forsburg and Nurse, 1991; Reed, 
1992; Nasmyth, 1993). 
The first clue that S. cerevisiae Cdc3 7p was involved in the function of CDKs was 
the discovery that the G  arrest in the cdc371ts  mutant is accompanied by a decrease 
in the kinase activity of Cdc28. This was shown to be due to the lack of association 
of Cdc28 with the GI cyclin C1n2 (Gerber et al., 1995), which could account for the 
defect in progression from GI to S phase in cdc371ts  cells. Also in these cells, the 
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kinase activity of Cdc28 associated with the mitotic cyclin C1b2 was also shown to 
be much lower. These results indicated that Cdc37 might play a role in regulating 
CDK activity in GI and G2 by somehow regulating the association between Cdc28 
and the cyclins. This evidence was supported by work carried out with the 
D. melanogaster homologue of CDC3 7, in which mutations were shown to 
dominantly enhance mutations in the cdc2 gene, the closest homologue of mammalian 
Cdkl (Cutforth and Rubin, 1994). 
1.6.2 The role of mammalian Cdc37p homologues with CDKs 
In mammalian cells, the Cdks 4 and 6 associate with D-type cyclins and are involved 
in the cell cycle at the GO/G1 transition and probably at the GUS phase transition 
(Nigg, 1995). At the same time as the S. cerevisiae work described in the previous 
section (1.6. 1) was going on, work on mammalian systems indicated that the 
assembly of these cyclin D-Cdk4/6 complexes was thought to require additional 
factors, partly due to the fact that the complexes were much more difficult to 
produce in vitro than other active complexes such as cyclin-Cdkl or cyclin-Cdk2 
complexes. When cells are stimulated with growth factors to enter the cell cycle from 
quiescence (GO), cyclin D and Cdk4 are synthesised and assemble into cyclin D-
Cdk4 complexes in mid-GI (Matsushime et al., 1994). However, when both cyclin 
D and Cdk4 are ectopically expressed in quiescent cells, cyclin D-Cdk4 complexes 
are not formed. It has since been shown that assembly of these complexes does 
indeed require a mitogen-dependent step that is independent of CAK function (Kato 
etal., 1994; Matsuoka etal., 1994). 
When a mammalian homologue of Cdc37p was found to associate directly in vitro 
with the mammalian kinases Cdk4 and Cdk6 (Stepanova et al., 1996), it began to be 
implicated as an additional factor for cyclin D-Cdk4/6 assembly. Furthermore, by 
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immunoprecipitation, Cdc37 was found to interact with Cdk4 in vivo and the 
immunoprecipitation results have been confirmed with the yeast-two hybrid system 
(Lamphere etal., 1997). Since Cdk4 had also been found to associate with Hsp90 
(Stepanova etal., 1996; Dai etal., 1996) and Cdc37 (p50 at the time), and Hsp90 had 
been shown to colocalise in the cytoplasm (Perdew and Whitelaw, 1991; Whitelaw et 
al., 1991), it was considered that this was all part of the same complex. This 
hypothesis was strengthened by the fact that Hsp90 could only associate with Cdk4 
when Cdc37 was present (Stepanova et al., 1996), suggesting that Cdc37 is a 
targeting subunit of Hsp90 which somehow directs it to and mediates its interactions 
with the protein kinases that require it. Therefore, the association of both Hsp90 
and Cdc37 with Cdk4 can be explained by the interaction of Cdk4 with the Hsp90-
Cdc37 complex. It is interesting to note, however, that no cyclin D was present in 
Cdc37 immune complexes. Based on gel-filtration analysis, there were two 
populations of Cdk4, one containing cyclin D, and the other as part of a high 
molecular weight complex (-450 kDa) containing Cdc37 and Hsp90 but no cyclin D 
(Stepanova etal., 1996). Cdk4 has been found in both the nucleus and the 
cytoplasm, though never in monomeric form, whereas Cdk4/cyclin D complexes are 
mainly located in the nucleus (Whitelaw et al., 199 1). Furthermore, Cdc3 7 has been 
shown to enhance the binding of cyclin D to Cdk4 (Dai et al., 1996). Together, these 
observations suggest that a Cdc37/Hsp9O complex may play a role in the assembly 
or activation of cyclin D-Cdk4 complexes, possibly by being required for 
stabilisation of newly-synthesised monomeric Cdk4, 'holding' it in a state in which it 
is able to bind its cyclin partner. 
Although there is a considerable amount of interest in Cdk4/cyclin Dl complexes 
now that it has been shown that they seem to play a role in tumorigenesis (Hall and 
Peters, 1996), much less is known about the regulation of Cdk6/cyclin D complexes. 
Some headway has been made since elevated Cdk6 activity was detected in squamous 
cell carcinoma cell lines, suggesting that deregulation of Cdk6 activity may play a role 
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in the onset of some tumours (Timmerman et al., 1997). Gel filtration 
chromatography has shown that Cdk6 exists in at least three forms in T-cells 
(Mahony et al., 1998). The most abundant form was as part of a complex (-450 
kDa) which was shown to contain both Hsp90 and Cdc37 and was present in 
cytoplasmic extracts but not in nuclear extracts. The second most abundant form 
was found to be monomeric Cdk6 and was found in both the nucleus and cytoplasm. 
The third and perhaps surprisingly least abundant Cdk6 complex was found to 
contain cyclin D and again, these complexes were found in both the nucleus and the 
cytoplasm. However, only Cdk6 that was complexed to cyclin D was active, and 
furthermore, Cdk6 kinase activity was largely confined to the nuclear extracts. 
The interactions between Cdk4 and Cdk6 with Hsp90/Cdc37 complexes are 
strikingly similar. The Cdk/Hsp90/Cdc37 complexes exist predominantly in the 
cytoplasm where the kinase activity is not detected and are not found in the nucleus 
where the kinase activity has been shown to exist. From these observations, it seems 
likely that Hsp90/Cdc37 complexes are required to bind and stabilise newly 
synthesised Cdk4/6 in monomeric form. 
The investigations of Cdc37 with the mammalian cell cycle CDKs, Cdk4 and Cdk6, 
and also with S. cerevisiae Cdc28 indicate that it is crucial in cell cycle regulation. It 
is interesting to note, however, that whilst physical interactions between Cdc37 and 
both Cdk4 and Cdk6 have been demonstrated, no evidence of binding between Cdc37 
and Cdc28 has yet been shown. 
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1.7 The genetic interactions of S.cerevisiae CDC37 with other 
protein kinases 
Cdc37 has been found to interact genetically with a number of genes encoding other 
kinases with seemingly diverse biological functions, examples of which are described 
here. The S. cerevisiae cdc3 7-1 mutant was used to investigate a S. cerevisiae 
homologue of mammalian mitogen-activated protein (MAP) kinase, FUS31DAC2 
protein kinase (Fujimura, 1994). Since the FUS31DAC2 kinase controls the activity 
of G 1 cyclins (Peter et al., 1993; Tyers and Futcher, 1993), it was investigated for 
interactions with the CDC28, CDC36, CDC37, or CDC39 gene products in GI 
progression or in the pheromone response pathway. FUS31DAC2 was shown to be 
required for the G 1 arrest of the cell cycle caused by the cdc3 7 mutation but not for 
the similar Gi arrest caused by the cdc28 mutation (Fujimura, 1994). These data 
suggest that either CDC37 and FUS31DAC2 regulate CDC28 positively and 
negatively, respectively, or that CDC37 negatively regulates FUS3/DAC2, which 
controls CDC28 for GI progression. 
Another genetic interaction of CDC3 7 in S. cerevisiae is that with the essential 
protein kinase gene MPS1, which is required for spindle pole body (SPB) duplication 
and for the mitotic spindle assembly checkpoint (Schutz et al., 1997). CDC3 7 was 
identified as a multicopy suppressor of the restrictive phenotype of the mpsl-]'5 
mutant and synthetic lethal interactions were shown to occur between mpsl and 
cdc37 alleles. The kinase activity of Mpslp was also shown to be diminished in the 
cdc37-1'3 mutant. 
Finally, a genetic interaction in S.cerevisiae has also been described between CDC37 
and JUN28, which encodes a putative CDK sharing 38% homology with Cdc28p but 
does not appear to be involved in the cell cycle (Valay etal., 1995). Instead, Kin28 
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has since been shown to be involved in the recruitment of mRNA processing 
machinery to RNA polymerase II (Rodriguez et al., 2000). 
1.8 Structure of Cdc37 in relation to its function 
Little is known about the structure of Cdc37 and how it relates to its function. It has 
been shown that the interaction of Cdc3 7 with Raf- 1 occurs via the N-terminal half 
of Cdc37 (Grammatikakis et al., 1999).. This work also suggested that the interaction 
of Cdc37 with Hsp90 occurs via the C-terminal half of Cdc37. The interpretation of 
these results propose that the highly conserved N-terminus of Cdc3 7 is required for 
interaction with the target protein kinase, whilst the less conserved C-terminus is 
involved in the association with the Hsp90 dimer. 
1.9 The physiological roles of Cdc37 
Even though there has been considerable analysis of Cdc37, its precise biochemical 
function is still largely unknown. There are many questions that remain unanswered 
and need to be addressed before the function of Cdc37 is elucidated in full. It is 
widely believed that Cdc37 acts as a targeting subunit for Hsp90 and that together 
the Hsp90/Cdc37 complex somehow aids in the folding of newly translated protein 
kinases and/or regulates their activity. These kinases include specific CDKs, which 
explains the cell cycle role of Cdc37 and the means by which it was first isolated in 
S. cerevisiae. It will be interesting to find out exactly what role it plays in the overall 
system and how it recognises monomeric kinases, or if indeed its function is limited 
to protein kinases. Fig. 1.5 shows the genetical and physical interactions that have 
been identified with various protein kinases, Cdc37 and Hsp90. 
9.1 
There is limited evidence that Cdc37 acts as a chaperone in its own right, so that as 
well as acting as an accessory factor for Hsp90, Cdc37 itself may perform a protein 
folding function similar to Hsp90 (Kimura etal., 1997). Other investigations have 
implicated Cdc37 in signal transduction processes other than regulation of protein 
kinases, such as steroid hormone receptor activation (Fliss et al., 1997). However, it 
does seem possible that Cdc37 has a targeting function, perhaps signalling transport 
to the plasma membrane such as in the cases with Raf and v-Src. 
1.10 Finding an S.pombe homologue of CDC37 
The principal aims of this project were to identify, clone and characterise any 
homologues of CDC37 in S. pombe. As described above, CDC37 homologues have 
been isolated from a variety of species and, given its essential function in CDK 
activity in S. cerevisiae, it seemed probable that at least one similar homologue would 
exist in S. pombe. Investigating for the presence of this gene or genes is interesting 
because it seems that Cdc37 in all species plays an important role in regulating CDK 
activity, so it may be that it is also important for the cell cycle in S. pombe via 
regulation of central kinases, an area which our lab has been interested in for some 
time. Also, examining Cdc37 in another system, such as S.pombe, is important for 
several reasons: firstly, by virtue of the way S.pombe grows and divides, the system 
is amenable to genetic and cytological techniques that are not possible in other 
systems. Also, due to fundamental differences in the cell cycle of S.pombe compared 
to that in, for example, S. cerevisiae, Drosophila and mammalian cells, studies of the 
effect on the cell cycle in S.pombe are extremely interesting. In particular, in 
S. cerevisiae, the major cell cycle control exists in G1, whereas in S.pombe, the main 
control is during G2. Therefore, of immediate interest would be whether Cdc37 
function is mainly involved in Gi, as in S.cerevisiae and mammalian systems, or 















Fig 1.5 Interactions between Cdc37, Hsp90 and various protein kinases 
Shown are the physical and genetical interactions found between Cdc37, Hsp90 and 
various protein kinases. Kinases shown in bold type indicate physical interactions 
with the chaperones and plain type show genetic interactions. This figure is 
reproduced and modified from a combination of diagrams from Hunter and Poon, 
1997 and Stepanova etal., 1997. 
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Chapter 2 
Materials and Methods 
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2.1 Materials and Reagents 
2.1.1 Chemicals 
All chemicals were of molecular biology grade, supplied by the Sigma-Aldrich 
Company Ltd., Dorset, UK, except where otherwise stated. 
2.1.2 Molecular biology reagents 
Amersham, Little Chalfont, Bucks, UK 
32P-labelled dCTP; Hybond-N nylon hybridisation transfer membrane; ECLTM 
detection kit; Hyperfi1mTMECLTM chemiluminescent film 
BioRad Laboratories Ltd., Hertfordshire, UK 
Muta-Geneo Phagemid In Vitro Mutagenesis Kit (Version 2); PVDF transfer 
membrane 
Boehringer Mannheim, Lewes, Sussex, UK 
Expand1M High Fidelity PCR polymerase mix; Klenow DNA polymerase; dNTPs 
Clontech Laboratories Inc., La Jolla, CA 
Herring testes carrier DNA 
Diagnostics Scotland, Edinburgh, UK 
HRP sheep anti-mouse IgG; HRP donkey anti-rabbit IgG 
GIBCO BRL, Paisley, UK 
1 kb DNA ladder; 0.24-9.5 kb RNA ladder 
New England Biolabs (UK) Ltd., Hertfordshire, UK 
Various restriction endonucleases; Calf Intestinal Alkaline Phosphatase 
PE Applied Biosystems, Perkin Elmer, Warrington, UK 
dRhodamine Terminator Cycle DNA Sequencing kit 
Pharmacia Biotech, St. Albans, UK 
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NICKTM Sephadex G-50 Columns; Hexadeoxyribonucleotides 
Promega Corporation UK, Southampton, UK 
Various restriction endonucleases; T4 DNA ligase; Taq DNA polymerase; PCR 
cloning vectors pGEM-T and pGEM-T Easy 
Oiagen Ltd., Dorking, Surrey, UK 
QlAquick Gel Extraction kit 
Sigma-Aldrich Company Ltd., Dorset, UK 
Acid-washed glass beads; Salmon sperm DNA 
Stratagene, La Jolla, CA 
QuikChangeTM Site-Directed Mutagenesis kit 
2.1.3 Deoxyoligonucleotide synthesis 
Synthesis of all oligonucleotides was carried out by Genosys Biotechnologies 
(Europe) Ltd., Cambridgeshire, UK. 
2.2 Nucleic acid manipulation protocols 
2.2.1 General techniques 
2.2.1a Phenol/chloroform extraction 
Proteins were removed from nucleic acid preparations by extraction with phenol. An 
equal volume of phenol: chloroform: isoamyl alcohol (25:24:1) was added to the 
preparation, vortexed for 1 min and then the phases were separated by centrifugation 
at 14,000 rpm. The upper, aqueous layer containing the nucleic acid was removed 
and recovered by precipitation. 
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2.2.1b Ethanol precipitation 
Nucleic acids were precipitated from solution by adding 0.1 vol of 3 M NaOAc, pH 
5.2 and 2.5 vol of absolute ethanol. The solution was mixed by vortexing, incubated 
for 15 min on ice and the DNA recovered by centrifugation at 14,000 rpm for 10 mm. 
The pellet was washed in 70% ethanol, air-dried and then dissolved in an appropriate 
volume of distilled water or TE buffer (10 mM Tris-HC1, pH 7.0; 1 mM EDTA). 
2.2.1c Quantification 
The amount and quality of DNA or RNA was assayed by measuring the absorbance 
of the preparations at 260 nm and 280 nm. The reading at 260 rim allowed 
calculation of the concentration of nucleic acid in the sample. An A 260 of 1 
corresponded to a preparation containing approximately 50 jig/ml of double stranded 
DNA or 40 p.g/ml of single stranded DNA or RNA. The ratio between the readings 
at 260 nm and 280 nm provided an estimate of the purity of the nucleic acid. Pure 
preparations of DNA and RNA have ratios of 1.8 and 2.0, respectively. Any ratios 
less than these values indicate protein and/or phenol contamination of the sample. 
2.2.2. Cloning in plasmid DNA vectors 
2.2.2a Restriction enzyme digestion 
Digestion of DNA with restriction enzymes was carried out according to the 
manufacturers' instructions. The DNA to be treated was incubated at 37°C (unless 
otherwise instructed) with the restriction enzyme, in the appropriate buffer and 100 
p.g/ml BSA (if instructed) for 1-16 hr. Often the DNA was treated with more than 
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one enzyme. If the conditions were compatible then the two enzymes were added 
together; where the conditions were incompatible the digests were performed 
sequentially, with a phenol extraction/ethanol precipitation step in between. 
2.2.2b Dephosphorylation of vector 5'-ends 
Where the cloning step only required digestion with one restriction enzyme, the 
vector DNA was phenol extracted/ethanol precipitated and treated with Calf 
Intestinal Alkaline Phosphatase (New England Biolabs) according to the instructions. 
The DNA to be treated was incubated with the ClAP in a final volume of 100 41 at 
37°C for 30 mm. After treatment, the DNA was phenol extracted/ethanol 
precipitated before ligation. 
2.2.2c Ligation 
Concentrations of vector and insert DNA were estimated by electrophoresis and 
comparison with DNA molecular weight markers of known concentration. A 
vector:insert molar mass ratio of between 1:1 and 1:3 was used in most cases and was 
found to work well. The molar mass ratio for DNA molecules was estimated using 
the following formula: [ng vector x insert size (kb)/ vector size (kb)] x molar ratio of 
insert = ng of vector required. Individual ligation reactions were set up in a final 
volume of 10 pi and carried out according to the T4 DNA ligase (Promega) 
manufacturers' protocol. The ligation reactions were incubated for 16 hr at 16°C for 
cohesive termini and for 16 hr at 25°C for blunt-ended termini. 
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2.2.3 Agarose gel electrophoresis of DNA 
Agarose gels of 0.5%-1 .5% were used depending on the size of the DNA that was 
being analysed. An appropriate amount of agarose (electrophoresis grade, Boehringer 
Mannheim) was dissolved in lx TBE buffer (10 mlvi Tris-HC1, pH 7.0; 90 mlvi 
Boric acid; 1mM EDTA) by boiling. The solution was allowed to cool to —50°C 
before adding ethidium bromide to a fmal concentration of 0.5 j.tg/ml (except where 
the gel was to be blotted) and pouring. 0.2 vol of 5x DNA loading buffer (33% 
glycerol; 0.25% bromophenol blue; 0.25% xylene cyanol) was added to each sample 
and once loaded, gels were run with an applied voltage of 4-8 V/cm in lx TBE. 
Following electrophoresis, the DNA was visualised with an ultra-violet 
transilluminator (Ultra-Violet Products, Inc.) and photographs taken with a UVP 
DOCITrM camera (Ultra-Violet Products, Inc.). 
2.2.4 Gel purification of DNA fragments 
DNA fragments were isolated using QIAGEN's QlAquick gel extraction kit, 
following the manufacturers' instructions precisely. The purified DNA was 
resuspended in an appropriate volume of distilled water or TE buffer (10 mM Tris-
HC1, pH 7.0; 1 mM EDTA). 
2.2.5 Denaturing agarose gel electrophoresis of RNA 
Agarose gels of 1% were used for all RNA gels. An appropriate amount of agarose 
(electrophoresis grade, Boebringer Mannheim) was dissolved in lx FRB 
(formaldehyde running buffer: 20 mM MOPS; 5 mlvi NaOAc; 1 mlvi EDTA). The 
solution was allowed to cool to —50 °C before adding 37% (v/v) formaldehyde to a 
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final concentration of 2.2 M and pouring. Each sample was incubated at 65°C for 15 
min in an equal volume of RNA loading buffer (50% (v/v) formamide; lx FRB; 2.2 M 
formaldehyde; 0.01% (w/v) bromophenol blue) and once loaded, gels were run with 
an applied voltage of 5 V/cm in lx FRB. Following electrophoresis, the gels were 
rinsed briefly in DEPC-treated distilled water. They were then stained for 30-45 mm 
in 0.5 p.g/ml ethidium bromide, destained in distilled water for 10 min and visualised 
as previously described. 
2.2.6 Filter hybridisation of DNA 
2.2.6a Southern blotting 
After restriction digestion and separation of the DNA by agarose gel electrophoresis 
(no ethidium bromide), the gel was stained for 30-45 min in 0.5 pg/ml ethidium 
bromide, destained in distilled water for 10 mm, and visualised as previously 
described. The DNA was denatured by soaking the gel in 1.5 M NaCl; 0.5 M NaOH 
for 30 min with gentle agitation. The gel was then rinsed briefly in distilled water and 
neutralised by soaking it in 0.5 M Tris, pH 7.2; 1.5 M NaCl; 0.001 M EDTA for 30 
min with gentle agitation. The transfer of DNA to the nylon filters (Hybond-N, 
Amersham) was carried out as described in Sambrook et al., 1989. After transfer, the 
DNA was crosslinked to the filters using UV-light in a Stratalinker (Stratagene), 
according to the manufacturers' instructions. Finally, the filters were baked at 80 °C 
for 2 hr in a vacuum oven (Townson & Mercer). 
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2.2.6b Random-primed labelling of DNA probes 
10-50 ng of fragment DNA to be used as probe was diluted in distilled water to 11 gil. 
The DNA was incubated at 100°C for 5 mm, then cooled rapidly on ice. 5 jtl of Rxn-
C (250 mM Tris HC1, pH 8.0; 25 MM  MgCl2 ; 50 mM 3-mercaptoethanol; 100 .tM 
each dATP, dGTP, dTTP; 1 M HEPES, pH 6.6; 2.7 OD units 
hexadeoxyribonucleotides (Pharmacia Biotech) in TE buffer (10 mM Tris-HC1, pH 
7.0; 1 mM EDTA)) was added, along with 1 jtl of Kienow enzyme (NEB) and 3 p.! 
(30 mCi) of [a- 32P] dCTP (Amersham). The contents were mixed thoroughly and 
incubated at 37°C for 30 mm. NICKTM Sephadex G-50 columns (Pharmacia Biotech) 
were used to remove unincorporated 32P, following the manufacturers' instructions 
precisely. The labelled probe was eluted in 400 pi of TE buffer (10 mM Tris-HC1, 
pH 7.0; 1 mM EDTA). 
2.2.6c Hybridisation of filters 
The filter was pre-hybridised for 1 hr at 65°C in hybridisation buffer (7.5 ml 20x SSC 
(3 M NaCl; 300 mM NaOAc); 2.5 ml 50x Denhardt's solution (5% (w/v) FicolI, 5% 
(w/v) polyvinylpyrollidine, 5% (w/v) BSA); 625 p.1 20% (w/v) SDS; 1 ml single-
stranded salmon sperm DNA (10 mg/ml, Sigma); 10.25 ml distilled water) in a rolling 
bottle hybridisation oven (Techne). The labelled probe was then added and allowed 
to hybridise for 16 hr at 65°C. Washing conditions were as follows: 
2x SSC; 0.1% SDS; 65°C; 2x 15 mm 
	
low stringency 
2x SSC; 0.1% SDS; 65°C; lx 30 mm 
	
moderate stringency 
0.2x SSC; 0.1% SDS; 65°C; lx 30mm 
	
high stringency 
After the final wash, the filters were wrapped in SaranWrap and autoradiographed. 
2.2.6d Autoradiography 
The wrapped filters were placed in an X-ray film cassette in contact with Kodak MS 
film and with an intensifying screen. The cassettes were incubated at -70 °C for a 
sufficient exposure time (between 1 hr and 16 hr) and then the films were developed 
in a Konica SRX-1O1A automatic developer for analysis. 
2.2.7 Filter hybridisation of RNA 
2.2.7a Northern blotting 
After denaturation and separation of the RNA by agarose gel, the gel was rinsed 
briefly in DEPC-treated distilled water for 5 min with shaking to remove excess 
formaldehyde and agarose. The transfer of denatured RNA to the nylon filters 
(Hybond-N, Amersham) was carried out as described in Sambrook et al., 1989. After 
transfer, the RNA was crosslinked to the filters using UV-light in a Stratalinker 
(Stratagene), according to the manufacturers' instructions. Finally, the filters were 
baked at 80°C for 2 hr in a vacuum oven (Townson & Mercer). 
2.2.7b Random-primed labelling of DNA probes 
DNA probes were used and were labelled as described for Southern blotting. 
2.2.7c Hybridisation of filters 
Labelled DNA probes were hybridised to filters as described for Southern blotting. 
2.2.7d Autoradiography 
Autoradiography was carried out as described for Southern blotting. 
2.2.8 Polymerase Chain Reaction (PCR) 
PCR (Saiki etal., 1985; Mullis et al., 1986) was used routinely in this project for 
amplification of specific regions of DNA for cloning. It was also used as a 
convenient tool for analysing transformants after cloning experiments (Gussow and 
Clackson, 1989), and for creating suitable restriction endonuclease sites to aid the 
cloning of specific DNA regions (Clackson etal., 1994). 
Every PCR experiment is unique and is differentiated by differences in thermal cycle 
conditions. The thermal cycle can be divided into three distinct steps: 
Denaturing step 
The reaction mixture was incubated at 95°C to denature the double stranded 
template. 
Annealing step 
The annealing temperature varies with each reaction depending on the melting point 
values of the primers in a specific reaction. Generally, the annealing temperature 
used was 5°C below the lowest melting point of the two primers. The melting point 
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of each primer was calculated using the following formula (Bolton and McCarthy, 
1962): 
Tm = 81.5 + 16.6(log 10[Na] + 41.0 (fraction C + G) - (600/N) 
where N = oligonucleotide length in bp 
(iii) Extension step 
The reaction mixture was incubated at the optimum temperature for the thermostable 
polymerase being used in the reaction. For this project two different PCR enzymes 
were used: Taq polymerase (Promega) where the fidelity of the product was not 
important, or Expand 1M High Fidelity (Boehringer Mannheim), which is a mixture of 
Taq and Pwo DNA polymerases, where the accuracy of the product sequence was 
important. 
PCR amplification was carried out using 25-30 thermal cycles on a Hybaid 
'Touchdown' PCR thermal cycler. The reactions were set up as follows: 
Tag DNA polymerase Expand1M High 
Fidelity 
Template DNA 0.1 - 0.75 ig 0.1 - 0.75 p.g 
MgCl2 1.5 mM 1.5 mM (in buffer) 
1 Ox buffer 1 0i1 (Promega) 1 0il (Boebringer) 
dNTPs 200 	g 200 	g 
Forward primer 200 nmol 200 nmol 
Reverse primer 200 nmol 200 nmol 
Enzyme 3 units 1.5 units 
Distilled water up to 50 j.il up to 50 .il 
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In every PCR amplification the addition of the thermo stable polymerase was 
withheld until the reaction had been incubated at 94°C for 1 mm. After that, the 
incubation times at each step were then generally as follows: 
Denaturing (94°C) 	1 mm 
Annealing (40°C - 60°C) 	1 mm 
Extension (68°C - 72°C) 	1 min per kb to be amplified. 
The oligonucleotides that were used as primers for PCR in this project are shown in 
Table 2.1. Their use is described in detail within the relevant sections. 
2.2.9 In vitro site-directed mutagenesis 
2.2.9a Single stranded mutagenesis 
Mutagenesis was carried out on single stranded phagemid DNA using the Muta-
Gene® Phagemid In Vitro Mutagenesis Version 2 kit (BioRad), following the 
manufacturers' instructions precisely. Single stranded phagemid DNA was prepared 
as described elsewhere in this section (Section 2.4.5). The oligonucleotides that were 
used as primers for mutagenesis in this project are shown in Table 2.1. 
2.2.9b Double stranded mutagenesis 
Mutagenesis was carried out on double stranded plasmid DNA using the 
QuikChangerM Site-Directed Mutagenesis kit (Stratagene), following the 
manufacturers' instructions precisely. The oligonucleotides that were used as 
primers for mutagenesis in this project are shown in Table 2.1. 
Table 2.1 Details of the oligonucleotides used as primers used for PCR and site-
directed mutagenesis 
PCR 
Oligo Sequence Length Direction T. Position 
(5 1 —*3 1 )  (Fig 3.1) 
PW3 AACATAAGGATCCGZAGG 21 bp Reverse 61.4 °C 680-9660 
AGA  
PW4 CGATGAATCGTAGGCTCT 21 bp Forward 63.0°C 601-621 
TGT  
PW5 CCGAATTCATATGGCAAT 28 bp Forward 70.6°C 1-18 
TGATTACAGC  
PW6 GCAGCCCGGGTTAAGACA 28 bp Reverse 75.1°C 1832—*1815 
ATTGAGGAAT  
PW7 CGTACCAGAAGGAATTCC 22 bp Forward 66.3 °C -956-9-935 
CATG  
PW8 GATCAAGCTTGCACCTAC 28 bp Reverse 72.4 °C -149—*-132 
CTTATGCGAA  
PW9 GATCAAGCTTCCATACCT 28 bp Forward 68.9°C 1943—*1959 
TGTGTGTACC  
PW10 GATGACTCGAGCAGAGGG 24 bp Reverse 69.1°C 2723-92746 
TTGTTC  
PW13 GTGCTCGAAGACGACTGA 18 bp 	1 Forward 60.3 °C -1065---1048 
RB1 GCATACATATAGCCAGTG 18 bp Reverse 50.9 °C - 
TG1 GCTATACCAAGCATACAA 26 bp Forward 64.4°C - 
TCAACTCC  
TG2 CGTATCTACCAACGATTT 23 bp Reverse 65.1°C - 
GACCC 
Mutagenesis 
Oligo Sequence Length Direction T. Position 
(5 1 -31 )  (Fig 3.1) 
PW19 CATAAGCATGTGATGATA 18 bp Reverse 49.2 °C 750—*767 
PW20 TCGGACATAAGTATTATG 18 bp Reverse 47.6°C 1461-1478 
PW27 CTATTCCTCAATTGTCTT 44 bp Forward 86.5°C 1813—*1829 
GCGGCCGCTACCGAGCTC 
GAATTCCC  
PW28 GGGAATTCGAGCTCGGTA 44 bp Reverse 86.5 °C 1829-91813 
GCGGCCGCAAGACAATTG 
AGGAATAG  
The position of the oligonucleotides designed using the S.pombe cdc3 7+ sequence 
can be located using the sequence information given in Fig 3.1. For the PCR oligos, 
the non-annealing, engineered regions are shown in bold. For the mutagenic oligos, 
the mutagenic bases are shown in bold and sequences complimentary to vector 
sequence are in italic. 
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2.2.10 DNA sequencing 
Sequencing was performed on an ABI 377 automated sequencer after carrying out the 
reactions using the Taq FS Dye-terminator kit (PE Applied Biosystems), following 
the manufacturers' instructions precisely. For all sequencing reactions carried out in 
this project a Hybaid 'Touchdown' PCR thermal cycler was programmed with 25 of 
the following cycles: 96°C for 30 sec; 50°C for 15 sec; 60°C for 4 mm. 
2.3 Protein manipulation protocols 
2.3.1 Iminunoprecipitation 
Immunoprecipitation was carried out using a modified version of that described by 
Sambrook et al., 1989. For each incubation, 0.1 ml of extract (section 2.5. 10) was 
used. An appropriate amount of antibody in 0.4 ml of ice-cold NET-gel buffer (50 
mM Tris-HC1, pH 7.5; 150 mM NaCl; 0.1% Nonidet P-40; 1 mM EDTA, pH 8; 
0.25% gelatin; 0.02% NaN 3) was added to each extract, mixed and incubated on a 
rotating wheel at 4°C for 1 hr. For each extract, 2.5 mg of Protein A-Sepharose was 
weighed out and incubated in 1 ml of dH20 for 10 min on a rotating wheel at 4°C. 
The swollen Sepharose beads were collected at 14,000 rpm for 30 sec at 4 °C, 
resuspended in another 1 ml of dH20 and centrifuged again. Finally, the beads were 
resuspended in 1 ml of NET-gel buffer and collected at 14,000 rpm for 30 sec at 4°C. 
10 il of NET-gel buffer was added to the swollen Sepharose beads to create a 50/50 
Protein A-Sepharose/buffer mix and 20 jil of this was added to each extract. The 
mixture was incubated on a rotating wheel at 4 °C for 1 hr. The Sepharose beads were 
then centrifuged at 14,000 rpm for 30 sec at 4°C, resuspended in 1 ml of NET-gel 
buffer and incubated on a rotating wheel for 20 min at 4°C. The Sepharose beads 
were again collected by centrifugation at 14,000 rpm for 30 sec at 4°C, resuspended 
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in 1 ml of NET-gel buffer and incubated on a rotating wheel for 20 min at 4 °C. After 
another centrifugation at 14,000 rpm for 30 sec at 4 °C, the Sepharose beads were 
resuspended in 1 ml 10 mM Tris-HC1, pH 7.5; 0.1% NP-40 and incubated on a 
rotating wheel for a further 20 min at 4°C. The washed Sepharose beads were 
collected at 14,000 rpm for 30 sec at 4 °C and the final wash completely removed. 
Finally, the Sepharose pellet was resuspended in 20 j.il in lx SDS sample buffer (50 
mM Tris-HC1, pH 6.8; 100 mM DTT; 2% (w/v) SDS; 0.1% (w/v) bromophenol 
blue; 10% glycerol) before loading on an SDS-polyacrylamide gel for electrophoresis. 
2.3.2 SDS-polyacrylamide gel electrophoresis of proteins 
The electrophoresis of proteins followed the method of Laemmli, 1970, with minor 
modifications. SDS-polyacrylamide gels were poured using the BioRad Mini-
PROTEAN II system, following the manufacturers' instructions precisely. The 
12.5% resolving gel was poured between the glass plates of the gel apparatus and 
overlaid with deionised water, made up as shown below, in the order shown: 
Component 	 M1 
Distilled water 1.57 
1.5 M Tris-HC1, pH8.8 1.25 
10%(w/v)SDS 0.05 
30% acrylamide mix (Severn Biotech) 2.1 




After the resolving gel had polymerised, the overlay was removed and the stacking 
gel was poured over. Before the stacking gel polymerised, the comb was inserted to 
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allow the wells to form. The 4% stacking gel was prepared by assembling the 
following in the order shown: 
Component 	 M1 
Distilled water 	 1.525 
0.5 M Tris-HC1, pH6.8 	 0.625 
10%(w/v)SDS 	 0.025 
30% acrylamide mix (Severn Biotech) 	0.325 




The samples were denatured by heating at 100°C for 5 min in lx SDS sample buffer 
(50 mM Tris-HC1, pH 6.8; 100 mM DTT; 2% (w/v) SDS; 0.1% (w/v) bromophenol 
blue; 10% glycerol). Once the stacking gel had polymerised, the comb was carefully 
removed and the wells flushed first with deionised water and then with running 
buffer (25 mM Tris; 250 mM glycine, pH 8.3; 0.1% (w/v) SDS) to remove 
unpolymerised acrylamide. After heat denaturation, the samples were loaded and 
voltage applied to the gel at 8 V/cm until the dye front had moved into the stacking 
gel and then 15 V/cm until the dye front reached the bottom of the resolving gel. 
2.3.3 Staining SDS-polyacrylamide gels with Coomassie Brilliant Blue 
SDS-polyacrylamide gels were immersed in Coomassie dye (0.005% (w/v) 
Coomassie Brilliant Blue R250 in 45% (v/v) methanol; 10% (v/v) glacial acetic acid) 
for 4 hours at room temperature. The gels were then destained by immersing in 5% 
(v/v) methanol/7% (v/v) glacial acetic acid for 24 hr, changing the destaining solution 
every few hours. 
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2.3.4 Filter hybridisation of proteins 
2.3.4a Western blotting 
The transfer of proteins from a gel to a membrane was achieved by electrophoretic 
elution (Towbin etal., 1979). Semi-dry transfer was used for all blots in this study, 
using a BioRad Trans-Blot SD semi-dry blotter, following the manufacturers' 
instructions precisely. The gels were sandwiched between absorbent paper soaked in 
transfer buffer (48 mM Tris-HC1; 39 mM glycine; 20% (v/v) methanol; 0.0375% 
(w/v) SDS, pH 9.2) before being placed between electrodes, in contact with the 
PVDF membrane (BioRad). A current of 2.5 mA/sq. cm of gel was applied for 40 
mm, after which the blots were removed and stained to analyse transfer. 
2.3.4b Staining of membranes for total protein 
After electrophoretic transfer, PVDF membranes were stained in an aqueous solution 
of Ponceau S to reveal the transferred protein and to monitor blotting efficiency and 
completeness. A concentrated stock of Ponceau S was prepared (2% (w/v) Ponceau 
5 in 30% (w/v) trichloroacetic acid) which was diluted ten times in deionised water 
before immersion of the blots. The blots were allowed to stain for 5 min before being 
washed gently in deionised water to remove unbound dye. 
2.3.4c Blocking, washing and antibody incubations 
The blots were blocked by immersing in lx PBS (50 mM sodium phosphate, pH 7.4; 
150 mM NaCl) containing 0.25% Tween 20 and 5% (w/v) non-fat milk ("Marvel" 
powder) overnight with gentle overnight. After blocking, the blocking solution was 
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removed and the first antibody added, diluted to an appropriate concentration in lx 
PBS containing 0.05% Tween 20 and 1% Marvel. Incubation with the first antibody 
was for at least 1 hr at room temperature with gentle agitation. After this incubation, 
the first antibody was removed and the blots washed four times in large volumes of 
Ix PBS containing 0.5% Tween 20 for 5 min each wash. After washing, the second 
antibody was added; either horseradish peroxidase conjugated donkey anti-rabbit 
IgG, or donkey anti-mouse IgG (both from Diagnostics Scotland), diluted 1:1000 in 
the same buffer as for the first antibody. Incubations with the second antibodies 
were for 1 hr at room temperature, followed by extensive washing as before. 
2.3.4d Detection of immune complexes on membranes 
The horseradish peroxidase conjugated second antibodies were detected using an 
enhanced chemiluminescent reagent (ECLTM,  Amersham), following the 
manufacturers' instructions precisely. HyperfilmTMECLTM chemiluminescent film 
(Amersham) was used to reveal the bands and the films were developed in a Konica 
SRX- 101 A automatic developer. 
2.4 Manipulation and handling of Escherichia coli 
2.4.1 Escherichia coil strains used 
DH10B: F mcrA, (mrr-hsdRMS-mcrBC), p80dlacThM15, AlacX74, deoR, 
recAl, endAl, araD 139, E(ara, leu)7697, galU, galK, ?, rpsL, nupG. 
MV! 190: A(lac-proAB), thi, supE, E(sr1-recA)3 06: :Tn 1 0(tetr)  [F' :traD3 6, proAB, 
lac iZMl5]. 
CJ236: dut- 1, ung- 1, thi- 1, relA 1; pCJ 105 (Cm'). 
XL1-Blue: recAl, endAl, gyrA96, thi-1, hsdRl 7, supE44, re/Al, lac [F' proAB 
lac]qZiiMl 5Tnl 0(TetI)]c 
2.4.2 Media and growth conditions for Escherichia co/i 
2.4.2a Temperature for growth of Escherichia co/i 
Cells were grown at 37°C unless otherwise stated. Cell growth in liquid cultures was 
estimated by measurement of optical density at 600 nm on a Hitachi U-2000 
spectrophotometer. 
2.4.2b Media for growth of Escherichia co/i 
L-Broth (LB) 
E. coli strains were routinely grown in rich medium LB: 
Bacto-tryptone (Difco) 	10 g/l 
NaCl 	 lOg/I 
Yeast extract 	 5 g/l 
Glucose 	 1 g/l 
2x YT 
Bacto-peptone (Difco) 	16 g/l 
Yeast extract 	 10 g/l 
NaCl 	 5g/l 
For solid medium, 15 gil Bacto-agar (Difco) was added. 
2.4.2c Antibiotics 
Ampicillin 
The sodium salt was dissolved in distilled water at 30 mg/ml to make the stock 
solution. This was added to the media at a final concentration of between 25-100 
Chloramphenicol 
Solid chioramphenicol was dissolved in absolute ethanol at 34 mg/ml to make the 
stock solution. This was added to the media at a final concentration of between 15-
34 pg/mI. 
Kanamycin 
Kanamycin sulphate was dissolved in distilled water at 50 mg/ml to make the stock 
solution. This was added to the media at a final concentration of between 50-70 
pg/mi. 
All antibiotic stocks were stored in aliquots at -20°C and were added to autoclaved 
media cooled to —50°C. 
2.4.2d X-gal and IPTG for blue/white screening 
(i) X-gal (5-bromo-4-chloro-3-indo1yl-3-D-ga1actoside) 
A stock solution of X-gal was made up by adding it to dimethylformamide at 50 
mg/ml and stored at -20°C. It was added to autoclaved media, cooled to --50°C, at a 
final concentration of 40 jig/ml. 
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(ii) IPTG (isopropyl-3-D-thioga1actopyranoside) 
A stock solution of IPTG was made up by adding it to distilled water at a 
concentration of 0.1 M and stored at 4 °C. It was added to autoclaved media, cooled 
to -P50°C, at a final concentration of 0.1 mM. 
2.4.2e Storage of Escherichia coli 
Bacteria were stored on LB agar plates for periods up to 4 weeks at 4°C. Long term 
storage was in LB medium containing 20% (v/v) glycerol frozen at -70°C. Frozen 
bacteria were revived from long term storage by removing a small stab from the 
frozen culture and streaking out onto LB agar containing appropriate antibiotics. 
2.4.3 Transformation of Escherichia coil 
Competent Escherichia coli cells were prepared by a rubidium chloride procedure 
modified from a protocol described previously Hanahan, 1983. A single colony from 
an LB plate was used to inoculate 2.5 ml of LB medium and left to grow overnight at 
37°C with shaking. The entire overnight culture was then used to inoculate 250 ml of 
LB medium containing 20 MM  MgSO4 and left to grow at 37°C with shaking until 
the 0D600 reached 0.4-0.6. The cells were harvested by centrifugation at 6,000 rpm 
for 5 min at 4°C, resuspended in 0.4 vol of ice-cold TFB1 (30 mM K-acetate, 10 mm 
CaC12, 50 mlvi MnC12, 100 mM RbC1, 15% glycerol, pH 5.8) and incubated on ice 
for 5 mm. The cells were again harvested by centrifugation at 6,000 rpm for 5 mm 
and resuspended in TFB2 (10 mM PIPES; 75 mM CaC1 2; 10 mM RbCI; 15% 
glycerol; pH 6.5). The resuspended cells were incubated on ice for 15-60 min and 




The DNA to be transformed was incubated on ice with 200 .tl competent cells for 20 
mm. The mixture was then incubated at 42°C for 45 sec before being replaced on ice 
for 2 mm. 4501.d of LB was added, mixed gently, and the mixture incubated at 37°C 
with shaking for 1 hr. An appropriate amount of the transformation mixture was 
plated on selective medium and left to grow overnight at 37 0C. 
2.4.4 Isolation of plasmid DNA from Escherichia coli 
Plasmid DNA was isolated from transformants by the Alkaline Lysis method 
Sambrook et al., 1989. 1.5 ml of an overnight culture of the transformant was 
centrifuged at 14,000 rpm for 1 mm, the supernatant discarded, and the cell pellet 
was resuspended in 100 p1 of BDI buffer (10 mM Tris-HC1 pH 7.0; 1 mM EDTA). 
200 il of BDII solution (200 mM NaOH; 1% SDS) was added, the solution was 
mixed well and incubated on ice for 5 mm. 150 RI  of BDIII (3 M KOAc) was added, 
mixed well and centrifuged for 5 min at 14,000 rpm. The supernatant was transferred 
to a fresh tube and an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1) 
added. The phases were mixed by vortexing and then centrifuged at 14,000 rpm for 2 
mm. The upper, aqueous layer was transferred to a fresh tube and 1 ml of absolute 
ethanol was added. After vortexing, the solution was incubated on ice for 10 min to 
precipitate the DNA. The precipitated DNA was recovered by centrifugation at 
14,000 rpm for 10 mm, drained, air-dried, and resuspended in 50 Ri  of TE buffer (10 
mM Tris-HC1, pH 7.0; 1 mM EDTA) containing 10 gg/ml RNase A. 
The most commonly used procedure to analyse recombinants was to isolate the 
plasmid DNA from individual clones as described, and then identify the insert in the 
recombinant plasmid by restriction digestion and agarose gel electrophoresis. 
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2.4.5 Production of single-stranded DNA from Escherichia coli 
The plasmids pTZ 18 (Appendix IF) contain the fl origin of replication, so on 
infection with the helper phage M13K07, cells containing these plasmids will 
synthesise single-stranded DNA from this origin, which will then be released in the 
form of phage particles. 
A colony of E.coli strain CJ236 containing pTZ18.cdc37 was used to inoculate 5 ml 
LBCUA (LB plus 100 j.tg/ml ampicillin, 34 jig/ml chloramphenicol, and 0.25 jig/ml 
uridine) and grown overnight at 37°C. 0.5 ml of the overnight culture was used to 
inoculate 50 ml LBCU (no ampicillin) and was grown at 37 °C until slightly turbid. 
M13 K07 helper phage was added to a final concentration of lx 108  pfu/ml and 
incubated at 37°C with vigorous aeration for 90 mm. Kanamycin was then added to a 
fmal concentration of 70 jig/ml and culture was left overnight at 37 °C with vigorous 
aeration. The cells were then harvested twice at 8,000 rpm for 10 mm. 250 jig of 
RNase A was added to the resulting supernatant and incubated at room temperature 
for 30 mm. 0.25 vol of 3.5 M ammonium acetate/20% PEG-6,000 was added, mixed 
well and incubated on ice for 30 mm. The phagemids were then recovered by 
centrifugation at 12,000 rpm for 15 mm. The supernatant was discarded, the pellet 
drained well and then resuspended in 200 ji.l of high salt buffer (3 00 mM NaCl; 100 
mM Tris, pH 8.0; 1mM EDTA). The resuspended phagemids were chilled on ice for 
30 min and then centrifuged at 14,000 rpm for 2 min to remove insolubles. The 
supernatant was extracted twice with neutralised phenol, once with 
phenol:chloroform:isoamyl alcohol (25:24:1), and three times with 
chloroform:isoamyl alcohol (24:1). 0.1 vol of 7.8 M ammonium acetate and 2.5 vol 
of absolute ethanol was added, mixed and incubated at -70°C for 1 hr. The single-
stranded phagemid DNA was recovered by centrifugation at 12,000 rpm for 15 mm, 
the pellet washed with 70% ethanol and resuspended in 20 jil of TE buffer (10 mM 
Tris-HC1, pH 7.0; 1 mM EDTA). 
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2.5 Manipulation and handling of Schizosaccharomyces pombe 
2.5.1 Schizosaccharomyces pombe strains used 
ED665 ade6-M210 leul-32 ura4-D18 h 
ED668 ade6-M216 leul-32 ura4-D18 h 
ED836 cdc2-M26 leul-32 ura4-D18 h 
ED837 cdc2-130 ura4-D18 h 
ED838 cdc2-18 leul-32 ura4-D18 h 
ED839 cdc2-48 leul-32 ura4-D18 h 
ED840 cdc2-17 leul-32 ura4-D18 h 
ED841 cdc2-45 ura4-D18 h 
ED881 cdc2-33 leul-32 h 
ED908 wee]-50 leul-32 ura4-D18 h 
ED918 cdcl3-117 leul-32 ura4-294 h 
ED1049 leul-32 h 
ED1169 cdc2-L7 ura4-D18 h 
ED1340 swol-26 leul-32 ura4-D18 h 
ED1502 cdcl3-9 leul-32 h- 
2.5.2 Media and growth conditions for Schizosaccharomycespombe 
2.5.2a Temperature for growth of Schizosaccharomyces pombe 
Appropriate temperatures varying from 25°C to 37°C were used to grow the strains 
depending on their phenotype. 
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2.5.2b Media for growth of Schizosaccharomyces pombe 
Yeast Extract (YE) 
S.pombe strains were routinely grown in YE medium supplemented with adenine and 
uradil: 
Yeast extract (Difco) 	5 g/l 
Glucose 	 30g/l 
Adenine 	 75 mg/l 
Uracil 	 75 mg/l 
Edinburgh Minimal medium (EMM) 
S.pombe strains were selectively grown in EMM medium, a modification of EMM2 
(Mitchison, 1970, Nurse, 1975): 
Glucose 20 g/l 
KR phthalate 3 g/l 
Na2HPO4 1.8g/l 
NH4C1 5g/l 
NaSO4 100 mg/l 
CaC12 15 mg/i 
MgC12 lg/l 
Vitamins 1 ml 
Minerals 	 100 il 
Vitamins: 5 g inositol; 5 g nicotinic acid; 0.5 g calcium pantathenate; 5 g biotin; all 
dissolved in 500 ml distilled water. 
Minerals: 1 g H 3B03 ; 1.04 g MnSO4 .4 H20; 800 mg ZnSO4.7 H20; 400 mg FeC13 .6 
H20; 288 mg H2Mo04; 80 mg CuSO 4.5 H20; 2 g citric acid; 20 mg KI; all dissolved 
in 200 ml distilled water. 
55 
Amino acids were added to the EMM medium as required for each strain or omitted 
for selection. Leucine, adenine, uracil or histidine were added when appropriate at 75 
mg/mi. 
(iii) Malt Extract (ME) 
A nitrogen limiting medium ME consisting of 30 g/l malt extract was used to induce 
conjugation and sporulation. 
For solid medium, 20 g/l Bacto-agar (Difco) was added to either YE, EMvI or ME 
media. 
2.5.2c Phioxin B 
To check ploidy of cells, phioxin B was added to solid media to a final concentration 
of 20 tg/ml. Diploid cells die faster than haploid cells and accumulate the dye more 
quickly, and therefore can be differentiated by relative colour staining. 
2.5.2d Storage of Schizosaccharomyces pombe 
Strains were stored on solid media for periods up to 4 weeks at 4°C. Long term 
storage was in medium containing 30% (v/v) glycerol, frozen at -70 °C. Frozen 
strains were revived from long term storage by removing a small stab from the frozen 
culture and streaking out onto appropriate media. 
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2.5.3 Genetical analysis of Schizosaccharomyces pombe 
2.5.3a Crossing strains 
For crossing strains, standard genetical procedures were followed (Gutz etal., 1974; 
Kohli et al., 1977). Strains were crossed by mixing together fresh isolates of two cell 
types (mating types h and k) on the surface of an ME plate with a loopfui of sterile 
water. The mating mix was incubated at 25°C for 2-3 days to allow zygotes to form 
and sporulation to proceed. The progeny of the crosses were examined either by 
random spore analysis or by tetrad analysis. 
2.5.3b Random spore analysis 
A loopful of mating mix was suspended in 1 ml of 0.2% helicase (Suc d'Helix 
pomatia, Industrie Biologique, France) and incubated overnight at 35°C. The spore 
concentration was estimated using a haemocytometer and an appropriate dilution, to 
give about 200 viable spores per plate, was spread onto appropriate solid media. 
2.5.3c Tetrad analysis 
A loopful of mating mix was streaked onto a thin YE plate. Single asci were isolated 
using a fine glass needle attached to a Leitz micromanipulator and the plate was 
incubated at 20°C overnight to allow the asci walls to break down. The spores were 
then separated on the surface of the plate with the micromanipulator and incubated at 
an appropriate temperature until visible colonies were formed. 
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2.5.3d Analysis of growth phenotypes 
Growth phenotypes of cells were tested by replica plating or by streaking from a 
master plate onto EMM plus or minus growth supplements for auxotrophs, and 
onto YE at the restrictive and permissive temperatures for temperature-sensitive 
strains. 
2.5.3e Diploid construction 
For this project, sporulation competent diploids were always constructed using hf /If 
strains with complementing alleles of ade6. The ade6-M210 and ade6-M216 both 
confer adenine requirement for growth, but heterozygous diploids ade6-M210 ade6-
M216 are prototrophic. Strains carrying the ade6 mutant alleles were crossed as 
previously described, left to conjugate overnight and then streaked onto selective 
media for adenine prototrophs. Diploid colonies were organised by their colour on 
plates containing phloxin, and their ability to sporulate checked microscopically. 
2.5.4 Cell physiology of Schizosaccharomyces pombe 
2.5.4a Growth of liquid cultures 
Exponentially growing cells were obtained by firstly inoculating a single colony into a 
10 ml pre-culture of YE or selective media. The pre-culture was incubated for 1-2 
days at the appropriate temperature until the cells had entered the stationary phase 
growth. An aliquot of the pre-culture was inoculated into an appropriate volume of 
YE or selective media in a conical flask, and incubated with shaking at an appropriate 
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temperature until the correct density of cells was reached. The volume of pre-culture 
used to inoculate the culture was calculated as follows: 
Volume to add = required density/density of preculture x volume of culture/2 
where n is the number of doublings 
The cell density of liquid cultures was estimated by measuring the optical density at 
595 nm on a Hitachi U-2000 spectrophotometer. 
2.5.4b Cell number count 
A 100 p1 sample of cell culture was mixed in 10 ml of ISOTON II solution and 
sonicated for 5 sec at setting 6 on a Lucas Soniprobe Sonicator. Two counts of 0.5 
ml volume were taken and combined to give a cell count per ml. Cell numbers were 
counted using a Coulter counter (Coulter Electronics). 
2.5.4c Cell length measurement 
The cell length of samples was measured using the measure length tool in the IPLab 
scientific imaging software following the manufacturers' instructions precisely. The 
cells were stained with Calcofluor (section 2.5.4e) to aid visualisation of the outline 
of the cells. Approximately 200 cells were measured for each sample. 
2.5.4d DAN staining 
DAPI staining was carried out using a variation of the procedure previously 
described (Toda et al., 1981). 1 ml of culture was added to 100 .tl of ice-cold 25% 
gluteraldehyde and incubated on ice for 15 mm. The cells were then washed three 
times in 250 p.l of ice-cold distilled water. After each wash the cells were harvested 
by centrifugation at 14,000 rpm for 1 mm. After the final wash, the cells were 
resuspended in the residual water and 1 j.il was mixed with 1 pJ of DAPI (20 j.tg/ml) 
on the microscope slide. A coverslip was used and the cells examined immediately 
under oil using an Axioskop 2 fluorescent microscope (Zeiss) with the 63x objective 
lens. Photos were taken on a digital camera (Princeton Instruments) and IPLab 
scientific imaging software (Scanalytics) was used to analyse the data. 
2.5.4e Calcofluor staining 
Calcofluor staining was carried according to a method previously described 
(Mitchison and Nurse, 1985). 1 ml of culture was added to 100 p.1 of ice-cold 25% 
gluteraldehyde and incubated on ice for 15 mm. The cells were then washed three 
times in 250 p.1 of ice-cold distilled water. After each wash the cells were harvested 
by centrifugation at 14,000 rpm for 1 mm. After the final wash, the cells were 
resuspended in the residual water and 1 p.1 was mixed with 1 p.1 of Calcofluor (1 
mg/ml) on a microscope slide. A coverslip was used and the cells examined 
immediately as previously described. 
2.5.4f Cell DNA content measurement (FACS analysis) 
The DNA content of cell samples was determined by flow cytometry after DNA 
was stained with propidium iodide (Alfa et al., 1993). Approximately 10 7 cells for 
each sample were harvested by centrifugation at 2,000 rpm for 5 mm. The cell were 
resuspended in 1 ml distilled water, centrifuged for 15 sec in a microfuge and 
resuspended in 1 ml cold 70% ethanol. The cells were stored at this stage at 4°C. To 
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process the cells, 300 j.tl (approx. 2x106 cells) of the preparation was added to 3 ml 
50 mM Na citrate, mixed and centrifuged at 2,000 rpm for 5 mm. The cell pellet was 
resuspended in 500 jil 50 mM Na citrate containing 0.1 mg/ml RNase A and 
incubated at 37°C for 4 hr. 500 p.1 50 mM Na citrate containing 4 p.g/ml propidium 
iodide was added and the cells processed immediately. Just before processing, the 
cells were sonicated for 45 sec at setting 6 on a Lucas Soniprobe Sonicator. The 
DNA content of the cell samples were measured using a Becton Dickinson FACScan. 
2.5.5 Transformation of Schizosaccharomyces pombe 
S.pombe strains were transformed by electroporation as described previously 
(Prentice, 1991), which achieves a high transformation efficiency. Cells to be 
transformed were grown in 200 ml of YE or selective media to a density of 
approximately 0.5-ix i0 7 cells/ml. They were then harvested by centrifugation at 
5,000 rpm for 10 mm. The cells were washed three times in 10 ml of ice-cold 1.2 M 
sorbitol and then resuspended in 1.2 M sorbitol to a concentration of I x10 9 cells/mi. 
The DNA to be transformed was mixed with 200 p.1 of the cell suspension and 
immediately transferred to an ice-cold 0.2 cm cuvette. This suspension was pulsed 
at 2.25 kV (11.25 kV/cm), 200 Q and 25 p.F. Immediately after the pulse, 500 p.1 of 
1.2 M sorbitol was added to the cuvette. Electroporated cells were spread onto 
selective media and incubated at the appropriate temperature until visible colonies 
were formed (4-6 days). 
2.5.6 Stability test of transformants 
For various reasons, the transformants had to be tested for stability of a selectable 
marker, therefore distinguishing between an autonomously replicating plasmid and an 
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integration event. If a plasmid carrying a selectable marker replicates autonomously 
it will be lost in the absence of selection, however, if the plasmid has integrated, or 
there has been a reversion or gene conversion event, the selectable phenotype will be 
maintained even after relaxing the selection. To carry out a stability test, a 
transformant colony was streaked out to single colonies on YE and incubated at an 
appropriate temperature with no selection until visible colonies were formed. 20-50 
colonies from this plate were then patched out on to a second YE plate and allowed 
to grow overnight. This second plate was then replica plated onto selective media 
(YE plates at restrictive temperature or EMM plates minus the required 
supplements) and incubated until growth or no growth of the patches could be 
scored. 
2.5.7 Preparation of chromosomal DNA from Schizosaccharomycespombe 
S. pombe chromosomal DNA was prepared by a large-scale version of a method 
described previously (Durkacz et al., 1985). This method yields DNA of sufficient 
quantity and quality for a variety of purposes such as Southern blotting and PCR 
amplification. 100 ml cultures of YE or selective media were inoculated and 
incubated until the cells reached stationary phase (013 595 of 2-3). The cells were 
harvested by centrifugation at 3,000 rpm for 10 min and the cells resuspended in 1.5 
ml of CPS buffer (50 mM citrate-phosphate buffer, pH 5.6; 40 mM EDTA, pH 8.0; 
1.2 M sorbitol). 15 mg of zymolyase-20T (ICN) was added and incubated at 37 °C 
for 5-30 min until the cell walls had been digested. The cells were then centrifuged at 
3,000 rpm for 5 min and resuspended in 15 ml of 5x TE buffer (50 mM Tris-HC1, 
pH 7.0; 5 mM EDTA). 1.5 ml of 10% SDS was added, mixed well and incubated at 
65°C for 5 mm. 5 ml of 5 M KOAc, pH 5.6 was added and incubated on ice for 30 
mm. The mixture was then centrifuged at 5,000 rpm for 15 mm, the supernatant 
passed through a gauze and then 20 ml of ice-cold isopropanol was added and left for 
62 
5 min at -70°C. The precipitate was recovered by centrifugation at 10,000 rpm for 
10 mm, drained well and air-dried. The pellet was then resuspended in 3 ml of 5x TE 
buffer (50 mM Tris-HC1, pH 7.0; 5 mM EDTA), RNase A added to a final 
concentration of 20 mg/ml, and incubated at 37°C for 2 hr. The preparation was 
extracted with an equal volume of phenol: chloroform: isoamyl alcohol (25:24:1), 
mixed well, and centrifuged at 10,000 rpm for 10 mm. The upper, aqueous phase 
was transferred and 0.1 vol of 3 M NaOAc and 2.5 vol of absolute ethanol were 
added, mixed and incubated on dry ice for 1 hr. The DNA was recovered by 
centrifugation at 10,000 rpm for 10 mm, washed with 70% ethanol and air-dried. 
Finally, the DNA was resuspended in 200 Rl  of TE buffer (10 mM Tris-HC1, pH 
7.0; 1 mM EDTA). 
2.5.8 Preparation of total RNA from Schizosaccharomyces pombe 
S. pombe total RNA was prepared as described previously (Kaufer et al., 1985). 
This method yields RNA of good quantity and quality, suitable for Northern 
blotting. 100 ml cultures of YE or selective media were inoculated and incubated 
until the cells reached mid log phase (0D 595 of —0.5). The cells were harvested by 
centrifugation at 3,000 rpm for 10 min and the cells resuspended in 2 ml of 0.9% 
NaCl. The cells were divided into two screw-cap tubes, harvested again at 14,000 
rpm for 1 mm, and each pellet resuspended in 75 il of STE buffer (0.32 M Sucrose; 
20 mM Tris, pH 7.5; 10 mM EDTA, pH 8). Acid-washed beads (Sigma) were added 
to just below the meniscus and vortexed for 30 sec. 600 p1 of NTES buffer (100 mM 
NaCl; 50 mM Tris, pH 7.5; 5 mM EDTA, pH 8; 1% SDS) was added and again 
vortexed for 30 sec. The preparation was then extracted with 500 .tl of hot phenol 
three times, each time incubating at 65 °C for 2 min with frequent vortexing. After 
each extraction, the phases were separated by centrifugation at 14,000 rpm and the 
upper, aqueous layer was transferred to a fresh tube. The preparation was then 
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extracted with phenol: chloroform: isoamyl alcohol (25:24:1) at room temperature by 
vortexing and then recovering the nucleic acids by centrifugation at 14,000 rpm for 1 
mm. 0.1 vol of 3 M NaOAc and 2.5 vol of absolute ethanol was then added to the 
final aqueous phase, vortexed and then precipitated at -70 °C for about 30 mm. The 
precipitated RNA was recovered by centrifugation at 14,000 rpm for 10 mm, washed 
with 70% ethanol, air-dried, and each pellet resuspended in 22 p.l of distilled water 
(treated with DEPC) before combining the two. 
2.5.9 Preparation of denatured protein extract from Schizosaccharomyces pombe 
S. pombe total protein extract was prepared using a modified (Shiozaki and Russell, 
1996) version of that described previously (Moreno et al., 1991). This method 
yields protein of good quantity and quality, suitable for Western blotting. 50 ml 
cultures of YE or selective media were inoculated and incubated until the cells reached 
mid log phase (0D 595 of —0.25). The cells were harvested by centrifugation at 3,000 
rpm for 10 min and resuspended in 1.5 ml of STOP buffer (150 mM NaCl; 50 mM 
NaF; 10 mM EDTA; 1 mM NaN3 , pH 8.0). The cells were harvested again at 3,000 
rpm for 10 min and resuspended in 2 vol extraction buffer (50 mM Tris-HC1, pH 7.5; 
1 m EDTA; 10% glycerol; 50 mM NaF; 1 mM Na vanadate; 1 mM PMSF; 1 mM 
DTT; lx protease inhibitors (completeTM-Boehringer Mannheim)) on ice. The 
preparation was then transferred to a 1.5 ml tube and acid washed beads (Sigma) 
added to just below the meniscus. Each preparation was vortexed for five 20 sec 
intervals, chilling on ice for 1 min in between. Cell breakage was monitored 
microscopically. Each tube was punctured at the bottom with a red hot needle and 
placed inside another 1.5 ml tube inside a 15 ml tube. The tubes were centrifuged for 
2 min at 2,500 rpm and the flow-through collected. The extracts were then 
centrifuged at 14,000 rpm for 15 mm. The supernatants were transferred to fresh 
tubes and stored at -20°C. 
2.5.10 Preparation of protein extract from Schizosaccharomyces pombe for 
immunoprecipitation 
S. pombe total protein extract for immunoprecipitation was prepared using a 
modified version of an enzymatic lysis protocol described by Sambrook et al., 1989. 
50 ml cultures of YE or selective media were inoculated and incubated until the cells 
reached mid log phase (0D 595 of-O.25). The cells in 10 ml of the culture were 
harvested by centrifugation at 5,000 rpm for 10 min at 0 °C and resuspended in 10 ml 
of ice-cold PBS (50 mM sodium phosphate, pH 7.4; 150 mM NaCl). The cells were 
harvested again at 5,000 rpm for 10 min at 0°C, resuspended in 10 ml stabilising 
buffer A (1 M sorbitol; 10 MM  MgCl2; 2 mM DTT; 50 mM K2HPO4 , pH 7.8; 100 
ig/ml PMSF) and incubated at 30 °C for 10 mm. The cells were collected again by 
centrifugation at 5,000 rpm for 10 min at 0°C before being resuspended in 10 ml 
stabilising buffer B (1 M sorbitol; 10 MM  MgC12; 2 mM DTT; 25 mM K2HPO4 , pH 
7.8; 25 mM sodium succinate; 100 .tg/ml PMSF) and incubated at 30°C for 2 mm. 
2.5 ml of a 50 mg/ml solution of Zymolyase 20T was added and the preparation 
incubated at 30°C for 20-30 min until the cell walls were digested. The protoplasts 
were then collected at 2,500 rpm for 15 min at 0°C. The pellet was resuspended in 
0.1 ml lysis buffer (50 mM HEPES, pH 7; 1% Nonidet P-40; 100 jig/ml PMSF; lx 
protease inhibitors) and incubated on ice for 30 mm. Finally, the cell debris was 
collected by centrifugation at 14,000 rpm for 10 min at 4°C and the soluble extract 
transferred to a fresh tube and stored at -20°C. 
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2.6 Manipulation and handling of Saccharomyces cerevisiae 
2.6.1 Saccharomyces cerevisiae strains used 
ED1373 	cdc37-1 leu2-3, 112 his3i ura3-52 lys- a 
ED1375 	cdc37-2 arol ura3-52 trpl a 
2.6.2 Media and growth conditions for Saccharomyces cerevisiae 
YPD 
S. cerevisiae strains were routinely grown in YPD medium: 
Yeast extract 	 10 g/l 
Glucose 	 20 g/l 
Peptone 	 20 g/l 
Synthetic Dropout medium (SD) 
S. cerevisiae strains were selectively grown in SD medium: 
Yeast nitrogen source (w/o amino acids) 	6.7 g/l 
Glucose 	 3 g(1 
Amino acids were added to the SD medium or omitted for selection using 0.1 vol of a 
1 Ox Dropout solution: 
L-Isoleucine 300 mg/ml 
L-Valine 1500 mg/mI 
L-Adenine hemisuiphate salt 200 mg/ml 
L-Arginine HC1 200 mg/ml 
L-Histidine HC1 monohydrate 200 mg/ml 
L-Leucine 1000 mg/ml 
M. 
L-Lysine HC1 300 mg/ml 
L-Methionine 200 mg/ml 
L-Phenylalanine 500 mg/ml 
L-Threonine 2000 mg/ml 
L-Tryptophan 200 mg/nil 
L-Tyrosine 300mg/mi 
L-Uracil 200 mg/ml 
For solid medium, 20 gIl Bacto-agar (Difco) was added to either YPD or SD media. 
2.6.3 Analysis of growth phenotypes 
Growth phenotypes of cells were tested by replica plating or by streaking from a 
master plate onto EMM plus or minus growth supplements for auxotrophs, and 
onto YPD at the restrictive and permissive temperatures for temperature-sensitive 
strains. 
2.6.4 Transformation of Saccharomyces cerevisiae 
S. cerevisiae strains were transformed by the lithium acetate procedure as developed 
by Ito etal., 1983 and modified by Schiestl and Gietz, 1989, Hill et al., 1991 and 
Gietz etal., 1992. Cells to be transformed were grown in 300 ml of YPD or selective 
media until the 0D600 reached 0.4-0.6. They were harvested by centrifugation at 
2,500 rpm for 5 min and resuspended in 30 ml of TE buffer (10 mM Tris-HC1, pH 
7.0; 1 mM EDTA). The cells were harvested again at 2,500 rpm for 5 min and 
resuspended in 1.5 ml of 100mM LiOAc in TE buffer. The DNA to be transformed 
was added to 100 p.1 of the cell suspension along with 0.1 mg of herring testes carrier 
DNA (Clontech) and mixed well. 600 pJ of 100 mM LiOAc, 40% PEG-4000 in TE 
buffer was added and vortexed at high speed for 10 sec to mix. The mixture were 
then incubated at 29 °C for 1 hr with constant agitation. 70 pJ of DMSO was added 
and mixed well by gentle inversion and then the mixture was heat shocked for 15 mm 
at 42°C. The cells were chilled on ice for 2 mm, centrifuged at 14,000 rpm for 5 sec 
and then resuspended in 500 j.tl of sterile TE buffer. Transformed cells were spread 
onto selective media and incubated at the appropriate temperature until visible 
colonies were formed. 
Chapter 3 
Cloning and sequence analysis of cdc37 
3.1 Introduction 
The initial aim of this project was to identify homologues of the S.cerevisiae gene 
CDC37 in S.pombe. At the beginning of this project, the S.pombe genome 
sequencing project was underway, co-ordinated by the Sanger Centre in Cambridge. 
Most of the genomic DNA had been cloned into cosmids, and about 50% of these 
cosmids had been sequenced and the results entered into the database. Several 
strategies were employed to attempt to isolate putative CDC3 7 homologues before 
one, named cdc3 7,  was identified by use of the database at the Sanger Centre. 
Fig 3.1 contains the nucleotide sequence of the region of S.pombe genomic DNA 
containing the putative cdc37 gene. Important regions of the sequence are annotated 
in this figure and are discussed throughout this chapter. This figure can be used as a 
map for the sequence analysis and cloning described in this chapter. The sequence 
used to design oligonucleotides can be also identified by using this figure together 
with the information contained in Table 2.1. 
This chapter describes the identification of this gene, the analysis of the genomic 
sequence and the construction of a clone containing the entire ORF. It also 
investigates how the predicted S.pombe Cdc37 sequence compares to that of 
S.cerevisiae Cdc37p and other Cdc37 proteins identified in various organisms. 
3.2 Approaches to identifying CDC37 homologues in S.pombe 
3.2.1 Degenerate PCR 
The initial strategy that was used to identify potential CDC37 homologues in 




aagaatagcgattacagt tgcgttcccaaggaaccctgttgacccgaagaaaataccgct -1500 





aagaccatcact taagtacattgaaaagacttaccgacaatactcgaatccgtcgtaag -1140 
acgggatatgagatccccatgt ttatgaaagtcaaaaaatgctccatctaatgacatgca -1080 
tttagcaaacaagcgtgctcgaagacgactgacaattct ttcactcagtagacgcaaggt -1020 
gatgattctaccaaagttacaagctgaaccaaggaaaaataaacccaacaaaccaatata -960 
EcoRI. 	 . 	 . 
aaacgtaccagaaggpttcccatgatatgcgtgacagaagaatcgcctgacgagccagc -900 




agcaagtgatcgtataggaagaatagatctagaaaaaggtaacggaaaactat Lt ttaaa -600 
aggatatatcttagaaccacttgaggccttttgagataacgaglttaggCtCaCattaaC -540 
















































aaacaat ttgtacatttgccatcaaagcaacgtggtcgctgggatatcttcCttC Laaag 2040 
gctccgcttccttcatctcactgggtaaaggcacacgtaacagtgcctttaattttataC 2100 
c ttcaacgacttgattttcgggagtttgaagtgaggtatcacgattcataacaaatatgt 2160 
agtccaaatggccctggtaagcatgagcccaattggtaaatgCtggatgatCadaCcSat 2220 
bttttgcatttctgggtgaaccagtttatagcccactgaataaagaCtgaaaagtaCgg 2280 
gattttgc tcgtgctgctgataaaaagaacggtagtgaggtacatagtcattttgtaCat 2340 
gcaaaattctctttt btggggtagaagctgtggattcgggaacacttgaggtagaagagg 2400 
attgacattcttctttgtcatcttcattggaatcattttctgtcttagtactagCatttt 2460 
ttt c ttccaactcagattccccaaatacgtaattcatactacgttctataatgtcagtag 2520 




aaaataaatgtgtagtagccaagaacaaccc tctgctcciatcatctaccctttcaaggc 2760 







EcoRI 	 . 
t ttcacgctttataaagtccgtattciaattcgggtggagcattgcttggtggagcaatag 3240 
73 
gttbtcgagcagccttcttagctaataatcagttaataaaattgagCaaCaaaaaataa 	3300 








































ccatgtgt:catgatatcgat 	 5640 
Fig 3.1 The genomic nucleotide sequence of the putative cdc3 7 gene in 
S.pombe 
Shown here is the sequence of the 7188 bp PstI -C/al region of genomic sequence 
believed to contain the S.pombe cdc3 7 sequence. The predicted ORF is shown in 
black uppertcase, the predicted UTR in black lowercase and unrelated sequence in 
grey lowercase. Also included are the predicted translational 'start' and 'stop' 
codons in red, putative splice consensus sequences in blue (Table 3.1) and the 
relevant restriction sites in the sequence are underlined. The position at which the 
poly-A Tail begins in the mRNA is shown in bold with an asterix. Table 2.1 
contains a list of all the oligonucleotides designed using the above sequence and the 
locations are referenced with respect to this figure. Numbering of the sequence is 
with respect to the first base of the ORF ie. the adenine residue within the predicted 
translational 'start' codon (A= 1, T=2, G3 . . .etc). * XhoJ site engineered by a single 
base pair change to create site for cloning the 3' flanking region in the deletion 
construct. 
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and to amplify from an S.pombe cDNA library (T. Gaskell, pers. comm.). Using the 
S. cerevisiae Cdc3 7p sequence and sequences of homologues from other species, the 
degenerate primers were designed complimentary to regions where the sequence is 
conserved among species. Primers were also used designed complimentary to the 
S. cerevisiae ADHJ promoter and terminator sequences in the library vector pDB20 
(Fikes etal., 1990). 
Various reaction conditions and primer combinations were used to attempt 
amplification from the cDNA library by PCR using Taq polymerase (section 2.2.8). 
However, this approach was unsuccessful in identifying potential CDC3 7 
homologues in S.pombe. 
3.2.2 Complementation of the S.cerevisiae Is mutant cdc37-2 
A second approach involved attempting to rescue the defect of a S. cerevisiae cdc3 7 
ts mutant using two S.pombe cDNA libraries. There were two cdc37 ts mutants 
available, kindly donated by M. Winey; cdc3 7-1 (Reed, 1980b) and cdc3 7-2 (Reed, 
1980a). In both of these mutants at 25°C the cells behave as wild-type S.cerevisiae, 
but at 36°C the cells cease to divide and become arrested at 'start'. For this study, 
the cdc3 7-2 mutant was used, as the arrest phenotype was much tighter than that of 
the cdc3 7-1 mutant. To transform these ts mutants, two different S.pombe cDNA 
libraries were used, both cloned into S. cerevisiae expression vectors. One library, 
expressed by the strong, constitutive ADH1 promoter in pDB20 (Fikes etal., 1990), 
was a gift from M. Yanagida, whilst the other, expressed by the PGK promoter in 
pFL61 (Lollier etal., 1995), was donated by M. Minet. 
The cdc3 7-2 strain was transformed with the S.pombe cDNA libraries and a cDNA 
containing the CDC37 ORF as a positive control (section 2.6.4), allowing colonies to 
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form at 25°C. The colonies were then tested for growth at the permissive and 
restrictive temperatures; 25°C and 36°C, respectively. Preliminary studies using this 
approach, where -6.4x 107  transformants were screened, were also unsuccessful in 
identifying potential CDC37 homologues in S.pombe. 
3.2.3 Searching the S.pombe sequence database with the S.cerevisiae Cdc37 
sequence 
The translated DNA database at the Sanger Centre was searched with the Cdc37 
protein sequence from S. cerevisiae using BLAST and sequences showing similarity 
were analysed further for potential genes. Only one cosmid in the translated DNA 
database contained a region which showed significant similarity to the sequence of 
Cdc37p. Cosmid c28E12 containing DNA from chromosome 2 contained three 
regions with significant similarity to Cdc37p. The largest region of 442 amino acids 
had an identity of 31% with the S. cerevisiae Cdc37, whilst in close proximity 
upstream, two smaller regions of 8 and 40 amino acids had identities of 100% and 
37%, respectively. The regions of similarity in the database sequence were not in the 
same reading frame, suggesting that the sequence contained introns, so the genomic 
sequence was analysed to determine its structure. It is worth noting at this point, 
that subsequent searches at the end of this project, with the S.pombe genome 
database project almost complete, still only result in this single region of genomic 
DNA with significant similarity, suggesting that only one homologue of CDC3 7 
exists in S.pombe. 
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3.3 Analysis of S.pombe cdc37 sequence 
Upon arrival of the cosmid c28E12, a 7182 bp region containing the putative cdc37 
gene was cloned into pBluescript SK- using ClaI and PstI sites predicted from the 
genomic sequence (Fig 3.1). The region of the clone containing the putative cdc37 
gene was subsequently sequenced and compared to the sequence published by the 
Sanger Centre. The sequences matched exactly except for one base pair. Since the 
discrepancy occurred at a region which was believed to be within the ORF, it was 
decided that sequencing a cDNA clone would reveal the correct sequence (section 
3.4). Meanwhile, the genomic structure of the cdc37 gene was predicted using 
splicing consensus sequences from previously analysed S.pombe genes (Zhang and 
Marr, 1994; Chen and Zhang, 1998) and by comparison with S.cerevisiae Cdc37p. 
3.3.1 Prediction of the transcriptional and translational initiation/termination 
sites 
As the N-terminal end of the Cdc37 proteins seem to be highly conserved in all 
species where they have been identified to date, the predicted 'start' translation site 
(ATG) was identified along with the subsequent few amino acids which were 
identical to the S. cerevisiae Cdc3 7p sequence. The translational start consensus 
sequence outside of the ATG codon does not appear to be particularly well 
conserved in S.pombe (Zhang and Marr, 1994), therefore, a definitive prediction of 
the site is impossible by sequence analysis alone and needed to be confirmed by 
analysis of a cDNA sequence. However, no other potential start codons exist in any 
reading frame within 250 bp upstream of the predicted start site. 
Due to the limited sequence similarity throughout most of the length of the 
S.cerevisiae and S.pombe Cdc37 proteins and the possibility of further introns, it 
A;1 
was difficult to predict the translational stop codon. As there appeared to be no 
consensus splice sites within the 442 amino acid largest region of similarity, which is 
furthest downstream, it was assumed that this was the final exon and that there were 
no more introns present. This region contained no stop codon, therefore the next 
stop codon within the same reading frame was predicted to be the translational stop. 
Promoters in S.pombe are not well understood and in particular, very little 
information exists on the range of sequences that can serve as functional TATA 
elements. However, TATA sequence motifs have been suggested for genes in 
S.pombe that are transcribed at moderate or high levels (Russell, 1989). The cdc37 
gene has no obvious TATA motif upstream, suggesting that cdc3 7 may only be 
expressed at moderate to low levels. The transcriptional initiation and termination 
consensus sequences in S.pombe are also not highly conserved and no obvious 
putative sequences exist. 
With the start and stop codons predicted, it was clear that there were introns present 
at the 5' end, therefore the sequence would need to be analysed further for the 
presence of splice donor, acceptor and branch sites. 
3.3.2 Prediction of exon-intron structure 
The presence of introns is relatively common in S.pombe genes and tend to be 
characteristically short (Zhang and Marr, 1994). S.pombe introns, as with 
S.cerevisiae, tend to be located towards the 5' end of the gene (Fink, 1987) and 
consensus sequences for branch and splice sites have been determined (Zhang and 
Man, 1994, Chen and Zhang, 1998). Using these consensus sequences and by lining 
up the genomic sequence with the S.cerevisiae Cdc37p sequence, 2 introns were 
predicted to be present at the 5' end of the gene. From analysing the genomic 
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sequence alone, the predicted structure of the gene suggested that the ORF was 1404 
bp long, consisting of 3 exons of 23 bp, 41 bp and 1340 bp and 2 introns of 60 bp 
and 368 bp in length (Fig. 3.2). After this extensive sequence analysis was carried 
out, the predictions had to be tested by sequence analysis of cDNAs containing the 
cdc37 ORF. 
3.4 PCR amplification of cDNAs containing the cdc3 7 ORF 
Since the accuracy of the sequence was obviously important in the following PCR 
amplification, Taq polymerase was considered not to yield high enough fidelity. 
However, high fidelity polymerases, such as Pwo, usually possess an integral 3'—* 5' 
proof-reading exonuclease activity which result in PCR products that are blunt-ended 
and thus difficult to clone. For this project a system was used, called ExpandTM High 
Fidelity PCR system, which reaches a compromise between fidelity and ease of 
cloning. It is composed of a mix containing Taq and Pwo DNA polymerases, 
designed to give higher fidelity PCR products that resemble a mixture of 3' single A 
overhang products similar to those generated by Taq DNA polymerase alone and 
blunt-ended products. This meant that the higher-fidelity PCR products could still 
be sub-cloned easily into the pGEM-T vector. 
The two cDNA libraries previously described (section 3.2.2) were used as templates 
for PCR amplification. However, amplification was only consistently achieved with 
one of them, in the library vector pDB20 containing the ADH1 promoter for 
expression. This was an oligo d(T)-primed library which was non-directionally 
cloned into the vector. Oligos were designed that were complementary to a region of 
either the promoter (5' forward - TG 1) or terminator (3' reverse - TG2) sequences 
of the library vector. 
Genomic DNA 
- 	 1.8kb 
mRNA 
-'4 	 1.4kb 
U ORF U Introns 
Fig 3.2 Original prediction of the genomic structure of the cdc37 gene in 
S.pombe by analysis of the genomic sequence 
The genomic structure of the cdc3 7 gene was predicted by sequence analysis of a 
genomic clone and alignment with the S.cerevisiae Cdc37p sequence. Shown here is 
the predicted structure of the cdc37 gene (not to scale). The gene contains 2 introns 
of 60 bp and 368 bp in length. The 1404 bp ORF is made up of 3 exons of 23 bp, 41 
bp and 1340 bp. 
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3.4.1 Analysis of the structure of the 5' end of the gene 
Initially, in order to test the prediction of the structure of the 5'end of the cdc371 
gene and to identify any 5' UTR, a reverse primer (PW3) was designed using the 
sequence at the 5' end of the final exon, together with both forward (TG1) and 
reverse (TG2) primers complimentary to the ADHJ promoter vector sequence. The 
DNA was amplified from the library by PCR (section 2.2.8) and the reactions were 
run on a 1% agarose gel (section 2.2.3). The reactions with primer PW3 and primer 
TG1 resulted in a band of-350 bp being amplified from the library. However, no 
amplification was seen with PW3 and the primer TG2. The band was excised from 
the gel and purified (section 2.2.4), before being cloned directly into pGEM-T. Once 
cloned into the vector the insert was sequenced using the T7 primer against the 
sequence of the vector adjacent to the polylinker site. 
The sequencing results revealed that although our prediction was almost accurate, we 
had failed to notice another extremely small exon of only 11 bp (Fig 3.1). This 
changed the structure of the gene slightly, resulting in a sequence with stronger 
consensus sequences for splicing and which lined up more readily with the 
S.cerevisiae Cdc37p sequence. The confirmed ORF from the cDNA is 1401 bp, 
consisting of 4 exons of 23 bp, 27 bp, 11 bp and 1340 bp and 3 introns of 60 bp, 329 
bp and 42 bp in length (Fig 3.3). As has been observed in the large majority of 
S.pombe genes examined, the longest region of the cdc37 ORF is present in the final 
exon (Chen and Zhang, 1998). The splice donor, acceptor and branch sequences for 
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Fig 3.3 Genomic structure of the cdc3 7 gene in S.pombe 
The genomic structure of the cdc37 gene was predicted by sequence analysis of a 
genomic clone and confirmed by sequence analysis of cDNAs amplified from a 
cDNA library. Shown here is the confirmed structure of the cdc37 gene (not to 
scale). The gene contains 3 introns of 60 bp, 329 bp and 42 bp in length. The 1401 
bp ORF is made up of 4 exons of 23 bp, 27 bp, 11 bp and 1340 bp. Also shown in 
the diagram is the 78 bp of 5' UTR and all of the 114 bp of 3' UTR established by 
sequence analysis of clones amplified from a cDNA library. 
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Table 3.1 Sequence of the predicted splice donor, branch and acceptor sites 
within the putative S.pombe cdc37 sequence 
Donor site Branch/acceptor site 
Intron 1 	GTAAGT TTAAC.. (8 bp) . . CAG 
Intron 2 	GTATGA CT?AC.. (6 bp) . . TAG 
Intron 3 	GTTTGT TTAAC.. (6 bp) . . CAG 
Bases shown in bold and underlined are those that are present in all S.pombe genes to 
date. Those shown underlined are those which are present in over 70% of genes to 
date (Zhang and Man, 1994). 
3.4.2 Elucidating the 5' and 3' UTR sequences 
As well as confirming the intron-exon structure of the 5' end of the gene, the 340 bp 
PCR product generated in section 3.4.1 also contained a region of 5' UTR upstream 
of the predicted translation start codon. Sequencing showed that this clone appeared 
to contain 78 bp of 5' UTR (Fig. 3.4). Without being able to confirm that this is 
completely all of the 5' UTR, this is probably the majority of it, supported by the 
results of Northern analysis (section 4.3.3). 
To discover if any 3' UTR was present and to confirm the structure of the remainder 
of the gene, a forward internal primer (PW4) was designed complimentary to the 5' 
end and PCR carried out (section 2.2.8) with the 3' reverse vector primer (TG2). 
This resulted in amplification of a -4400 bp band which was subsequently cloned 
into pGEM-T and sequenced. The sequencing confirmed that no more introns were 
present and identified the predicted stop codon. It also shows that a cDNA 
containing all 114 bp of 3' UTR is present in the library, as the sequence extends to 
the poly(A)-tail (Fig 3.4). 
3.4.3 Constructing a clone containing the entire ORF 
In order to compare the cDNA sequence with the genomic sequence and to create a 
reagent for further investigations, clones containing the whole ORF were amplified 
by PCR from an S.pombe cDNA library constructed in the S. cerevisiae multicopy 
vector pDB20 (Fikes et al., 1990). To carry this out, two further primers were 
designed complimentary to the cdc37' sequence; one at each terminus of the ORF, 
containing engineered recognition sites for the restriction enzymes NdeI (5' end - 
PW5) and Smal (3' end - PW6) for cloning the ORF into the pREP series of S.pombe 
expression vectors (section 4.3.1). Six independent PCR products were cloned into 
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gtcaaatcgacgagaatagcaaagacatttgt.gtcttttactttttttaaatttCttgaa 	-18 
attataat ttgc ttcgagATGGCAATTGATTACAGCAAGTGGGAThAGCTAGAACTTAGT 	42 
MAID Y S K W D K L EL S 14 
GATGACAGTGACATTGAAGTTCATCCAAATGTCGATAAAAAGTCTTTTATTAGATGGCGC 102 
D D S D I E V H P N V D K K S F I R W R 	34 
CAACGTGATATCCACGAAAAACGGGCTGTTAGAAAGCAAAAAATGGAAGATATCAAAGGT 162 
Q R D I H E K P. A V P. K Q K M E D I K G 	54 
GC?ATGGCGATGAATCGTAGACTCTTGTCTCGCATCTCCGAPATGGAGACTGTTCTTGAG 222 
AM AM N R R L L SRI SE MET V L E 	74 
BarnH I 
AAGGAATCTCCTTCGGATCCTTATGTTTTATTGGGTTCATTTTTAGAGGCAAAAAAGTCT 282 
K E S P S D P Y V L L C S F L E A K K S 	94 
NdeI a 
GAAGATATGGATAGTGCCATTCCTGGAGGCATGTCGTATCATCATATGCTTATGTCTTTA 342 
ED MD S Al PG GM S Y H H ML MS L 	114 
TTAAGTAJTTAAAGATGCCGAGACACTACCGAAG?JLkAATCTATGGATGATTCGGAT 402 
L K V I K D A E D T T E E K S M D D S D 	134 
?J'.ATGCTTGAGACGATTAAAGTCACACAAAGAGCGTCTTCTGAAGTTGCTAGAAGATGCA 462 
K C L R R L K S H K E R L L K L L E D A 	154 
CAAAAGGAGTATGATACTTTAGAGGCTGAGAGTPAAAATTACATCACTTCTGAAGACTTG 522 
Q K E Y D T L E A E S K N Y I T S E D L 	174 
CATTTGGGCTTTGATTCCACCTATGTTCAGAAAAAGGAGCCTGAAAACCTAAAAAGACT 582 
H L C F D S T Y V Q K K E P E K P K K T 	194 
AAAACCAAAAAGGAGACCATCCAGGTCATTGAATCTCTTAATACCCTACACCTCCTACT 642 
K T K K E T I Q V I E S L N N P T P P P 	214 
GATTTTCCCQGCGCTAAAGAGCAkGCTTCTACTGGTAATGCCCCTAA1AATCCTGTCAAT 702 
D F P C A K E Q A S T G N A P K N P V N 	234 
GAGAATGAGTCGGAAGATGAAGAAGGGTTGTCTCTTTCTGAAGATGGTAACAGTTTGCC 762 
E N E S E D E E G L S L S E D G K K F A 	254 
AATATTGATTTTGGTGATTATTCTTCATCGGAGAGTTTTTGAAAGACATTTAAATATC 822 
N I D F G D Y S S S E E F L K E H L N I 	274 
TTGGCAGATGAGGAAGAATCTGATGCTATTCTTTTGCAAGCCTTTAATGCTCAACTAGAA 882 
L A D E E E S D A I L L E A F N A E L E 	294 
GGGAAGCCGTCCTTAGCAAAACATATGTTCATCAAGCCCTTTTGATCAGCTATTCCAGA 942 
G K P 5 L A K Q Y V H Q A L L I S Y C P. 	314 
CAGCTTGGACCAATGGTTTATCAATATTTTTTCAJAAATTAAAGACCCAAATCACCAA 1002 




S Q R L F L E D V H N T Y V R I H E R S 	354 
GCTGCCATCAGCAAAGAACAAGCTGAAAGCGGTGAAGGAGTAGAACAAATCCAGCTCTGT 1122 
A A I S K E Q A E S G E G V E Q I Q L C 	374 
GCAGTTGATCCTAATACGAAACTTTCCATCACCATCCCCGAGCCAGGTTCTACTGATCCA 1182 
A V D P N T K L S I T I P E A G S T D P 	394 
GAGACACAAAAAGCTCGTGCAGCTTTTGAGTCTTTTCCTCCTAACCTCCAAAAAGCTCTT 1242 
E T Q K A R A A F E S F P P N L Q K A L 	414 
ATGACCMTGATTTAGACAAGATT?JTGTAGTTCTTGGAAAAATGGCAGTTGAAAATGCA 1302 
MT ND L D KIN V V L G K MAVEN A 	434 
GAAGAAGTTCTGGAAAAGCTCAGCAGTACTGGTATGTTGAGTATCGAAGAAGGAATCATC 1362 
E E VV E K L S ST CML S 	E E GIl 	454 
GACACAACGAAAGGTGAGACTATTCCTCAATTGTCTTAAatttttctgcttacgggtgtg 1422 
D T T K GET I P Q L S • 	 466 
CttttagtaagcgaaaacaccaaagttacatgtttgccgttggcattLttaaatggataa 1482 
acaacaatgaattttatttat tgatttaaaaaaaaaaaaaaaaaa 	 1527 
Fig 3.4 The predicted nucleotide and deduced amino acid sequence of the 
cdc3 7 gene in S.pombe 
Shown here is the predicted sequence of cdc3 7+ mRNA sequenced by amplification 
from a cDNA library. All of the 3' UTR is included but the existence of additional 5' 
UTR within cdc3 7 mRNA cannot be ruled out. The DNA sequence is shown in 
grey, the predicted 'start' and 'stop' translation sites in red and the deduced amino 
acid sequence in black. The 1401 bp predicted ORF is shown in upper case and the 
UTR in lower case. 
pGEM-T and sequenced. All 6 clones had PCR-induced mutations somewhere in 
their sequences but by comparison to each other, a consensus sequence was 
constructed which agreed exactly with my genomic sequence. The single base pair 
difference with the database sequence was communicated to the Sanger Centre and 
subsequently corrected. 
The pREP vectors that were to be used for expression in S.pombe all required a 5' 
terminal NdeI site, which was introduced into the ORF by PCR. However, the 
cdc37 ORF contains two internal NdeI sites at positions 326 (labelled a) and 1038 
(labelled b) of the ORF. This meant that a two-step cloning strategy was necessary 
to insert the full-length ORF into the expression vectors (Fig 3.5). The presence of 
an internal BamHI site at position 237 of the ORF gave a convenient method for 
piecing together clones which between them contained an error-free full-length ORF. 
One of the clones containing the full-length ORF generated by the PCR just 
described, contained correct sequence from the internal NdeI sites out to either 
termini, but contained a PCR-induced mutation in the middle region between the two 
NdeI sites. The BamHI-SmaI region of this clone was inserted into pBluescript SK-. 
The middle NdeI fragment was then replaced by the corresponding fragment (which 
contains no introns) from the genomic cosmid, resulting in an error-free region of the 
3' end of the cdc3 7 ORF from the BamHI site to the engineered Smal site at the 
extreme C-terminus. This construct was used for further cloning described in other 
sections (Appendix 1B). A second PCR product containing the 5' end of the ORF 
from the engineered NdeI site at the extreme N-terminus to the internal BamHI site 
was also cloned into pGEM-T. This construct with the NdeI-BamHI 5' end was 
also used for further cloning (Appendix 1C). Sequential cloning of these two 
fragments allowed the full-length cdc37 ORF to be cloned into the NdeI-SmaI sites 
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Fig. 3.5 Strategy for cloning the full-length cdc3 7 ORF in S.pombe 
Two clones were assembled that between them contained the full-length ORF of 
cdc3 7 A 1417 bp PCR product (using primers PW5 and PW6) was cloned into 
pGEM-T containing the full-length ORF. This clone had no errors between the 
engineered Ndelc site and the BamHI site or between the Ndelb site and the Smal 
site, but a PCR-induced error between the Ndela and Ndelb sites (represented by a 
red cross). A. The 1167 bp BamHI-SmaI fragment was then cloned into pBluescript 
SK-. B. The fragment in pBluescript SK- was digested with NdeI, removing the 712 
bp region which was replaced with the corresponding fragment from a genomic clone 
(Fig 3. 1, Appendix IA), thus removing the PCR-induced mutation. This resulted in a 
construct with the 1167 bp error-free BamHI-SmaI 3' end ready for further cloning 
(Appendix IB). Also, a 253 bp PCR product (using primers PW3 and PW5) 
containing the 5' end of the ORF from the engineered Ndelc site to the internal 
BamHl site was cloned into pGEM-T. This resulted in a construct with the 238 bp 
NdeI-BamHI 5' end ready for further cloning (Appendix 1C). These two constructs 
(B and C) were used for sequentially cloning the ORF into various vectors described 
in later chapters. Amplified DNA is shown in green, genomic DNA is shown in blue 
and vector sequence in black. 
3.5 Predicted amino acid sequence of cdc37' 
Translation of the ORF of cdc3 7+ is predicted to encode a polypeptide of 52 kDa 
containing 466 amino acids (Fig. 3.4). Although the similarity between S.pombe 
Cdc37 and S.cerevisiae Cdc37p is only moderate overall (34% identical), the two 
proteins are —P85% identical over the first 40 amino acids and conserved motifs exist 
in several regions throughout the length of the proteins (Fig. 3.6). In fact, 
homologues previously identified from other species also have only moderate 
similarity with the Cdc37p sequence overall but high identity at the N-terminus (Fig. 
3.7). However, despite this, the Drosophila cdc3 7+ gene rescues the temperature-
sensitive defect of the S.cerevisiae mutant allele cdc37-1 (Cutforth and Rubin, 1994). 
3.6 Summary 
A homologue of the S.cerevisiae gene CDC37 has been identified in S.pombe. The 
gene contains 3 introns, a predicted ORF of 140 1 b and has been named cdc37+. 
The S.pombe Cdc37 protein has a predicted molecular weight of'-52 kDa, similar to 
that of the Cdc37 proteins found in other species. All of the Cdc37 protein 
sequences identified from a variety of species, including the S.pombe protein 
identified here, show high conservation at the N-terminus but only moderate 
sequence similarity overall. The S.pombe Cdc37 sequence is most similar to the 
S.cerevisiae Cdc37p sequence. The sequences of the Cdc37 proteins identified so far 
contain no consensus motifs that give any clue as to their function. 
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pombe MAIDYSKWDKLELSDDSD IEVHPNVDKKSFIRWRQRD IHEKRAVcQKME 50 
Cerlev 	MAIDYSKWDKIELSDDSDVEVHPNVDKKSFIKWKQQS IHEQRFKQDIK 50 
pombe DIKGAMAJRRLLSRISEMETVIEKE$PSD.PYV. . . $LGSJp. . LEAK S 94 
cerev 	NLETQVDMYSHLNKRVDRI LSNLPESSLTDLPAVTKFLNANFDK4KS 	100 
pombe IDKMSAMPGGMSEHHIL4SIKVIK DI TE S!mDIKCL
I
RIKS 143 
cerev 	 E .. ATNERVEDEQ L. . 	LDKKDSKSLIAILK  145 
pombe KERLLKLLEDAQKEYDTLEAESKNYITSEDLHLGFDSTYVQKKEPEKPKK 193 
cerev 	RAKIDSVTVEAKKKLDELYKEKNAHISSEDIHTGFDSSFMNK ........ 187 
pombe TKTKKETIQVIVSLNNPPTDFPGAX*QASTGNAPKNPVNENESE. DER 242 
cerev 	. . . QKGGAXP LEA .... TPSEALSSAAISNILNKLAKSSVPQTFIDFKDD 230 
pombe GLSLSEDGKK N*DFGDYSSSEEVLKERLNLADrESD-AILLFAFNAE 292 
cerev 	PMKLAKETEE K1SINEYSKSQKLLEELPIS.QKDLMMKAF'EYQ 279 
pombe LEGKPSLAKQYVHQALLISYCRQ ......... LGP.. . .NGLSIFFQKI. 328 
cerev 	L}IGDDKMTLQVIHQSELMAYIKEIYDMKKIPYLNPNELSNVINMFFEKVI 329 
pombe .. 	NHQSQRLFLEDWNTYVRIHEAISKQAE. . 	 374 
cerev 	FN . KPMGKEsPLRSVQEKFLHIQKKILQQEMDESNAEGVETIQLK 378 
pombe A VPNTKLS IT I PEAGSTDPETQKRAAFESFPPNIQKALMTNDLDK I  NV 424 
cerev 	SLD 	 4VKVFKTLPEKMQEAINTKNLDNINK 428
pombe VLGKMAVENAEEVVEKLSSTGMLSIEEGIIDTTGETIPQLS 	 466 
cerev 	VFEDIPIEEAEKLLEVFNDIDIIGI . KAILENEK. .DFQSLKDQYEQDHE 475 
pombe 
cerev 	DATMENLSLNDRDGGGDNHEEVKHTADTVD 505 
Fig. 3.6 Sequence comparison of S.cerevisiae Cdc37p and S.pomlie homologue 
Shown is an optimal alignment of S. cerevisiae Cdc37 (from Gerber el al., 1995) with 
predicted amino acid sequence of S. pombe homologue. Residues identical are shaded 
in red and those similar are shaded in yellow. Alignment was performed using the 
default settings in the gcg pileup program. 
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pombe MAID YSKWDKLELSDDSDI 1VHPNVDKKSFIRWRQRDIHEKRAVRXQKME 50 
cerevisiae MAIDYSKWDKIELSDDSDV EVHPNVDKKS FIKWKQQ S I}IE cR5 SRNQ DIK 50 
drosophila M .VDYSKWKNIEISDDEDDT.HPNIDTPSLFRWR.- . .HQARVERMAEMD 44 
chicken M.VDYSVWDHIEVSDDEDET}IPNIDTASLFRWR.. . .HQARVERNEQF 44 
human M .VDYSVWDHIEVSDDEDET. RPNIDTASIaFRWR.. . .HQABVERMEgP 44 
pombe DIKGAMANNRR.LLSRISEMETVLEKE 	.SPSDPYVLLGSFLEAKKSED 96 
cerevisiac NLETQVDNYSH LNKRVDRILSNLPESSLTDLPAVTKFLNANFDKMEKSK 99 
drosophila MEKDELKKKRQSYQARLMDVKERISK ................KDGDEEA. 77 
chicken KEKEELDKGCRECKRKLAECQKKLKE ................LEVAEPG. 77 




148 cerevisiae P 
drosophila ....... LKKELEKIEAECKELDRIE.S ...................... 98 
chicken . . GGSGGGRGERERLQAEAQQLRHEERNWESK ............... MU 110 
human GGKAELERLQAEAQQL.RKEERSWEQK ...............LE 104 
pombe LLKLLEDAQKEYDTLEAESKNYITSELHLGFDSTYVQKKEP. EKPKKTK 195 
cerevisiae IDSVTVEAKKKLDELYKEKNAHISSEDIHTGFDSSFMNKQKGGAKPLAT 198 
drosophila MIKKEKKTPWNVDTISKP ............ GFEKTVINKKAG. RKPDEN. 134 
chicken LRKKEKNM PWNVHTLSKD ........... .GFS KSVFNVKA. . EEKEE.. 144 
human MRKKEKNMPWNVDTLSKD ............ GFSKSMVNTKP. . EKTEE.. 138 
pombe TKKETIQVIESLNNPTPPTDFPGAKEQASTGNAPKNPVNENESEDEEG.L 244 
cerevisiae ................ PSEALS SAAESNI LNKLAKS SVPQTFI DFKDDPM 232 
drosophila ................... LSEEEREQR .....MKQFVKENE ........ 152 
chicken .................... TEEQKEQK .....RKTFVERHE ........ 161 
human ................... DSEEVREQK .....HKTFVEKYE ........ 156 
pombe SISEDGKKPANIDFGDYSSSEEFLKEHLNILADEEESDAILLEAFNAELE 294 
cerevisiae KLAXETEEFGKISINEYSKSQKFLLEHLPIIS. EQQKDALMMKAFEYQLH 281 
drosophila . . .IcLCQQYGMLRKYDDS. .KRFLQEHLHLVG. EETANYLVIWSINLEME 196 
chicken . . .KQIKHFGMLRRWDDS. . QKYLSDNPHLVC. EETANYLVIWCIDLEVE 205 
human • ..KQIKHFGMLRRWDDS. .QKYLSDNVHLVC.EETANYLVIWCIDLEVE 200 
pombe GKPSLAKQYVHQALLISYCRQLG ......... P... .NGLSIFFQKIKD. 330 
cerevisiae GDDKMTLQVI}IQSELMAYIKEIYDMKKIPYLNPMELSNVINMFFEKVIFN 331 
drosophila EKHELMAHVAHQCICMQYILELAKQLDV. . .DPR.. .ACVSSFFSKIQH. 239 
chicken EKQALMEQVAHQIVMQFILELAKSLKV. . .DPR.. .ACFRQFFTKIKT. 248 
human EKCALMEQVAHQTIVMQFILELAKSLKV. . .DPR.. .ACFRQFFTKIKT. 243 
pombe . PNHQSQRLFLEDVHNTYVRIHERSAAI. . .SKEQAESGEGVEQIQL.CAV 376 
cerevisiae KDKPMGKBSPLRSVQEKFLHIQKRSKILQQEEMDESN.AGVETIQLKSL 380 
drosophila . CHPEYRAQFDSEIEGFKGRIQKRAQEKIQEAIAQAEEEERKERLGPGGL 288 
chicken - ADQ QYMEGFNDELEAFKERVR GRAKARI ERAMREY EEEERQKRLGPGGL 297 
human . ADRQYMEGFNDELEAFKERVRGRAKLR. EKAMKEYEEEERKKRLGPGGL 291 
pombe TKLSITIPEAGSTDPET.. .QKARAAFESFPPNLQKALMTNDLDKIN 423 
cerevisiae DSTELEVNLPDFNS KDPEE.. . MKKVKVFKTL PEKMQEA IMTKNLDNIN 427 
drosophila DP.ADVFESLPDELKACFESRDVELLQKTIAAMPVDVAKLRMKRCVDSGL 337 
chicken flP.VDVYESLPPELQKCFDAKDVQMLQDTISRMDPTEAKYHMQRCIDSGL 346 
human IDP.VEVYESLPEELQKCFDVKDVQMLQDAISKMDPTDAKYHMQRCIDSGL 340 
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pombe V LGKMAVENAEEVVLSSTGMLSIEEGIIDFT *GE 	460 
cerevisiae FEDIPIEEAEKLL 	FNDIDIIGI .KAILENEK .DFQSLKDQYEQDH - 474 
drosophila WVPNAADLE.GDKKZDD. SDVAGGERKTDDAI ............. SU 	372 
chicken WVPNAXAAA.EGGGQGGAHGQPGGADSEALYEtIP ............ KS 383 
human WVPNSKAS E . LXEGEEAGP GOP LLEA VPKTGDZK ............. DVS 	376 
pombe TIPQLS ......................... 466 
cerevisiae EDATMENL STJNDRDGGGDNHEEVKHTAD'PVD 	505 
drosophila AAKEEPIY P.. . . GVSTEDVD .......... 389 
chicken GEEEGGEGK ...................... 392 
human V .............................. 377 
% identity pombe cerevisiae drosophila chicken human 
pombe - 34.7 23.9 25.3 24.6 
cerevisiae - - 24.8 24.4 24.6 
drosophila - - - 51.9 50.8 
chicken - - - * 84.1 
human - - - - - 
Fig. 3.7 Sequence comparison of S.cerevisiae Cdc37p, a S.pombe homologue 
and homologues from other species 
Shown is an optimal alignment of S.cerevisiae Cdc37p (Ferguson et al., 1986; Gerber 
et al., 1995) with predicted amino acid sequence of the S.pombe homologue identified 
in this project, together with homologues from D.melanogaster (Cutforth and Rubin, 
1994), chicken (Huang et al., 1998) and human (Stepanova et al., 1996). Residues 
identical are shaded in red and those similar are shaded in yellow. Alignment was 
performed using the default settings in the gcg pileup program. Also included is a 
table showing the percentage amino acid identity between each homologue using the 
Jotun Hein default settings of the MegAlign program in DNA Star. 
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Chapter 4 
Construction and analysis of 
a cdc3 7 deletion mutant 
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4.1 Introduction 
The classical route to investigating the function of a novel gene in yeast is to disrupt 
or delete the gene of interest at the chromosomal locus. These two techniques are 
very similar and their aim is to eliminate the function of the gene that is targeted. In a 
disruption experiment, a selectable genetic marker is inserted into the target gene 
using a convenient restriction site; in a deletion experiment, part or all of the target 
gene is replaced with the genetic marker. It is preferential to use a deletion strategy 
where possible, because removal of the gene assures that a null mutant is generated, 
whereas disruption does not always do so. Deletion or disruption strategies have 
been widely used to create null mutants of many yeast genes. 
For this project, a cdc37' null mutant was created by deletion of the entire ORF 
using the one-step gene replacement method (Rothstein, 1983). The method relies 
upon a double recombination event taking place at the chromosomal locus of the gene 
of interest. The first step is to create a construct that contains a linear fragment 
containing the DNA normally flanking either side of the target gene and a selectable 
marker inserted in between. Next, the linear fragment is released from the plasmid 
vector, containing the selectable marker flanked by sufficient length of DNA 
sequence to allow homologous pairing with both sides of the chromosomal target 
sequence. Standard transformation techniques are then used to introduce the linear 
fragment into a suitable strain and transformants that show stable mitotic inheritance 
for the genetic marker are isolated and tested further for correct integration. 
If the gene of interest is essential for cell growth or division, then loss of function will 
be lethal and no transformants will be isolated. To avoid this, the gene replacement is 
carried out in a diploid strain. The replacement results in a heterozygous diploid 
which may then be allowed to sporulate and the haploid progeny analysed. Where 
the gene of interest is essential for viability, the null mutant haploids created by 
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sporulation can be maintained by expression of the gene from an introduced plasmid 
and thus analysed further. For this study, we used a set of S.pombe expression 
vectors known as the pREP plasmids (Maundrell, 1990, Basi etal., 1993), in which 
expression is regulatable by the addition (represses promoter) or omission 
(derepresses promoter) of thiamine from the medium. 
4.2 Creation of a cdc37 deletion mutant strain 
4.2.1 Deletion of cdc3 7  at the chromosomal locus 
Since the cdc37+ ORF sequence had already been determined (Chapter 3), it was 
possible to construct a replacement experiment that would unambiguously create a 
null mutation of cdc37' by complete removal of the predicted ORF. 
The deletion construct was created in the cloning vector pBluescript SK- (Fig 4.1). 
Eight hundred and twenty six bp of 5' and 804 bp of 3' flanking regions were 
amplified separately from the pBluescript.cdc3 7+ plasmid by PCR and each was 
cloned into pGEM-T seperately. These regions were then cloned sequentially into 
pBluescript SK- using the appropriate restriction enzymes. Using a restriction site 
engineered by the PCR, the selectable marker, ura4, was inserted between these 
regions. The final construct contained a linearisable deletion fragment including two 
827 bp regions of DNA normally either side of the cdc37+ gene with the ura4 
marker inserted between (Appendix 1D). The linear cdc37+ deletion fragment could 
be released from the plasmid by digestion with the appropriate restriction enzymes. 
Two haploid strains were used to construct a diploid of the genotype ade6- 
M21 O/ade6-M21 6 ura4-D181ura4-D1 8 leul -32/leul-32 h/h (section 2.5.3 a,e). 
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Fig 4.1 Constructing a fragment for cdc37 deletion in S.pombe 
A 3388 bp EcoRI-XhoI linear cdc374 deletion fragment was constructed in 
pBluescript SK-. A. An 826 bp region of genomic DNA immediately upstream of 
the cdc3 7 gene was amplified by PCR using primers PW7 (containing an EcoRI site) 
and PW8 (containing an engineered HindIH site). The PCR product was cloned into 
pGEM-T, sequenced and then cloned into pBluescript SK- using EcoRI and Hind!!!. 
B. An 804 bp region of genomic DNA immediately downstream of the cdc37 gene 
was also amplified by PCR using primers PW9 (containing an an engineered Hind!!! 
site) and PW1O (containing aXhol* site). This PCR product was also cloned 
separately into pGEM-T, sequenced and then cloned into pBluescript SK- (already 
containing 5' flanker) using HindlII and Athol. C. Finally, a 1758 bp Hindul 
fragment, containing the ura4 gene, was digested from pBR322 and inserted into the 
engineered Hind!II between the two flanking regions. 
* 5 out of 6 bp of the XhoI recognition site were present in the genomic sequence of 
the 3' flanking region, therefore primer PW1 0 contained I engineered base to create a 
XhoI restriction site. 
transform the diploid (section 2.5.5). Heterozygous diploid transformants were 
selected on minimal, plates supplemented with leucine. These stable transformants 
needed to be tested further to ensure that homologous recombination had taken place 
as expected and indeed, a 2074 bp region of the cdc37 gene containing the entire 
ORF had been replaced by a 1758 bp fragment containing the selectable marker, 
ura4 (Fig 4.2). 
4.2.2 Phenotype of cdc37 deletion mutation 
From the 32 diploid transformants tested, 9 showed stable mitotic inheritance of the 
ura4 marker (section 2.5.6) and were sporulation competent. Two of these 
transformants (1 and 25) were selected, allowed to sporulate and tetrad analysis 
carried out. Analysis of 20 tetrads from each transformant showed that only two 
viable spores were ever generated and in all cases the viable spores were unable to 
grow without uracil, suggesting that cdc37 is essential for viability in S.pombe and 
deletion of this gene results in a lethal phenotype. The inviable spores generated from 
meiosis in the diploids had varying phenotypes; mostly, the spores were able to 
divide 0-5 times (Fig 4.3). Some of these cells were elongated, indicating a cell cycle 
defect; some cells appeared as normal, whilst others were round and swollen, 
suggesting other biological roles for cdc37. However, a significant number of iicdc37 
spores failed to germinate at all. 
4.2.3 Confirmation of ura4 integration at the cdc37F  chromosomal locus 
Before further characterisation of the cdc37V,icdc37 strain took place, transfonnant 
1 was tested by Southern analysis and PCR to show that the ura4 marker had 
integrated at the cdc37 locus as expected. Both the PCR and Southern blot analysis 
A 	 -' 	cdc3 gene 	10 
I 
EcoR I 	 Ip 	V/Ic)! 
B 
p 	 ( 
C 	 ura4ne 
Fig 4.2 Strategy of one-step gene replacement for cdc37 deletion in S.pombe 
The cdc3 7 gene was replaced in one chromosome in a ura4-D181'ura4-D18 diploid 
by replacement with the ura4 gene using the one-step gene replacement method. A. 
Normal arrangement of cdc37 gene on chromosome 2 in S.pombe. B. The linear 
deletion fragment was released from plasmid pBluescript SK- .cdc3 7 (Appendix I D) 
by digestion with EcoRI and XhoI. It was then transformed into a ura- diploid strain 
and integrated into one chromosome by homologous recombination. C. Final 
arrangement at cdc3 7 locus in one copy of chromosome 2 in transformed diploid 
strain. Transformants were selected for their ability to grow on minimal medium 
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Fig 4.3 Phenotypes of progeny derived from cdc371zcdc37 heterozygous 
diploid 
A cdc3747cdc37 heterozygous diploid was allowed to sporulate on ME medium at 
20°C for 2 days. Tetrad analysis was then carried out and the progeny analysed. 
Shown is a typical set of cells grown at 30 °C for 2 days from spores. Spores A and 
B are viable, containing the cdc3 7 gene and therefore do not carry the ura4 marker. 
Spores C and D are zLcdc3 7 cells and are inviable, managing only between 0 and 5 
divisions. The white bar in the top right hand corner represents 10 gm. 
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were carried out on the heterozygous diploid, the parent haploid strains and the 
viable progeny haploid cells. The chromosomal DNA was prepared from the strains 
after growing overnight in suitably supplemented minimal medium at 30 °C (section 
2.5.7). The Southern blot shows that bands corresponding to both the cdc37 locus 
and the Acdc37 locus are present in the cdc37/4cdc37 diploid, whilst a band 
corresponding only to the wild-type locus is visible in the parent haploids and viable 
progeny (Fig 4.4). The PCR confirms this observation; amplification is possible 
with both the cdc3 7 -specific and ura4 -specific primers in the cdc3 7Vztcdc3 7 
diploid, whilst only with the cdc37-specific primer in the parent haploids and viable 
progeny (Fig 4.5). These analyses confirmed that the cdc37 gene was deleted at one 
chromosomal locus in the diploid by a single integration event of the urar gene. 
Transformant 1 was used in all subsequent experiments. 
4.3 Rescue of cdc3 7 deletion lethality by regulatable expression of 
the cdc37'ORF 
4.3.1 Cloning cdc37F  into the pREP S.pombe expression vectors 
Ectopic expression of cdc3 7 was carried out in the pREP 1 vectors, which carry the 
S. cerevisiae marker LEU2 and various strength versions of the thiamine-repressible 
S.pombe nmtl promoter. pREP 1 carries the wild-type, full-strength nmtl promoter. 
By site-directed mutations in the TATA box, two lower strength versions of the 
nmtl promoter were generated. They are contained in pREP41 (mid-strength) and 
pREP8 1 (low-strength). For this project, these set of selectable plasmids allow 
regulatable expression of cdc3 7+ at various levels. When thiamine is absent from the 
medium, the promoters are fully functional and cdc37+ is expressed. When thiamine 
is added to the medium, expression of cdc3 7+ is repressed. 
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5' flanking probe 
ivf 	 o*— 4187 bp 
cdc37 probe 
4.0 4040411140 -.0— 4187 hp 
ura4 probe 
123456 
- 	 ------- 3841 hp 
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D. Probe location 









u- a4 - 
Probe  
Fig 4.4 Southern analysis of cdc3714cdc37 heterozygous diploid 
Genomic DNA was extracted from a cdc37/4cdc37 heterozygous diploid, the parent 
haploids and the viable progeny derived from sporulation of the diploid. The 
genomic DNA was digested with EcoRI at 37°C for 8 hr before electrophoresis on a 
1% agarose gel and Southern blotting on to a nylon filter. Panel A shows the filter 
hybridised with an 827 bp radiolabelled EcoRI-HindlIl fragment of DNA normally 
flanking the 5' end of the cdc37 gene, panel B hybridised with a 712 bp radiolabelled 
NdeI-NdeI fragment of the cdc3 7 ORF and panel C hybridised with an 820 bp 
radiolabelled NsiI fragment of the ura4 ORF. The 4187 bp band corresponds to the 
wild-type locus and the 3841 bp band to the deleted locus. Lanes I and 2 contain the 
digested DNA from two independent colonies of the diploid, lanes 3 and 4 the DNA 
of the two parent haploids and lanes 5 and 6 the DNA of the two viable spores 

















Fig 4.5 PCR analysis of cdc3 7/ijcdc3 7 heterozygous diploid 
Genomic DNA was extracted from cdc371,dcdc37 heterozygous diploid 
transformant 1, the parent haploids and the viable progeny derived from sporulation 
of the diploid. PCR was carried out using a forward primer against the sequence that 
flanks the cdc3 7+ gene (primer PW 13) and either a reverse primer against the cdc3 7 
ORF (primer PW3), or a reverse primer against the ura4 ORF (primer RB 1). The 
results were run on a 1% agarose gel containing 0.5 gg/ml ethidium bromide. Gel A 
shows the results with the cdc3 7+-specific primer and gel B shows the results with 
the ura4 primer. The 1746 bp bands are the amplification products from the wild-
type locus and 971 bp bands from the deleted locus. Lanes 1 and 2 contain the PCR 
products from two independent colonies of the diploid, lanes 3 and 4 the products of 
the two parent haploids and lanes 5 and 6 the products of the two viable spores 
derived from meiosis of the diploid. 
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The gene was cloned in two stages into the pREP vectors because of the two internal 
NdeI sites in the cdc37+ ORF as previously described (Fig 3.1). Firstly, a 238 bp 
fragment containing the translation initiation site was cloned into the corresponding 
restriction sites contained in the pREP vectors, pREP!, pREP41 and pREP81 (Fig 
4.6). Subsequently, the remaining 1167 bp fragment of the ORF was then inserted 
into each vector. This resulted in the cdc37 gene cloned downstream of the nmtl 
promoter in the pREP vectors (Appendix 1E). 
4.3.2 Phenotypes resulting from various expression levels of the cdc3 7+ Offl in 
the cdc3 7 deletion mutant 
The pREP.cdc37+ORF constructs were transformed into the cdc37+/4cdc37 
heterozygous diploid (section 2.5.5). Diploid transformants were selected on 
minimal plates with no supplements. The resultant diploids were then allowed to 
sporulate by incubating on ME plates at 25°C for 48 hr. Random spore analysis was 
then carried out (section 2.5.3b) and 4cdc37 haploids (containing ura4) were 
selected for on minimal plates containing adenine and leucine. These haploids were 
then tested on minimal plates supplemented only with adenine for presence of the 
leucine marker carried on the plasmid. Every haploid isolated that carried the ura4 
marker for cdc3 7+ deletion, also contained the leucine marker from the pREP plasmid 
expressing cdc37+. Thus, the 4cdc37 haploids can only survive when maintained by 
the pREP1/41/81.cdc37+ORF constructs; further evidence that the cdc37+ gene is 
essential for viability in S.pombe. 
The 3 new strains - cdc3 7: :ura'[' [pREP 1 .cdc3 7+ ORF]; 
cdc3 7+: :ura4 [pREP4 1 .cdc3 7+ ORF]; cdc3 7+: :ura4 [pREP8 1 .cdc3 7+ORF] - were 
maintained on minimal plates supplemented with adenine. In order to investigate the 
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Fig 4.6 Cloning cdc3 7 into the pREP S.pombe expression vectors 
The cdc3 7 ORF was cloned into the S.pombe expression vectors, pREP, in two 
stages. A. The 238 bp NdeI-BamHI fragment (Fig 3.5) containing the 5' end of the 
cdc37 ORF was cloned into the corresponding sites in the pREP vectors. B. The 
1167 bp BamHI-SmaI fragment (Fig 3.5) containing the remaining 3' end of the 
cdc3 7 ORF was then cloned into the pREP vectors that already contained the NdeI-
BamHI fragment. 
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on minimal plates supplemented with adenine in the presence or absence of thiamine 
for 4 days at 30°C and scored for colony formation (Fig 4.7). All three icdc37 
strains formed normal-size colonies in the absence of thiamine after 4 days. The 
strain expressing cdc37' from pREP 1 also formed normal-size colonies in the 
presence of thiamine. However, the strain expressing cdc37 from pREP41 only 
formed small colonies and the strain expressing from pREP8 1 barely formed colonies 
at all, with growth restricted to the formation of microcolonies. Both of these strains 
failed to form normal colony size even after extended incubation. 
In order to gain some insight into what was causing this defect in colony formation in 
the strain expressing cdc3 7 from pREP8 1, the cells were examined more closely 
under the microscope after 24 and 48 hr at 30 °C (Fig 4.8). After 24 hr, the cells 
grown in the presence of thiamine (promoter repressed) appeared normal and very 
similar to those incubated in the absence of thiamine (promoter derepressed). 
However, after 48 hr, whilst the cells incubated in the absence of thiamine remained 
as normal, many of those grown in the presence of thiamine became elongated, 
indicating that repressing expression of the cdc37 gene from pREP81 leads to a cell 
cycle defect. Phenotypes that were also visible included cells which were swollen 
and/or misshapen, suggesting biological roles for cdc3 7 other than its involvement in 
the cell cycle. 
4.3.3 Relative RNA levels of cdc3 7 overexpression 
To ensure that the cdc37 gene was being expressed from the various strength pREP 
vectors as expected and to compare the expression levels with that of a wild-type 
strain, the relative RNA levels were analysed by Northern blot (Fig 4.9). Each of the 
strains was grown in minimal medium supplemented with adenine (in the absence or 
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Fig 4.7 Effects of cdc37 overexpression in zcdc37 strain 
4cdc3 7 haploids surviving by expression of plasmid-borne cdc3 7 from various 
strength versions of the thiamine-repressible nmt1 promoter were allowed to grow 
in the presence (promoter repressed) or absence (promoter derepressed) of 4 tg/ml 
thiamine. The cells were streaked to single colonies on plates containing 
appropriately supplemented minimal media and incubated at 30 °C for 4 days until 
visible single colonies were formed. Plate A shows the colony formation of the 
various strains in the absence of thiamine (-T) and plate B in the presence of thiamine 
(+T). ,icdc3 7 strains are expressing cdc3 7f  from, anti-clockwise from top, pREP 1 
(high expression), pREP41 (mid expression) and pREP81 (low expression). 
Fig 4.8 Effects of switching off cdc37' expression from pREP81 in Ac,,lc37 
strain 
A zcdc3 7 haploid strain surviving by expression of plasmid-bome cdc3 7 from the 
low- strength version of the thiamine-repressible nmtF promoter in pREP8 1 was 
allowed to grow in the presence (promoter repressed) or absence (promoter 
derepressed) of 4 pg/mi thiamine. The cells were streaked to single colonies on plates 
containing appropriately supplemented minimal media and incubated at 30 °C for 2 
days. Panel A shows the morphology of the cells in the absence of thiamine (-T) and 
panel B in the presence of thiamine (+T). The white bar in the bottom right hand 
corner represents 10 tim. 
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Fig 4.9 Northern analysis of zcdc37 haploids overexpressing plasmid-borne 
cdc37 
Total RNA was extracted from iicdc3 7 haploids, expressing plasmid-borne cdc3 7± 
from various strength versions of the thiamine-repressible nmt1 promoter. The 
strains were allowed to grow in the presence (promoter repressed) or absence 
(promoter de-repressed) of 4 gg/ml thiamine for 24 hr at 30'C. The RNA was 
denatured, before electrophoresis on a 1% agarose gel and Northern blotting on to a 
nylon filter. Panel A shows the gel, stained with ethidium bromide to check loading, 
whilst panel B shows the filter hybridised with a 712 bp radiolabelled NdeI fragment 
of the cdc37± ORF. The -'1.5 kb bands correspond to the cdc37 mRNA. Lanes I 
and 4 contain the RNA extracted from a iicdc3 7 strain expressing cdc3 7± from 
pREP 1; lanes 2 and 5 contain the RNA from the 4cdc3 7 expressing cdc3 7± from 
pREP4 1; lanes 3 and 6 contain the RNA from a Acdc3 7 strain expressing cdc3 7± 
from pREP8 1 and lane 7 contains RNA from a wild-type strain. Lanes 1-3 contain 
RNA extracted from cells grown in the absence of thiamine and lanes 4-6 contain 
RNA extracted from cells grown in the presence of thiamine. The RNA in lanes 1 
and 2 were diluted 1:80 and 1:12 respectively, to reduce signal to levels comparable 
with that in the other lanes. 
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presence of thiamine) at 30 °C with constant shaking for 24 hr. RNA was then 
extracted from each of the strains as previously described (section 2.5.8). 
The derepressed level of cdc3 7' expressed from pREP 8 1 is slightly higher than the 
level of expression in wild-type cells, whilst the derepressed expression from 
pREP41 and pREP! is much higher. However, the repressed expression levels in all 
3 strains are not high enough for the RNA to be visible on the blot, indicating that 
they are much lower than wild-type expression. Interestingly, the level of expression 
with the promoter repressed in the strain expressing cdc3 7 from pREP 1 is much 
lower than that of wild-type, yet the cells continue to grow and appear as normal. 
4.4 Summary 
This chapter describes the investigation on the effects of the removal of cdc37 from 
the S.pombe genome. When a cdc3774cdc37 diploid is allowed to sporulate only 
two of the four progeny are ever viable and they never carry the marker for cdc3 7 
deletion. This shows that the cdc37' gene is essential for viability in S.pombe. A 
null mutant can be maintained by expression of cdc37 from the low-strength nmtl 
promoter in pREP 8 1. With expression derepressed, the cells appear to grow as 
normal; when repressed, many of the cells become elongated. This elongation 
phenotype is indicative of a cell cycle role for cdc3 7' in S.pombe. This evidence 
agrees well with that from S. cerevisiae where the CDC3 7 gene has also been shown 
to be essential and ts mutants predominantly display a cell cycle defect at the 
restrictive temperature. However, it appears that cdc37 also has other biological 
functions in S.pombe, as some of the cells appeared swollen and/or misshapen. 
Since the AcdO7 strain expressing cdc37 from pREP81 had identified the cell cycle 
role of cdc3 7 in S.pombe, the next obvious step seemed to be to examine the 
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physiology of this strain more closely. Detailed experiments were planned to 
attempt to identify at which stage(s) of the cell cycle cdc3 7' is required. These 
experiments are described in Chapter 5. 
Ip 
Chapter 5 
Effects of Cdc37 depletion 
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5.1 Introduction 
The cdc37.:ura4[pREP81.cdc37ORF] strain described in the previous chapter 
provides a convenient tool for analysing the physiological role of Cdc37. As 
described previously, this conditional mutant grows normally when the promoter is 
derepressed but when repressed (by the addition of thiamine to the growth medium), 
some of the cells become elongated, indicating a cell cycle defect. 
S.pombe cells grow by tip elongation; they co-ordinate cell growth and cell division, 
therefore cell length is a good measure of the cell cycle stage of a cell. The detailed 
analyses described in this chapter, including cell length studies and FACS analysis, 
can provide useful information about the specific stage of a defect in the cell cycle. 
In order to gain further understanding of the physiological role of Cdc37, a depletion 
experiment was carried out. The cells were allowed to grow in liquid culture 
overnight in the absence of thiamine, with the promoter derepressed, before they 
were moved into minimal medium containing thiamine, with the promoter repressed. 
Several physiological effects of Cdc37 depletion were then analysed at certain time-
points throughout the experiment. 
5.2 Effect of Cdc37 depletion on growth and division 
In the expression experiments on plates described in the last chapter (section 4.3), 
little or no effect of repressing cdc37 expression in the 
cdc37::ura4[pREP81 .cdc37ORF] strain was observed after 24 hr incubation. 
However, after 48 hr, the phenotypes were visible and severe. Because of this, both 
growth and cell number of a liquid culture were monitored between 24 and 48 hr after 







24 	28 	32 	36 	40 	44 	48 
Time (hrs) 
Fig 5.1 Measurement of culture growth and cell number of the 
cdc37::ura4LpREP81.cdc37'ORFI strain grown in the presence or absence of 
thiamine 
Samples to measure the culture growth and cell number of the 
cdc3 7:: ura4[pREP8 1 .cdc3 7ORF] strain grown in the presence or absence of 
thiamine were taken every 2 hrs between 24 and 48 hrs after the addition of thiamine. 
Culture growth was estimated by measurement of the OD at 595 nm and cell division 
was monitored by a cell number count using a Coulter Counter. A y-axis value of 1 
on the graph represents an 0D 595 of 1 for the relative 0D 595 plot and a value of 10 
represents 107  cells/ml for the relative cell no. plot. 
115 
the OD at 595 nm (section 2.5.4a) and cell division was monitored by a cell number 
count using a Coulter Counter (section 2.5.4b). Samples for both culture growth and 
cell number were taken every 2 hr. 
Agreeing well with the observations described in the last chapter (section 4.3.2), 
between 0 and 24 hr after the addition of thiamine, the culture growth is exponential 
and has grown slightly faster than a culture grown in the absence of thiamine (Fig 
5.1). However, approximately 28 hr after the addition of thiamine, cell division 
begins to slow down, followed shortly after by a decrease in the culture growth rate. 
Forty hours after the addition of thiamine, both culture growth and cell division has 
almost stopped, whilst the cells grown in the absence of thiamine continued to grow 
and divide exponentially throughout the duration of the experiment. It is not 
understood why the cells in the presence of thiamine should grow faster than those 
grown without for the first 24 hr and no obvious explanation exists for this 
phenomenon. 
5.3 Cell length studies on Cdc37 depleted cells 
In order to confirm the observation (section 4.3.2) that one of the primary 
phenotypes of repressing cdc3 7 expression was elongation of the cells, thus 
suggesting a defect in cell cycle progress, cell length analysis was carried out (Fig 5.2, 
Fig 5.3). Initially, as with all of the rest of the analyses carried out in this chapter, 
samples were taken every 4 hr between 24 hr and 40 hr after the addition of thiamine 
and cell length measurements were taken of several hundred cells in each sample using 
the IPLab software (section 2.5.4c). However, it was noticed that after 24 hr, the 
cells grown in the presence of thiamine were significantly shorter than those grown in 
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Fig 5.2 Mean cell length of cdc37::ura4[pREP81.cdc37ORF1 cells grown in the 
presence of thiamine 
The lengths of cdc37..ura4[pREP81 .cdc37ORF] cells were measured from cultures 
grown in the presence of thiamine. Shown is a graph of mean cell length for each 
sample, taken every 4 hr between 16 hr and 40 hr after the addition of thiamine. The 
dashed line represents the mean cell length of cells grown in the absence of thiamine. 
Above the main graph is a plot of cell number for this experiment. A y-axis value of 
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Fig 5.3 Cell length distribution of cdc37::ura4tpREP81.cdc37i cells grown in 
the presence of thiamine 
The lengths of -200 cdc3 7:: ura4[pREP8 I .cdc3 T] cells were measured from cultures 
grown in the presence of thiamine. Shown is a histogram of the cell length data for 
each sample, taken every 4 hr between 16 hr and 40 hr after the addition of thiamine. 
The mean cell length for each sample is represented by a black triangle on the X-axis. 
A typical sample from a culture grown in the absence of thiamine is also shown as a 
control. 
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Sixteen hours after the addition of thiamine, the mean cell length is significantly 
shorter than the control cells grown in the absence of thiamine and continues to drop 
for another 12 hr (Fig 5.2). This is due to the presence of a population of cells that 
are much smaller than wild-type and their presence is difficult to explain (Fig 5.3). It 
is unknown if this is a direct effect of Cdc37 depletion or whether it is the cells 
adapting in some way to the loss of Cdc37 protein. After -28 hr after the addition of 
thiamine the mean cell length begins to increase dramatically and this continues 
throughout the remainder of the experiment (Fig 5.2). This increase in mean cell 
length is due to the appearance of a significant population of elongated cells (Fig 5.3). 
However, despite the fact that a significant proportion of the cells become elongated 
after 28 hr after the addition of thiamine, a population of small cells remain 
throughout the experiment (Fig 5.3). 
It seems highly significant that cell division appears to slow down at a similar time to 
when this increase in mean cell length begins to occur (Fig 5.2). However, although 
there is definite and significant elongation after 28 hr after repressing cdc37 
expression, this elongation phenotype alone does not appear to be severe enough for 
proliferation to cease. This suggests further biological roles for cdc3 7f• 
5.4 Measuring DNA content of Cdc37 depleted cells 
The cell length analysis (section 5.3) confirmed that elongation is a primary 
phenotype of cells where cdc3 7 expression is repressed, indicative of a cell cycle 
defect. Significant elongation in S.pombe usually reveals that a cell cycle defect is 
occurring during interphase (G I, G2 or S phase) as these are the stages during which 
most growth occurs. Defects in mitosis do not cause significant elongation as very 
little growth occurs during these stages. To gain more insight into the stages of the 
cell cycle at which this visible defect occurs, the DNA content of the 
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cdc37::ura4[pREP81 .cdc37+ORF] cells grown in the presence or absence of thiamine 
were subjected to flow cytometric analysis (Fig 5.4). Samples were processed every 
4 hr between 24 hr and 40 hr after the addition of thiamine (section 2.5.40. 
In the culture growing in the absence of thiamine, a sharp 2C peak is seen in all 
samples, which is typical of an exponentially growing S.pombe culture (Nurse etal., 
1976). This 2C peak is seen because S.pombe replicate their DNA almost 
simultaneously with septation. In the culture growing in the presence of thiamine, 
only 2C peaks are seen in all samples as well; however, the peaks become less sharp 
after —'24 hr. This is probably due to effects caused by other roles of cdc3 7+. 
Unfortunately, due to the way S.pombe cells grow and divide it is impossible to 
distinguish on this basis alone between a G2 arrest and exponentially growing cells. 
However, since there is no significant 1C peak, indicative of a G  arrest, or a 4 or 8C 
peak, indicative of a septation defect, it can be concluded with some confidence that 
the population of elongated cells caused by Cdc37 depletion is due to a defect in the 
G2 and/or the mitotic phase of the cell cycle, where the cells have a 2C DNA 
content. 
5.5 Nuclear and cell wall staining of Cdc37 depleted cells 
In order to gain further insight into the mechanism of cell cycle arrest caused by 
Cdc37 depletion, cdc37::ura4[pREP81.cdc37+ORF] cells were stained with either 
DAPI, which stains the nucleus (Toda etal., 1981), or calcofluor, which stains the 
cell wall and particularly the septum (Mitchison and Nurse, 1985), after growth in 
the presence or absence of thiamine (Fig 5.5-Fig 5.6). Samples were taken every 4 hr 
between 24 hr and 40 hr after the addition of thiamine, stained and visualised 
immediately (sections 2.5.4d and 2.5.4e). 
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Fig 5.4 FACS analysis of cdc37::ura4[pREP81.cdc37] cells in the presence of 
thiamine 
The DNA content of cdc3 7::ura4[pREP8 1 .cdc3 7] cells stained with propidium 
iodide was measured by flow cytometry from cultures grown in the presence of 
thiamine. The linear fluoresence diagrams show relative DNA content (arbitrary 
units) on the x-axis and cell number on the y-axis for each sample, taken every 4 hr 
between 24 hr and 40 hr after the addition of thiamine. A typical sample from a 
culture grown in the absence of thiamine (-T) is also shown as a control. 
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At —24 hr after the addition of thiamine, the calcofluor staining shows that most of 
the cdc37::ura4[pREP81 .cdc37ORF] cells are shorter than the control cells grown 
in the absence of thiamine (Fig 5.5). At —32 hr, some of these cells have begun to 
elongate and some are beginning to look swollen and/or misshapen whereas at —40 hr 
most of the cells have ceased proliferation, showing a variety of phenotypes 
previously described (section 4.3.2). These include cells that are small and round, 
some that are swollen and/or misshapen and some that are elongated, whilst some are 
a combination of these phenotypes. Also, there is a significant number of cells that 
are clearly defective in septation and cytokinesis, containing multiple septa and have 
also become elongated. 
The DAPI staining also reveals a variety of phenotypes (Fig 5.6). At —24hr after the 
addition of thiamine, the majority of cells still appear to be dividing normally. 
However, at —32 hr and even more so at —40 hr, cell division ceases to continue 
normally. The most noticable cells are those that are elongated: some contain what 
appear to be normal interphase nuclei, perhaps arrested in G2; others contain nuclei 
that have failed to migrate properly; a smaller number of elongated cells appear to 
contain multiple nuclei (3 or 4) with or without a septum that have failed to undergo 
proper division at the septum. There are also a significant proportion of fairly 
normal length cells that appear to have undergone a defective mitosis and have 
arrested with hypercondensed chromosomes. As already described with the 
calcofluor staining, however, there is considerable heterogeneity within the 







Fig 5.5 Calcofluor staining of cdc37::ura4IpREP81.cdc371 cells grown in the 
presence of thiamine 
cdc37:.'ura4[pREP8I .cdc37] cells were grown in the presence of 4 pg/mlthiamine 
and stained with Calcofluor. Samples were taken at 24 hr, 32 hr and 40 hr after the 
addition of thiamine. The cells were processed by fixation with 2.5% glutaraldehyde, 
stained with 0.5 mg/ml Calcofluor and visualised immediately. Typical samples from 
a culture grown in the absence of thiamine (-T) are also shown as a control. The 






Fig 5.6 DAN staining of cdc37::ura4Icdc37VpREP81J cells grown in the 
presence of thiamine 
cdc37::ura4[cdc37/pREP81] cells were grown in the presence of thiamine and 
stained with DAPI. Samples were taken at 24 hr, 32 hr and 40 hr after the addition 
of thiamine. The cells were processed by fixation with 2.5% glutaraldehyde, stained 
with 10 mg/ml DAPI and visualised immediately. Typical samples from a culture 
grown in the absence of thiamine (-T) are also shown as a control. The white bar in 
the top right hand corner represents 10 gm. 
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5.6 Summary 
The examination of the cdc37::ura4[pREP81.cdc37ORF] strain described in this 
chapter provides further information on the role of Cdc37 in the S.pombe cell cycle. 
Cell length analysis confirms that elongation is a primary phenotype of cells where 
cdc3 7 expression has been repressed. This is strong evidence that cdc3 7 plays an 
important role in the cell cycle. 
Interestingly, the FACS analysis and cell staining data suggest that, unlike in 
S.cerevisiae where CDC37 is required at START in Gi, the primary cell cycle 
defects in S.pombe occur during both G2 and mitosis. However, it appears that 
Cdc37 is not only involved in the cell cycle in S.pombe. Depletion of Cdc37 results 
in a very heterogenous population, suggesting other biological roles. Obvious 
phenotypes which appear to be unconnected with the cell cycle include swollen 
and/or misshapen cells. Also, a significant number of cells showed defects in 
septation; many cells have formed septa but have not undergone cytokinesis, 
resulting in multiseptated cells. It would be very interesting to examine these other 
phenotypes in more detail and to investigate the mechanisms involved. 
The variety of observations described in this chapter indicates that the biological role 
of Cdc37 in S.pombe is complex and it will take some time to separate the functions 
and understand them completely. However, there does appear to be a considerable 
number of cells present with specific cell cycle defects caused by Cdc37 depletion 
which appear to affect cells in the G2 and mitotic stages of the cell cycle. As 
explained in Chapter 1, the complex which regulates the G2/M transition in S.pombe 
is the Cdc2/Cdc13 complex. This complex seemed to be a good target for preliminary 




Towards determining the 
cell cycle role of Cdc37 
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6.1 Introduction 
Observations from the previous chapter indicate that cdc3 7 is required both during 
the G2 phase of the cell cycle and during mitosis. As described in Chapter 1, the 
G2IM transition is regulated by the Cdc2/Cdc 13 complex. Therefore, both of these 
proteins provided obvious targets for interaction with Cdc37. Also, as described in 
Chapter 1, Cdc37 has previously been shown to physically interact with the 
mammalian cell cycle regulator Cdk4 (Dai et al., 1996), though no interaction with 
Cdc28 has yet been shown in 5'. cerevisiae. This chapter describes preliminary 
experiments designed to examine the potential interactions of Cdc37 with Cdc2 and 
Cdcl3 using both genetic and biochemical approaches. 
The expression constructs described in Chapter 4 (section 4.3. 1) allowed examination 
of the effects of overexpression of cdc3 7 in a wild type strain and various ts 
mutants. This type of analysis is often used in S.pombe to detect potential 
interactions and thus suggest possible biological roles of the gene of interest. Several 
alleles of cdc21s  and cdcl3ts  mutants were available for this investigation and 
overexpression of cdc3 7 was examined thoroughly in all of these strains. 
In order to determine whether any physical interactions of Cdc37 could be detected, 
a strain expressing a functional His6-tagged version of the protein was constructed. 
Since we had available a previously successful commercial anti-His antibody (Santa 
Cruz), anti-Cdc2 and anti-Cdcl3 antibodies, it was decided that this was the best 
approach to use due to the time constraints which were existent. 
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6.2 Levels of Cdc2 protein in Cdc37 depleted cells 
Since the observations from the FACS and cytological analysis suggest that the 
primary cell cycle defect in Cdc37 depleted cells is during G2 and mitosis, the Cdc2 
levels were analysed by Western blotting (section 2.3.4) in another depletion 
experiment identical to that described in the last chapter (Fig 6.1). Every 4 hr 
between 24 hr and 40 hr after the addition of thiamine, samples were removed from 
the culture and denatured protein was extracted as previously described (section 
2.5.9). 
To monitor the Cdc2 levels, the blot was probed with an antibody raised against a 
peptide with the amino acid sequence PSTAIR (Hamaguchi et al., 1992), a motif 
conserved in all p34 2 kinases which include Cdc2 in S.pombe. This showed that 
the level of Cdc2 is significantly reduced in the cdc37::ura4[pREP8l.cdc37ORF] 
cells 24 hr after the addition of thiamine, when the cells still appear to be dividing 
normally. The expression level appears to diminish from 24 hr onwards in this 
experiment, until eventually, the Cdc2 level 40 hr after the addition of thiamine is 
significantly reduced. This appears to be a significant finding, as the levels of cdc2 
are normally very stable in S.pombe. 
An attempt was also made at monitoring the cdc13 expression levels in this 
depletion experiment. However, neither of the available antibodies was found to 
detect Cdcl 3 in this lab, even in wild type extracts. 
6.3 Genetic interactions of cdc37 
Another strategy designed to find out more about the interactions of Cdc37 in 
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Fig 6.1 Western blot showing Cdc2 levels in cdc37::ura4IpREP81.cdc37ORF1 
cells grown in the presence of thiamine 
Protein was extracted from cdc37::ura4[pREP8l.cdc37ORF] cells grown in the 
presence of thiamine. The protein extracts were boiled immediately before 
electrophoresis on a 12.5% polyacrylamide gel and Western blotting on to a nylon 
filter. Panel A shows the blot probed with anti-PSTAIR for analysing Cdc2 protein 
levels whilst panel B shows the blot probed with anti-u-tubulin as a loading control. 
Lane I contains the protein extract from a wild-type strain and lane 2 contains the 
extract from cdc3 7:: ura4[pREP8 1 .cdc3 
7f  ORF] cells grown in the absence of 
thiamine, and lanes 3, 4, 5, 6 and 7 contain the extract from cells grown in the 
presence of thiamine 24, 28, 32, 36 and 40 hr after the addition of thiamine, 
respectively. 
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observations described in Chapter 5 had suggested the interaction of Cdc37 with the 
Cdc2/Cdc 13 complex, it seemed a sensible step to carry out further analysis with 
various cdc2 and cdc13 mutants that were available. As discussed in Chapters 1 
and 7, other potential targets for interaction included Swol (Hsp90) and Wee 1, for 
which ts mutants were available. Also, the effect of overexpression in a wild-type 
strain was tested. 
Overexpression of cdc37' from pREP41 and pREP81 appeared to have no effect in 
any of the strains tested and overexpression from any of the pREP plasmids had no 
effect on the swol-26 and wee]-50 mutant strains. However, overexpression of 
cdc37 from pREP1 had various effects on the cdc2s  and  cdcl3(s  mutants (Table 6. 1, 
Table 6.2). 
In wild-type cells overexpression of cdc3 7 from pREP 1 has little or no effect (Fig 
6.2, Fig 6.3). At all temperatures between 28°C and 35°C, wild-type cells form 
normal colonies with or without overexpression of cdc37' (Fig 6.2). The cells also 
appear as normal, though those overexpressing cdc37 may be slightly longer (Fig 
6.3). 
The effect of overexpression of cdc3 7 from pREP 1 was then tested in strains 
containing cdc2'3 and cdc13ls  alleles (Fig 6.4 - Fig. 6.7). In two strains containing 
different cdcl3Is  alleles, cdcl3-11 7 and cdc13-9, overexpression of cdc3 7' had a 
drastic effect (Fig 6.4, Fig 6.5). The restrictive temperature of the two mutants was 
severely reduced to such an extent that both of the strains failed to form normal 
colonies even at 25°C, normally a permissive temperature (Fig 6.4). When examined 
under the microscope, the cdc13 cells overexpressing cdc3 7 were greatly elongated 
(Fig 6.5). 
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Table 6.1 Colony formation of strains carrying various cdc2ts and cdcl3 ts 
alleles 
wild-type 28°C 32°C 33.5°C 35°C 
REP! +T *** 
REP1 -T 
cdc37t'REPl +T 
cdc37/REP1 -T *** 
cdcl3-11 7 28°C 32°C 33.5 °C 35°C 
REP! +T ** - 
REP  -T ** - 
cdc37/REP1 +T  
cdc37'-iREPl -T  
cdcl3-9 28°C 32°C 33.5°C 35°C 
REP  +1'  
REP1 -T  
cdc37/REP! +T  
cdc37t'REPl -T  
cdc2-33 28°C 32°C 33.5°C 35°C 
REP1 +T  
REP1 -T  
cdc37/REP1 +T  
cdc37/REP1 -T  
cdc2-L7 28°C 32°C 33.5°C 35°C 
REP  +1'  
REP1 -T  
cdc37t'REPl +T  
cdc37/REP1 -T  
cdc2-45 28°C 32°C 33.5°C 35°C 
REP  +T  
REP1 -T  
cdc37/REP1 +T  
cdc37/REP1 -T  
cdc2-17 28°C 32°C 33.5°C 35°C 
REP  +T *** *** *** ** 
REP1 -T *** *** *** ** 
cdc37/REP1 +T *** *** ** 
cdc37/REP1 -T *** ** * 
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cdc2-48 28°C 32 °C 33.5°C 35°C 
REP 1+T  
REP 1.-T  
cdc37/REP1 +T  
cdc37iREP1 -T  
cdc2-18 28°C 32°C 33.5°C 35°C 
REP! +T *** *** *** 
REP  -T *** *** *** *** 
cdc37/REP1 +T *** *** *** 
cdc37/REP1 -T *** *** ** 
cdc2-130 28°C 32 °C 33.5°C 35°C 
REP  +T *** ** ** ** 
REP1 -T *** ** ** ** 
cdc371REP1 +T ** ** ** 
cdc37/REP1 -T ** ** ** * 
cdc2-M26 28°C 32 °C 33.5°C 35°C 
REP 1+T  
REP1-T  
cdc371REP1 +T  
cdc37/REP1 -T  
Strains containing various cdc2 and cdcl3 ts alleles were transformed with the 
pREP1.cdc37ORF plasmid and empty pREP 1 as a control. The strains were then 
grown at various temperatures in the presence (promoter repressed) or absence 
(promoter derepressed) of 4 p.g/ml thiamine. The transformants were patched on to 
appropriately supplemented minimal media at 28 °C, 32°C, 33.5°C or 35°C for 24 hr, 
streaked to single colonies and incubated for a further 3 days when visible single 
colonies were formed. The formation of colonies was scored as follows: - no colony 
formation, * microcolonies formed, ** small colonies formed, 	normal color.ies 
formed. 
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Table 6.2 Morphology of cells carrying various cdc2 and cdcl3 ts alleles 
wild-type 28°C 32°C 33.5°C 35°C 
REP 1+T 3 3 3 3 
REP1-T 3 3 3 3 
cdc37/REP1 +T 3 3 3 3 
cdc3717REPl -T 3 3 3 3 
cdcl3-117 28°C 32°C 33.5°C 35°C 
REP! +T 3 3/4 4 5/6 
REP  -T 3 3/4 4 5/6 
cdc37/REP1 +T 3 3/4 4 5/6 
cdc3 7k/REP 1 -T 4 5/6 6 6 
cdcl3-9 28°C 32°C 33.5°C 35°C 
REP1 +T 3 3/4 4 5/6 
REP  -T 3 3/4 4 5/6 
cdc3 7k/REP 1 +T 3 3/4 4 5/6 
cdc3 7,REP 1 -T 4 5/6 6 6 
cdc2-33 28°C 32°C 33.5°C 35°C 
REP  +T 3 3/4 4/5 6 
REP  -T 3 3/4 4/5 6 
cdc3 7k/REP 1 +T 3 3/4 4/5 6 
cdc3 7/REP 1 -T 4 4/5 6 6 
cdc2-L7 28°C 32°C 33.5°C 35°C 
REP  +T 3 3/4 4/5 6 
REP1 -T 3 3/4 4/5 6 
cdc3 7k/REP 1 +T 3 3/4 4/5 6 
cdc3 7iREP 1 -T 4 4/5 6 6 
cdc2-45 28°C 32°C 33.5°C 35°C 
REP  +T 3/4 4 5/6 6 
REP1 -T 3/4 4 5/6 6 
cdc3 7k/REP 1 +T 3/4 4 5/6 6 
cdc3 7k/REP 1 -T 4 4/5 6 6 
cdc2-17 28°C 32°C 33.5°C 35°C 
REP 1+T 3 3 3 4/5 
REP1-T 3 3 3 4/5 
cdc3 7VREP 1 +T 3 3 3 4/5 
cdc3 7k/REP 1 -T 3/4 4/5 2/6 3/6 
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cdc2-48 28°C 32°C 33.5°C 35°C 
REP! +T 3/4 5/6 6 6 
REP  -T 3/4 5/6 6 6 
cdc377REP1 +T 3/4 5/6 6 6 
cdc3 7k/REP 1 -T 4 5/6 5/6 6 
cdc2-18 28°C 32°C 33.5°C 35°C 
REP  +T 3 3/4 3/4 4 
REP1 -T 3 3/4 3/4 4 
cdc37iREP1 +T 3 3/4 3/4 4 
cdc3 7iREP 1 -T 4 4/5 4/5 4/5 
cdc2-130 28°C 32°C 33.5°C 35°C 
REP1 +T 2/3 2/4 2/4 4/5 
REP1 -T 2/3 2/4 2/4 4/5 
cdc37/REP1 +T 2/3 2/4 2/4 4/5 
cdc3 7IREP 1 -T 2/3 2/4 2/4 3/5 
cdc2-M26 28°C 32°C 33.5°C 35°C 
REP1+T 3 4/5 6 6 
REP1-T 3 4/5 6 6 
cdc37/REP1 +T 3 4/5 6 6 
cdc3 7k/REP 1 -T 4 5/6 6 6 
Table 6.2 Morphology of cells carrying various cdc2 and cdc13 ts alleles 
Strains containing various cdc2 and cdcl3 ts alleles were transformed with the 
pREP1.cdc37ORF plasmid and empty pREP1 as a control. The strains were then 
grown at various temperatures in the presence (promoter repressed) or absence 
(promoter derepressed) of 4 ig/ml thiamine. The transformants were patched on to 
appropriately supplemented minimal media at 28°C, 32°C, 33.5°C or 35°C for 24 hr, 
streaked to single colonies, used to inoculate a liquid culture and incubated for a 
further 24 hr. The cell morphology was scored as follows: 1, very short, 2, short, 3, 
wild-type length, 4, long, 5, very long (still proliferating), 6, very long (causing 
proliferation to cease). 
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Fig 6.2 Effects of cdc37 overexpression in a wild-type S.pombe strain 
A wild-type strain was transformed with the pREPl.cdc37'ORF plasmid and empty 
pREP 1 as a control. The strain was then grown at various temperatures in the 
presence (promoter repressed) or absence (promoter derepressed) of 4 ig/ml 
thiamine. The transformants were patched on to appropriately supplemented 
minimal media at 28°C, 32°C, 33.5'C or 35°C for 24 hr, streaked to single colonies 
and incubated for a further 3 days when visible single colonies were formed. Plate A 
shows the colony formation of the strain grown at 32°C in the presence of thiamine 
(+T) and plate B in the absence of thiamine (-T). On both plates, the strain on the 
left contains pREP I and the strain on the right contains pREP I .cdc37ORF. 
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Fig 6.3 Effects of cdc37+ overexpression in a wild-type S.pombe strain 
A wild-type strain was transformed with the pREP I .cdc3 7+ ORF plasmid and empty 
pREP 1 as a control. The strain was then grown at various temperatures in the 
presence (promoter repressed) or absence (promoter derepressed) of 4 tg/ml 
thiamine. The transformants were patched on to appropriately supplemented 
minimal media at 28°C, 32°C, 33.5°C or 35°C for 24 hr, used to inoculate a liquid 
culture and incubated for a further 24 hr. Panel A shows the morphology of cells 
grown at 32°C containing pREP 1 and panel B shows cells containing 
pREP1.cdc37+ORF. The white bar in the bottom right hand corner represents 10 
pm. 
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Fig 6.4 Effects of cdc3 7 overexpression in two cdcl3 Is S.pombe strains 
Two cdcl3 ts strains (cdcl3-1 17 and cdcl3-9) were transformed with the 
pREP1.cdc37ORF plasmid and empty pREP1 as a control. The strains were then 
grown at various temperatures in the presence (promoter repressed) or absence 
(promoter derepressed) of 4 .tg/ml thiamine. The transformants were patched on to 
appropriately supplemented minimal media at 28 °C, 32°C, 33.5 °C or 35 °C for 24 hr, 
streaked to single colonies and incubated for a further 3 days when visible single 
colonies were formed. Plate A shows the colony formation of the strain grown at 
32°C in the presence of thiamine and plate B in the absence of thiamine. On both 
plates, the strains are, clockwise from top: cdcl3-117 (pREP1), cdc]3-117 
(pREP 1 .cdc3 7ORF), cdcl 3-9 (pREP 1), cdcl3-9 (pREP I .cdc3 7 OpJ) 
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Fig 6.5 Effects of cdc3 7+ overexpression in two cdcl3 Is S.pombe strains 
Two cdcl3 ts strains (cdcl3-11 7 and cdcl3-9) were transformed with the 
pREP1 .cdc37+ORF plasmid and empty pREPI as a control. The strains were then 
grown at various temperatures in the presence (promoter repressed) and absence 
(promoter derepressed) of 4 pg/ml thiamine. The transformants were patched on to 
appropriately supplemented minimal media at 28°C, 32°C, 33.5°C or 35°C for 24 hr, 
used to inoculate a liquid culture and incubated for a further 24 hr. The panels above 
show the morphology of cells grown at 32°C in the absence of thiamine. Panel A 
shows cdcl3-117 (pREPI) cells, panel B cdcl3-117 (pREP1.cdc37ORF), panel C 
cdc13-9 (pREP1) and panel D cdc13-9 (pREP1.cdc37ORF) cells. The white bar in 
the bottom right hand corner represents 10 m. 
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Most of the 8 strains containing cdc2ts  alleles were also affected by overexpression of 
cdc3 7+ but to a lesser degree than with the cdc13 mutants (Table 6. 1, Table 6.2). 
The two cdc2' alleles where the overexpression of cdc3 7+ had most effect were cdc2-
33 and cdc2-L7 (Fig 6.6, Fig 6.7). In these mutants, at all temperatures the colony 
formation of the strains was affected by overexpression ofcdc37+, though to a lesser 
degree than the cdcl3t5 mutants (Fig 6.6). When examined under the microscope, the 
cdc2ts cells overexpressing cdc37+ were much more elongated and branched than those 
without overexpression, similar to the cdc13'3 mutants (Fig 6.7). This is an 
interesting observation; although the elongation of both the cdc13Is  and the two cdc2ts 
mutants were both made considerably and comparably worse by cdc3 7 
overexpression, the ability to form colonies was only slightly affected in the cdc2ls 
mutants, whilst being drastically affected in the cdcl3ls  mutants. For clarity, a 
diagram showing the location of mutations of the various cdc2ts  alleles tested is also 
included (Fig 6.8). 
6.4. Creation of a 4cdc37 strain expressing a C-terminally His-
tagged Cdc37 protein 
In order to find out whether there is any physical interaction of Cdc37 with the 
Cdc2/Cdc13 complex, reagents were prepared for attempting immunoprecipitation of 
these proteins. Due to the time constraints, a His-tagged version of the Cdc37 
protein was constructed. As described in Chapter 3, the N-terminus of the Cdc37 
proteins is highly conserved in all species to date, so the His6-tag was engineered on 
to the C-terminus. 
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Fig 6.6 Effects of cdc37"' overexpression in two cdc2 ts S.pombe strains 
Two cdc2 ts strains (cdc2-33 and cdc2-L 7) were transformed with the 
pREP I .cdc3 7+ ORF plasmid and empty pREP 1 as a control. The strains were then 
grown at various temperatures in the presence (promoter repressed) and absence 
(promoter derepressed) of 4 .tg/ml thiamine. The transformants were patched on to 
appropriately supplemented minimal media at 28 °C, 32°C, 33.5°C or 35 °C for 24 hr, 
streaked to single colonies and incubated for a further 3 days when visible single 
colonies were formed. Plate A shows the colony formation of the strain grown at 
32°C in the presence of thiamine and plate B in the absence of thiamine. On both 
plates, the strains are, clockwise from top: cdc2-33 (pREPI), cdc2-33 
(pREP 1 .cdc3 7 ORF), cdc2-L 7 (pREP!), cdc2-L 7 (pREP I .cdc3 7+ ORF). 
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Fig 6.7 Effects of cdc3 7 overexpression in two cdc2 ts S.pombe strains 
Two cdc2 ts strains (cdc2-33 and cdc2-L7) were transformed with the 
pREP 1 .cdc3 7+ ORF plasmid and empty pREP I as a control. The strains were then 
grown at various temperatures in the presence (promoter repressed) and absence 
(promoter derepressed) of 4 [tg/ml thiamine. The transformants were patched on to 
appropriately supplemented minimal media at 28°C, 32°C, 33.5°C or 35°C for 24 hr, 
used to inoculate a liquid culture and incubated for a further 24 hr. The panels above 
show the morphology of cells grown at 32°C in the absence of thiamine. Panel A 
shows cdc2-33 (pREP1) cells, panel B cdc2-33 (pREP1 .cdc37+ORF), panel C cdc2-
L7 (pREPI) and panel D cdc2-L7 (pREP1.cdc37ORF) cells. The white bar in the 
bottom right hand corner represents 10 gm. 
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TyrLS 	 Thilô7 
N C 
M26 33130 45L717 	18 48 
FIATP-binding site (aa 10-33) 
Central catalytic core region (aa 120-200) 
Allele Position (aa) Mutation Defect 
cdc2-33 177 Ala-Thr Gl/G2 arrest 
cdc2-1-7 210 Phe-Leu Gl/G2 arrest 
cdc2-45 208 Pro-Ser (ii /G2 arrest 
cdc2-17 212 Gly-Ser G2 arrest 
cdc2-48 309 Tyr-His G1/G2 arrest 
cdc2- 18 269 Leu-Ser G2 arrest 
cdc2-130 183 Gly-Glu GIIG2 arrest 
cdc2-M26 137 Pro-Ser G l/G2 arrest 
Fig 6.8 Location of mutations and phosphorylation sites of S.pombe Cdc2 
8 strains containing independent mutant alleles of cdc2 were investigated in this 
study. The schematic representation of Cdc2 shows the location of the mutations and 
the two phosphorylation sites, tyrosine 15 and threonine 167. The ATP-binding site 
is shown in orange and the catalytic region in red. Also shown in black is the region 
containing the PSTAIR motif. This sequence is present in all CDKs and is the 
antigenic region recognisable by the antibody used to detect Cdc2 in this study. 
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6.4.1 Construction of a cd67(His6) expression construct 
To create a Cdc37 protein with a C-terminal His6-tag, the cdc37 ORF was cloned 
into pREP1(His6), a plasmid derived from pREP1. The pREP1(His6) plasmid was 
created by replacing the Smal site ofpREPl (Appendix 1E) with a Notl site followed 
by the sequence that encodes 6 histidine residues and a stop codon (I.Samejima, pers. 
comm.). To create a His-tagged protein, an ORF with the stop codon removed can 
be inserted into the NdeI -Not! sites in-frame with the His6-stop sequence, resulting 
in the expression of a C-terminal His-tagged protein. 
In order to modify the 3' end of the cdc3 7+ ORF for cloning into the pREP 1 (His6) 
plasmid, site-directed mutagenesis was carried out. At the same time time as carrying 
out this 3' end modification, the two internal NdeI (a and b, Fig 3.4) sites were also 
removed to ease further cloning in the future. To carry out the mutagenesis, the 1167 
bp BamHI-SmaI fragment of the cdc37+ ORF (Appendix 1B) was cloned into the 
corresponding sites in the plasmid pTZ 1 8u (Appendix IF), which allows production 
of single-stranded DNA (section 2.4.5). The two NdeI sites were removed by single-
stranded site-directed mutagenesis (section 2.2.9a) by a single base pair change in 
each case, mutating the recognition site whilst at the same time conserving the amino 
acid sequence (Table 6.3). This mutagenesis proved extremely troublesome and for 
modification of the 3' end a different mutagenesis technique was used. 
The 3' end of the cdc37+ ORF was modified to allow cloning into the pREP 1(His6) 
plasmid. The plasmid pTZ18u.3'cdc37+ORF (Appendix IF) containing the 
modified ORF (lacking the two internal NdeI sites) was modified at the 3' end by 
double-stranded site-directed mutagenesis (section 2.2.9b). The stop codon and 3' 
Smal site were replaced with a Not! site (Table 6.3). When the resulting 1164 bp 
BamHI-NotI modified fragment was cloned into the corresponding sites in the 
pREP 1 (His6) plasmid, this resulted in a sequence encoding 6 histidines and a stop 
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Table 6.3 Sequence changes created by site-directed mutagenesis 
Ndela site (PW19) 
Ndela 
.CAT CAT ATG CTT.. 	 . .CAT CAC ATG CTT.. 
H H M L 	 H H M L 
Ndelb site (PW20) 
Ndelb 
.AAT ACA TAT GTC.. 	......4i 	. . AAT ACT TAT GTC.. 
N T Y V 	 N T Y V 
3' end (PW27+28) 
Sma I 
CAA TTG TCT TAA CCC GGG.. 
Q L S 
1 
Not I 
CAA TTG TCT TGC GGC CGC CAC CAT CAC CAT CAC CAT TAA.. 
Q L S C G R H H H H H H 
The two internal NdeI sites (a and b) were removed from the sequence for future ease 
of cloning (see Fig 3.4 for sequence). This was carried out by single-stranded site-
directed mutagenesis. The single base pair change in each case removed the NdeI 
recognition site but the amino acid sequence was preserved. The 3' end of the ORF 
was modified to allow cloning into the His-tag pREP 1 plasmid. This was carried out 
by double-stranded mutagenesis. This resulted in the stop codon and Smal site being 
replaced with a NotI site followed by a run of sequence encoding 6 histidine residues 
and a stop codon. 
codon being added to the end of the modified cdc37 ORF. Finally, the remaining 
238 bp 5' NdeI-BamHI fragment of the cdc37+ ORE (Appendix 1C) was then cloned 
into the pREP 1 (His6) vector to create the pREP 1 .cdc3 7(His6) construct (Appendix 
1G). 
6.4.2 Creation of a 4cdc37 strain expressing a C-terminally His-tagged Cdc37 
protein 
A Acdc3 7 strain expressing pREP 1 .cdc3 7(His6) was created exactly the same way as 
the zlcdc3 7 strains expressing the cdc3 7 ORE from the pREP vectors described in 
Chapter 4 (section 4.3). The ,cdc371cdc37+ heterozygous diploid 1 was transformed 
with the pREP1.cdc37(His6) construct (section 2.5.5). Diploid transformants were 
selected on minimal plates with no supplements. The resultant diploids were then 
allowed to sporulate by incubating on ME plates at 25 °C for 48 hr. Random spore 
analysis was then carried out (section 2.5.3b) and 4cdc37 haploids (containing ura4) 
were selected for on minimal plates containing adenine and leucine. These haploids 
were then tested on minimal plates supplemented only with adenine for the presence 
of the leucine marker carried on the plasmid. Again, every haploid isolated that 
carried the ura4 marker for cdc3 7 deletion also contained the leucine marker from 
the pREP1 plasmid expressing cdc37(His6). Thus, the 4cdc37 haploids can only 
survive when maintained by the pREP 1 .cdc3 7(His6) construct; this indicates that the 
Cdc37(His6) protein is functional. Furthermore, growing several icdc37 haploids 
expressing cdc3 7(His6) in the presence or absence of thiamine revealed that this 
strain behaves in exactly the same manner as the zicdc3 7 strain expressing cdc3 7+ 
from pREP 1 (Fig 4.7). 
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6.4.3 Testing for expression of the C-terminally His-tagged Cdc37 protein 
To confirm that the 4cdc3 7 strain containing the pREP 1 .cdc3 7(His6) plasmid was 
expressing a His-tagged Cdc37 protein, a Western blot (section 2.3.4) was carried 
out. The strain was grown in appropriately supplemented minimal medium (in the 
presence or absence of thiamine) and denatured protein extracted as previously 
described (section 2.5.9). The blot was probed with an anti-His6 antibody (Santa 
Cruz) to detect expression (Fig 6.8). A -'60 kDa His-tag protein is expressed in the 
4cdc37 strain containing the pREP1 .cdc37(His6) plasmid and its expression is 
thiamine-regulatable. The protein is not expressed in either the 4cdc3 7 strain 
expressing pREP! .cdc37'ORF or in wild-type extracts. Therefore, this confirmed 
that the icdc37 strain is expressing a thiamine-regulatable His-tagged Cdc37 protein. 
6.5 Immunoprecipitation using Cdc37(His6) 
The cdc37[pREPl.cdc37(His6)] strain was used for immunoprecipitation to 
investigate any physical interaction of Cdc37 with either Cdc2 and Cdcl3. Although 
the mammalian Cdc37 protein has been shown to associate with Cdk4 (Dai et al., 
1996), in S.cerevisiae, no physical interaction has been observed between Cdc37 and 
Cdc28. Therefore, it seemed a very interesting question to find out whether Cdc37 
and Cdc2 physically interact in S.pombe. 
Physical interaction between a His-tagged Cdc37 protein and Cdc2 was investigated 
by immunoprecipitation using protein extracts from the zcdc3 7 strain expressing 
cdc3 7(His6) from pREP 1. The strain was grown in appropriately supplemented 
minimal medium (in the presence or absence of thiamine) and protein extracted as 
previously described (section 2.5.10). Immunoprecipitation was carried out (section 
2.3. 1) using the anti-His6 antibody. The immunopreciptated extracts were then 
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2 	3 	4 	5 
4 	-6OkDa 
Fig 6.9 Western blot of icdc37 strain expressing cd67(His6) from pREP! 
Protein was extracted from cdc37::ura4[pREPI.cdc37(His6)] and 
cdc3 7::ura4[pREP1.cdc37] cells grown for 24 hr in the presence or absence of 
thiamine. The extracts were boiled immediately before electrophoresis on a 12.5% 
polyacrylamide gel and Western blotting on to a nylon filter. The blot shown was 
probed with anti-His6 (1:1000). Lane I contains the extract from the 
cdc3 7:: ura4[pREP I .cdc3 7(His6)] cells grown in the absence of thiamine and lane 2 
the extract from the cells grown in the presence of thiamine. Lane 3 contains the 
extract from the cdc37::ura4[pREP1.cdc37] cells grown in the absence of thiamine 
and lane 4 the extract from the cells grown in the presence of thiamine. Lane 5 
contains the protein extract from a wild-type strain as a further control. 
147 
anti-HM 
1 	2 	3 
4 	60kDa 
34 kDa 
Fig 6.10 Western blot of extracts from immunoprecipitation with anti-HIS6 
antibody 
Protein complexes were extracted from cdc37::ura4[pREP1 .cdc37(His6)] cells grown 
in the absence of thiamine. Immunoprecipitation was then carried out using a 1:100 
dilution of the anti-His6 antibody. The blot shown was probed with anti-His6 
(1:1000) and anti-PSTATR (1:50) simultaneously. Lane 1 contains the total protein 
extract from a wild-type strain as a control for the anti-PSTAIR antibody. Lane 2 
contains the immunoprecipitated extract from the cdc37::ura4[pREPI.cdc37(His6)] 
cells grown in the absence of thiamine, and lane 3 contains the no antibody 
immunoprecipitation control. 
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analysed by Western blot (section 2.3.4) and probed with the anti-PSTAIR antibody 
(Fig 6.9). However, despite numerous attempts with varying conditions, no binding 
of Cdc2 to Cdc37 was seen. 
Though the physical interaction may be less likely since no interaction between 
Cdc37 and a cyclin has been observed in any other system, investigation of the 
binding of Cdcl3 with Cdc37 would also have been a worthwhile experiment. 
However, as previously mentioned, neither of the available anti-Cdc 13 antibodies 
was found to detect Cdcl3 in this lab. 
6.6 Summary 
As a preliminary investigation into the role of cdc3 7+ in the S.pombe cell cycle, Cdc2 
protein levels were monitored in a Cdc37 depletion experiment. Cdc2 levels were 
found to be significantly reduced in a iicdc3 7 strain expressing the cdc3 7+ ORF from 
the pREP81 promoter grown in conditions where cdc37+ expression is repressed. 
When cdc37+ is strongly overexpressed (from pREP 1 promoter) in S.pombe strains 
containing ts alleles of cdc2 or, more strikingly, cdc13, the phenotypes of the cells 
become more exaggerated. In some cdc21s  alleles, there is a moderate effect, in others 
there is none, suggesting that cdc37+ does interact with cdc2 in an allele-specific 
manner to some degree. However, the locations of the mutations in the cdc2 alleles 
give no clue to the reason why cdc37+ overexpression is detrimental to the cdc2ts 
mutants. Also, in two independent cdc13s  alleles, overexpression of cdc37+ 
drastically reduces the restrictive temperature of the strains so even at the normally 
permissive temperature, the cells are unable to divide and proliferate normally. 
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These observations appear to show real interactions since overexpression of cdc3 7+ 
in a wild-type strain has little or no detectable effect. 
These preliminary analyses, together with the data from Chapter 5, seem to indicate 
that Cdc37 is involved in some way in the Cdc2/Cdc13 complex which regulates the 
cell cycle through G2 and mitosis in S.pombe. However, preliminary experiments 






The work in this thesis has identified a gene encoding a S.pombe Cdc37 protein 
which has been cloned and has undergone preliminary characterisation. The cdc3 7+ 
gene has been shown to be essential for viability, and appears to have several roles in 
vivo. This work has begun to investigate these various functions in S.pombe, with 
particular emphasis on those functions involving the key mitotic regulator, Cdc2 and 
its G2 cyclin partner, Cdc 13 (see Chapter 1). 
7.2 Cdc37 sequence and relation to its function 
The homologues of S.cerevisiae Cdc37p from various species, including Drosophila, 
human, rat, mouse and chicken, all share only moderate sequence similarity across the 
whole length of the proteins. However, all of the protein sequences are highly 
conserved at the extreme N-terminus. This project has revealed another structural 
homologue of Cdc37p, from S.pombe, which shares the same sequence conservation 
and is presently the most closely related to S.cerevisiae Cdc37p (Fig 3.6). Analysis 
of the Cdc37 protein sequences from the variety of species already mentioned shows 
that not only are the S.pombe and S. cerevisiae proteins most similar to each other 
but also that the Drosophila and vertebrate are more similar to each other than they 
are to the two yeast proteins (Fig 3.7). This becomes more interesting when taken 
together with the observation that the D. melanogaster cdc3 7 gene has been shown to 
rescue the S. cerevisiae ts mutant cdc3 7-1 (Cutforth and Rubin, 1994), whilst there is 
no evidence of rescue from the vertebrate homologues. It is not particularly clear 
whether this is because experiments to test complementation of the cdc3 7-1 mutant 
by mammalian homologues have been unsuccessful or whether the question has not 
been investigated thoroughly. However, the only publication that appears to directly 
address this question (Ozaki et al., 1995), reports that a clone containing the rat 
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cdc3 7 gene has been tested and does not rescue the temperature sensitive phenotype 
of the cdc37-1 mutant. The ability of the S.pombe cdc37 gene to rescue the 
S.cerevisiae cdc37-1 mutant has not been tested (see section 7.6.2). Due to the 
higher degree of similarity between the yeast proteins compared to that between the 
S. cerevisiae and D. melanogaster proteins, it might be expected that the cdc3 7 gene 
will rescue the restrictive phenotype of the cdc3 7-1 mutant. 
As mentioned above, the N-terminus of the Cdc37 proteins is the most highly 
conserved region. Over the first 40 amino acids the S.cerevisiae and S.pombe Cdc37 
proteins are -85% identical (Fig 3.6). The Cdc37 proteins in multicellular organisms 
are also highly similar to each other in this region and slightly less similar to the yeast 
proteins. Since the N-terminus is highly conserved among all of the species, it seems 
probable that it plays an essential role. Although little is known about the structure 
of the Cdc37 proteins in relation to its function, it has been shown that the N-
terminus of mammalian Cdc37 binds the kinase Raf-1 in vitro, whilst the C-terminus 
binds Hsp90 (Grammatikakis et al., 1999). Given that the N-terminus is so highly 
conserved, this suggests that in all species the N-terminus may bind the target 
kinases, although there is no other evidence to support this theory to date. 
7.3 The effects of loss of cdc37F function 
The work in this thesis has shown that loss of cdc3 7 gene function in S.pombe is 
lethal, consistent with the observation that CDC3 7 is an essential gene in S. cerevisiae 
(Gerber et al., 1995). Furthermore, the depletion experiments described in Chapter 5 
show that some of the primary effects of reduced Cdc37 protein levels affect cell 
cycle progress. However, there is evidence that indicates that S.pombe can survive 
even with only very low levels of Cdc37. For example, the analysis of 4cdc37 
haploid strains carrying pREP plasmids in Chapter 4 shows that cdc3 7+ mRNA 
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levels well below that of wild-type are sufficient to maintain normal proliferation 
(Fig 4.9), suggesting that wild-type S.pombe express far more cdc3 7 than is 
necessary for survival. It may be that some of the functions of Cdc37 are not crucial 
and when levels are low, the cells are able to do without or find replacement proteins 
to carry out the necessary roles. Also, further evidence indicating that only low 
levels of Cdc37 protein are required is provided by the depletion experiments 
described in Chapter 5, where the 4cdc37 haploid strain is able to survive and 
grow/divide for several generations once cdc3 7 expression from pREP 8 1 has been 
repressed (Fig 5.1). Assuming that repression of the promoter inhibits almost all 
cdc3 7 expression and even allowing for plasmid copy number heterogeneity, it is 
likely that the Cdc37 protein is stable and probably only required at low levels. 
When the expression of cdc3 7 from the pREP 8 1 promoter is repressed in a cdc3 7 
S.pombe strain, a sub-population of short cells appear and after 16 hours, some are 
extremely short (Fig 5.2, Fig 5.3). Cells with this phenotype are present throughout 
the duration of the experiment. Despite the reduction in the mean cell length caused 
by the presence of these cells, the rate of proliferation appears to be similar, if not 
slightly higher, than control cells expressing cdc37 from pREP81 (Fig 5.1). It is 
difficult to conclude whether the appearance of short cells is a direct effect of Cdc37 
depletion or whether there are secondary effects that cause this phenotype. Two 
explanations are that depletion of Cdc37 affects target kinase(s) that cause the cell 
length to shorten, either by slowing down growth relative to cell cycle progression, or 
by affecting kinase(s) involved in the cell cycle. A potential target could be the 
inhibitory kinase Wee 1, which has already been shown to require Swo 1 (Hsp90) for 
function (Aligue et al., 1994). If Weel protein function is only moderately affected 
by a depletion in Cdc37 levels, or even a complete lack of Cdc37, then the cells 
would become shorter due to premature entry into mitosis (see Chapter 1) but would 
continue to proliferate normally. 
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After expression of cdc37 from pREP81 has been repressed for around 30 hours in 
the ,.tcdc37 strain, a significant population of the cells begin to elongate noticeably 
(Fig 5.2, Fig 5.3). It is shortly after this that overall cell proliferation begins to 
decline (Fig 5.2). It therefore seems a reasonable conclusion that these two events are 
directly related. The data from the depletion experiments described in Chapter 5 
suggest that the cell elongation is due to a defect in the G2 or M phase of the cell 
cycle. From work carried out on other systems (see Chapter 1), one explanation for 
the observations described is that the depletion of Cdc37 begins to affect the function 
of Cdc2. If Cdc2 stability and/or kinase activity was to drop due to a lack of 
association with Cdc37 then it would seem likely that cell elongation would occur 
due to a delay in the onset of mitosis (see Chapter 1). 
The exact mechanisms behind the all of the observations in the Cdc37 depletion 
experiment are unclear and are very difficult to explain with the data to date. The 
heterogeneity within the population suggests that Cdc37 plays several important 
roles and therefore models that attempt to explain the experimental observations are 
probably over-simplified. A possible scenario is a combination of that described 
above. When the expression of cdc3 7 is repressed, the first target may be a kinase 
that performs less well when Cdc37 protein levels drop, but retains some sort of 
functionality. As mentioned above, a possible target could be Wee!. Thus, Wee  
may require high levels of Cdc37 to perform properly and when the levels drop, 
Wee  may still be able to play its important role but is less efficient in doing so, 
leading to shorter cells. If Cdc37 preferentially binds to Cdc2, then when the levels 
start to drop, the remaining Cdc37 could remain involved with Cdc2, hence the 
reason why Wee  may be affected first. Then, when the Cdc37 levels drop even 
further, Cdc2 becomes affected as well, which would result in delayed cell cycle 
progression, elongation of the cells and cessation of proliferation. This would also 
explain some of the heterogeneity in cell length that is observed. The cells will have 
different levels of Cdc37, thus varying the time at which Cdc2 begins to be affected 
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and elongation becomes visible. This is a tentative and over-simplified attempt at 
finding an explanation for the observations seen in this experiment. Of course, the 
heterogeneity observed is also probably due in part to other factors such as plasmid 
copy number. 
Previously, it was shown in S.cerevisiae that Cdc28p ( Cdc2 in S.pombe) levels are 
three to five times lower in the cdc37-1 mutant (Gerber et al., 1995). Recent work 
has suggested that the low Cdc28p levels are due to instability of the protein caused 
directly by of a lack of Cdc37p (Farrell and Morgan, 2000). This, together with the 
idea that cell elongation described in Chapter 5 may be due to a lack of interaction 
between Cdc37 and Cdc2 in S.pombe, led to the Cdc2 protein levels being analysed in 
the depletion experiment. The Cdc2 levels were found to decrease as Cdc37 is 
depleted (Fig 6. 1), consistent with the idea that an interaction between Cdc37 and 
Cdc2 is necessary for the stability of Cdc2. This observation agrees well with that 
seen in S.cerevisiae as mentioned above. A lack of stability of Cdc2 when Cdc37 is 
depleted would result in a gradual decrease in Cdc2 protein levels as Cdc37 is 
depleted from the cell. Therefore, it may be that once the Cdc2 protein levels drop 
to a point at which the cell can no longer maintain viability, cell cycle arrest occurs 
either in G2 or mitosis and thus proliferation ceases. However, it is very difficult to 
confirm or disprove that the drop of Cdc2 protein levels seen in the depletion 
experiment is enough to account for the arrest. Also, if cell cycle arrest was solely 
due to a lack of Cdc2p, a more uniform G2 arrest would be expected rather than a 
mixture of cells arrested at G2 or mitosis as seen in these experiments (Fig 5.5 - 5.6). 
7.4 Proteins that associate with Cdc37 
From work already described in other systems (Chapter 1), together with the cell 
cycle observations gathered in Chapter 5 of this thesis, it seems likely that S.pombe 
156 
Cdc37 is involved in the association between Cdc2 and Cdcl3 (see Chapter 1). As 
discussed above, it appears that Cdc37 has several biological roles and is likely to be 
involved in mediating the association of several kinase complexes other than that of 
Cdc2 with Cdcl3, including other Cdc2 complexes. The major role of the 
Cdc2/Cdc13 complex is entry into and during mitosis (see Chapter 1) and therefore 
this is potentially the most interesting interaction of Cdc37. For this reason, the 
work described in Chapter 6 investigates the relationship specifically between Cdc37 
and the Cdc2/Cdc13 complex. 
It has been shown in S.cerevisiae that Cdc37p appears to assist the folding of 
Cdc28p and may not directly interact with the associated cyclins at all (Farrell and 
Morgan, 2000). The conclusions by the authors of this work were that Cdc37p 
binds only to Cdc28p - not the cyclins Cln2p or Clb2p - thus holding it in a 
conformation that is accessible to the cyclins and aiding the formation of the 
CDK/cyclin complexes. These conclusions are supported by work carried out in 
mammalian systems which appears to suggest that mammalian Cdc37 specifically 
interacts with Cdk4 and Cdk6 but not with their associated cyclins (Stepanova et al., 
1996). Also, in S.pombe, genetic interactions between Swol and Cdc2 have 
previously been documented (Munoz and Jimenez, 1999). With these observations 
in mind, it seems more likely that in S.pombe, Cdc37 will interact with Cdc2 but not 
with Cdc 13. Therefore, it is an interesting observation that overexpression of cdc3 7+ 
appears to have a more marked effect on cdcl3ts  mutants than it does on cdc2 
mutants (Fig 6.5 - 6.8). It is also interesting that this overexpression enhances the 
mutant phenotypes, rather than partial or complete rescue as might be expected. 
One model which appears to explain the overexpression observations described in 
section 6.3, would be if the function of Cdc37 is to bind and hold Cdc2 in an 
activatable conformation as is believed for S.cerevisiae (Farrell and Morgan, 2000). 
If this were true, then in the case of both the cdcl3ts  and cdc21s  mutants, the excess 
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Cdc37 around may be binding excessively to Cdc2 and preventing the Cdc2/Cdc13 
interaction. The cdcl3ts  mutants might be affected because the mutant Cdcl3 
proteins may not be able to bind the wild-type Cdc2 as strongly as wild-type Cdc 13. 
The Cdc21s  mutants may be less affected because Cdc37 cannot bind as well to the 
affected mutant forms of Cdc2, therefore interfering less with the Cdc2/Cdc 13 
interaction. If this was the case, then the phenotypes of cdc3 7+ overexpression in 
cdc2 mutants would be expected to be allele-specific and this is true to a certain 
extent, where the mutant strains cdc2-33 and cdc2-L7 are most affected (Tables 6.1 
and 6.2). The model described here is extremely tentative and there are other ways to 
explain the cdc37+ overexpression observations described in section 6.3. The model 
described above may well oversimplify the underlying mechanisms. It is interesting 
to note, however, that one of the cdc2 alleles (cdc2-33) most affected by cdc37' 
overexpression (section 6.3) has also been shown to be synthetically lethal with a 
mutant allele of swot (encoding Hsp90, Munoz and Jimenez, 1999) and is severely 
affected by overexpression of wos2, a homologue encoding a cochaperone of Hsp90 
(Munoz etal., 1999). 
Also described in Chapter 6 is the observation that a his-tagged version of the Cdc37 
protein does not appear to immunoprecipitate with Cdc2 (Fig 6.9). As has been 
previously mentioned, it is thought that the conserved N-terminus of Cdc37 is 
responsible for the interaction with the target protein kinase (Grammatikakis et al., 
1999), although, Cdc37 proteins with an N-terminal tag have previously been used 
successfully (Grammatikakis et al., 1999). For this reason, the his-tag for the 
S.pombe Cdc37 protein used in this work was placed at the C-terminus to avoid any 
disruption of this interaction. The lack of physical evidence in S.pombe is 
disappointing, since a direct interaction between Cdc2 and Cdc37 would have been an 
important discovery and naturally there remains a question of the clarity of this 
negative result. Although to date, there is significant physical evidence of mammalian 
Cdc37 directly interacting with CDKs (Dai etal., 1996; Stepanova et al., 1996; 
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Mahony etal., 1998) there has been no evidence of a physical interaction between 
Cdc28 and Cdc37 in S.cerevisiae. Maybe this is because in yeast the interaction is 
more transient. This could also be the reason why it was not possible to show a 
physical interaction between the his-tagged Cdc37 protein and wild-type Cdc2 in 
S.pombe. 
As mentioned in Chapter 1, Hsp90 has usually been found in mammalian Cdc37-
Cdk4/Cdk6 complexes (Hunter and Poon, 1997). For this reason, it seems reasonable 
to predict that Cdc37 will interact with Swol (Hsp90) in S.pombe. The only Swol 
reagent that was available during this project was the swo]2  6 mutant and 
overexpression of cdc3 7+ appeared to have no effect on the phenotype of this 
mutant (section 6.3). Also, the cell cycle protein Wee  has been shown to require 
Swo 1 interaction for function (Aligue et al., 1994). Therefore, we also tested the 
wee] -50' mutant by overexpression of cdc37+ and again there was no obvious effect 
(section 6.3). If normal function of wee1 requires the formation of a 
Wee 1/Hsp9O/Cdc37 complex, then it might have been expected that overexpression 
of cdc3 7+ might partially rescue a weel ts mutant unless the mutant is completely 
without function at the restrictive temperature. Obviously, the observations 
described when cdc37+ is overexpressed in the swo]' and wee] ts  mutants do not rule 
out possible interactions of Cdc37 with either of these two proteins, but additional 
reagents such as tagged proteins and antibodies are required for further investigation. 
7.5 The biological roles of Cdc37 
The work in this thesis suggests that in S.pombe, Cdc37 has several biological roles. 
To separate and identify these roles will take a great deal of careful investigation and 
is the next logical step in this project. This work does strongly suggest however, that 
one of the most important functions of Cdc37 is its involvement with the interaction 
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between Cdc2 and Cdcl3, and thus entry into and during mitosis. The most likely 
model is that Cdc37 acts as a molecular chaperone, binding and stabilising Cdc2, 
preventing aggregation or misfolding of the kinase and thus allowing association with 
Cdc 13 to form the active complex when it is required (see Chapter 1). Other 
potential targets of Cdc37 are fairly broad but evidence from other systems suggests 
strongly that the majority of these will be specific protein kinases, some of which 
may also be involved in the cell cycle (see Chapter 1). It will be interesting to find 
out whether Cdc37 performs some or all of these functions as part of a complex with 
Hsp90 or whether it has some functions that it carries out alone (Kimura et al., 
1997). 
7.6 Further research for this project 
7.6.1 Immediate experiments 
This project has reached an exciting stage where many paths can be followed to 
investigate further the biochemical and cellular role of Cdc37 in S.pombe. One 
experiment that could be carried out without too much preparation would be to carry 
out a spore germination experiment similar to the depletion experiment described in 
Chapter 5. This may result in a less heterogenous population and the phenotypes 
may be easier to identify. In the depletion experiment factors such as plasmid 
number and stability may affect the resultant phenotypes and these would be 
eliminated in a spore germination experiment. Also, further staining including that of 
the microtubules and spindle pole bodies could also help to identify the phenotypes 
more specifically. From the DAPI staining described in section 5.5, it appears that a 
population of the Cdc37 depleted cells arrest with condensed chromosomes, 
suggesting a mitotic defect. Staining the microtubules and spindle pole bodies may 
help to confirm this observation and narrow down the exact role of Cdc37. However, 
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to carry out most of these next stages, more reagents are required. This section 
describes the questions that are of most interest in the future. 
7.6.2 Testing the complementation between the S.pombe and S.cerevisiae 
homologues 
It is an interesting question to find out whether the S.pombe cdc3 7 gene rescues the 
defects of the previously described S.cerevisiae mutant cdc37-1. Obviously, the 
reciprocal of this experiment could be carried out, whether a S.pombe cdc37ts  mutant 
could be rescued by the S.cerevisiae CDC37 gene. The results of this experiment 
would probably not be hugely informative since the D. melanogaster cdc3 7 gene 
rescues the cdc37-1 mutant but the vertebrate homologues do not appear to, even 
though the Drosophila gene is more similar in sequence to the mammalian genes than 
the S. cerevisiae gene. 
7.6.3 Construction and examination of a S.pombe cd67 mutant 
So far, the approaches described in this thesis have been informative about the effects 
of gradual removal of Cdc37 from the cell. A better insight into the roles of a gene 
such as cdc37 could be obtained by examining the behaviour of a ts mutants. The 
advantage of this is that the gene product is rapidly inactivated and the observed 
phenotype reflects the immediate consequences of this, without allowing the cells 
time to adapt to the lack of Cdc37 as might happen in depletion experiments. The 
generation of a cdc37ls  mutant is a high priority for the next stages of this project. 
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7.6.4 The cell cycle targets of Cdc37 and investigation of its activity 
throughout the cell cycle 
The work carried out in this thesis has shown that in S.pombe, Cdc2 is a likely target 
of Cdc37. This could be tested by examining the levels of Cdc2, Cdcl3 and the GI 
cyclin Cig2, in cells with compromised cdc3 7 function. Also, the extent of 
association between Cdc2 and these two cyclins could be determined by co-
immunoprecipitation, and the kinase activities of these complexes could also be 
analysed. Cdc37 immunoprecipitation experiments in cdc2 and cdc2t3 strains could 
also be carried out to determine whether Cdc37 can be shown to associate directly 
with Cdc2. It is possible that any interaction of Cdc37 with wild-type Cdc2 may be 
transient and difficult to detect, whilst mutant proteins may bind more stably as 
discussed in Hunter and Poon, 1997. Other potential cell cycle targets of Cdc37 
include Wee 1, which has been previously shown to bind Swo 1 (Hsp90), requiring it 
for normal function (Aligue et al., 1994). This and other interactions could be 
investigated in a similar manner. 
Since cdc37 has been shown to genetically interact with genes involved in the cell 
cycle and loss of Cdc37 in S.pombe affects cell cycle progress, it is possible that 
Cdc37 abundance or activity may vary periodically during the cell cycle. Therefore, 
it would be interesting to determine the abundance of Cdc37 mRNA and protein in 
synchronous cultures generated by elutriation. Also, it would be interesting to 
investigate whether Cdc37 is subject to control by phosphorylation as this does not 
appear to have been investigated in other systems. If Cdc37 is phosphorylated and 
this results in a gel mobility shift, it will be straightforward to ask whether the 
phosphorylation pattern varies during the cell cycle which may give clues to its 
possible roles within the cell cycle. 
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7.6.5 Other cellular targets of Cdc37 and proteins it interacts with 
Due to the heterogeneity of the population in the depletion experiments described in 
this thesis, it seems likely that there are several targets of Cdc37. A genetic screen 
could be carried out for mutants showing synthetic lethality with a cdc3 7 defect, as 
some of these mutations will probably lie in genes whose products require Cdc37 for 
function. Following the isolation of synthetically lethal mutations, the corresponding 
genes could be identified by genetic analysis (such as crossing to candidate genes) and 
library screening by complementation. For this approach, a cdc3 7' mutant would 
probably be most useful. Other genetic screens include using a cdc3 7' strain to 
screen for genes whose overexpression rescues the lethality at the restrictive 
temperature of the mutant, thus leading to isolation of Cdc37 target genes directly, or 
screening for mutants whose growth depends on high level expression of cdc37, 
which has also been shown to be an effective approach to identifying functionally 
interacting genes (Cullen et al., 2000). 
Direct interactions of Cdc37 could be investigated by two approaches: firstly, the 
yeast two-hybrid approach using Cdc37 as bait. The second is a more direct 
biochemical method, where recombinant Cdc37 is attached to a column and extracts 
from S.pombe are passed over it. Proteins that bind could then be subjected to mass 
spectrometric procedures in order to identify them. Since Cdc37 has been shown to 
interact directly with Hsp90 and with specific protein kinases, Hsp90 and specific 
target protein kinases may be isolated by this approach, along with other proteins 
that may be involved in these complexes. 
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7.6.6 The structure of Cdc37 and relation to its function 
Since few structure-function studies have been carried out on any Cdc37 protein, this 
would also be an interesting point of investigation in S.pombe. In at least one 
system, the N-terminal region of the Cdc37 protein binds to a protein kinase domain 
and the C-terminal region binds to Hsp90 (Grammatikakis et al., 1999). This could 
be investigated in S.pombe in detail. The regions and residues that are required for 
interaction with Swo 1 (Hsp90) and various protein kinases could be identified if they 
occur in S.pombe. This would then allow further genetic analysis of cdc37 in 








ColE 1 on 
pBluescript SK. cdc37* 
10.15 kb 
cdc37 
Bam}{I 	( 2.1 kb 
Ndela 	Ndelb 
Plasmid pBluescript SK-.cdc37. Described in section 3.3. 
166 










Plasmid pBluescript SK-.3'cdc37'ORF. Described in section 3.4.3. 
IWO 
167 




Plasmid pBluescript SK-.zlcdc37. Described in section 4.2.1. 
169 
dela 
PstI\ 	 1.4 kb 	Ndelb 
nmt prom. 	cdc37 
nmt term. 
SstI 



















Adkins, B., Hunter, T. and Sefton, B.M. (1982) The transforming proteins of PRCII- 
virus and Rous-sarcoma virus form a complex with the same 2 cellular 
phosphoproteins. I Virol., 43, 448-455. 
Aim, N.G. (1993) The map kinase cascade - discovery of a new signal transduction 
pathway. Mol. Cell. Biochem., 128,201-209. 
Alfa, C., Fantes, P., Hyanis, J., McLeod, M. and Warbrick, E. (1993) Experiments 
with fission yeast: A laboratory manual. Cold Spring Harbour Press, Cold Spring 
Harbour, New York. 
Aligue, R., Akhaven-Niak, H. and Russell, P. (1994) A role for Hsp90 in cell cycle 
control: Wee  tyrosine kinase activity requires interaction with Hsp90. EMBO 1, 13, 
6099-6106. 
Basi, G., Schmid, E. and Maundrell, K. (1993) TATA box mutations in the 
Schizosaccharomyces pombe nmtl promoter affect transcription efficiency but not 
the transcription start point or thiamine repressibility. Gene, 123, 131-136. 
Boddy, M.N., Furnari, B., Mondesert, 0. and Russell, P. (1998) Replication 
checkpoint enforced by kinases Cdsl and Chkl. Science, 280, 909-912. 
Bohen, S.P. and Yamamoto, K.R. (1994) The biology of heat shock proteins and 
molecular chaperones. Cold Spring Harbor Laboratory Press. 
Bolton, E.T. and McCarthy, B.J. (1962) A general method for the isolation of RNA 
complementary to DNA. Proc. Nat. Acad. Sci. USA, 48, 1390. 
Booher, R. and Beach, D. (1987) Interaction between cdc13 and cdc2 in the 
control of mitosis in fission yeast; dissociation of the G  and G2 roles of the cdc2 
protein kinase. EMBO J., 6, 3441-3447. 
Booher, R. and Beach, D. (1988) Involvement of cdc13 in mitotic control in 
Schizosaccharomycespombe: possible interaction of the gene product with 
microtubules. EMBOJ, 7, 2321-2327. 
Borkovich, K.A; (1989) Hsp82 is an essential protein that is required in higher 
concentrations for growth of cells at higher temperatures. Mol. Cell. Biol., 9, 3919- 
3930. 
Boschelli, F., Uptain, S.M. and Lightbody, J.L. (1993) The lethality of p60(v-src) in 
Saccharomyces cerevisiae and the activation of p34(cdc28) kinase are dependent on 
the integrity of the SH2 domain. J. Cell Sci., 105, 519-528. 
174 
Breter, H.J., Ferguson, J., Peterson, T.A. and Reed, S.I. (1983) Isolation and 
transcriptional characterization of 3 genes which function at start, the controlling 
event of the Saccharomyces cerevisiae cell division cycle - CDC36, CDC37, and 
CDC39. Mol. Cell. Biol., 3, 881-89 1. 
Broek, D., Bartlett, R., Crawford, K. and Nurse, P. (199 1) Involvement 0f34ccic2 
in establishing the dependency of S phase on mitosis. Nature, 349, 388-393. 
Brugge, J., Yonemoto, W. and Darrow, D. (1983) Interaction between the Rous 
sarcoma virus transforming protein and two cellular phosphoproteins: analysis of the 
turnover and distribution of the complex. Mo!. Cell. Biol., 3, 9-19. 
Brugge, J.S. (1986) Interaction of the Rous sarcoma virus protein pp60SI with the 
cellular proteins pp50 and pp90. Curr. Top. Microbiol. Immunol., 123, 1-23. 
Brugge, J.S., Erikson, E. and Erikson, R.L. (1981) The specific interaction of the 
Rous sarcoma virus transforming protein, pp60src,  with 2 cellular proteins. Cell, 25, 
363-372. 
Buchberger, A., Schroder, H., Hesterkamp, T., Schonfeld, H.J. and Bukau, B. (1996) 
Substrate shuttling between the DnaK and GroEL systems indicates a chaperone 
network promoting protein folding. .1 Mo!. Biol., 261, 328-333. 
Bukau, B. and Horwich, A.L. (1998) The Hsp70 and Hsp60 chaperone machines. 
Cell, 92, 351-366. 
Caplan, A.J. (1999) Hsp90's secrets unfold: new insights from structural and 
functional studies. Trends Cell Biol., 9, 262-268. 
Can, A.M., MacNeill, S.A., Hayles, J. and Nurse, P. (1989) Molecular cloning and 
sequence analysis of mutant alleles of the fission yeast cdc2 protein kinase gene: 
implications for cdc2+  protein structure and function. Mol. Gen. Genet., 218, 41-49. 
Carrello, A. (1999) The common tetratricopeptide repeat acceptor site for steroid 
receptor-associated immunophilins and Hop is located in the dimerization domain of 
Hsp90. I Biol. Chem., 274, 2682-2689. 
Chen, T. and Zhang, M.Q. (1998) Pombe: A gene-finding and exon-intron structure 
prediction system for fission yeast. Yeast, 14, 701-710. 
Clackson, 1., Gussow, D. and Jones, P.T. (1994) General applications of PCR to 
gene cloning and manipulation. In McPherson, M.J., Quirke, P. and Taylr, G.R. 
(eds.), PCR: A practical approach. Oxford University Press, Oxford, pp.  187-214. 
175 
Coleman, T.R., Tang, Z. and Dunphy, W.G. (1993) Negative regulation of the Wee  
protein kinase by direct action of the Niml/Cdrl mitotic inducer. Cell, 72, 919-929. 
Courtneidge, S.A. and Bishop, J.M. (1982) Transit of pp6ov -src to the plasma 
membrane. Proc. Natl. Acad Sci. USA, 79, 7117-7121. 
Cullen, C.F., May, K.M., Hagan, I.M., Glover, D.M. and Ohkura, H. (2000) A new 
genetic method for isolating functionally interacting genes: HighploF -dependent 
mutants and their suppressors define genes. Genetics, 155, 1521-1534. 
Cutforth, T. and Rubin, G.M. (1994) Mutations in hsp83 and cdc37 impair signalling 
by the sevenless receptor tyrosine kinase in drosophila. Cell, 77, 1027-1036. 
Dai, K., Kobayashi, R. and Beach, D. (1996) Physical interaction of mammalian 
Cdc37 with Cdk4. I Biol. Chem., 271, 22030-22034. 
Dey, B., Lightbody, J.J. and Boschelli, F. (1996) CDC37 is required for p60\'src 
activity in yeast. Mo!. Biol. Cell, 7, 1405-1417. 
Draetta, G. and Beach, D. (1988) Activation of cdc2 protein kinase during mitosis in 
human cells: cell cycle-dependent phosphorylation and subunit rearrangement. Cell, 
54,17-26. 
Ducommun, B., Draetta, G., Young, P. and Beach, D. (1990) Fission yeast Cdc25 is 
a cell-cycle regulated protein. Bichem. Biophys. Res. Commun., 167, 301-309. 
Durkacz, B., Beach, D., Hayles, J. and Nurse, P. (1985) The fission yeast cell cycle 
control gene cdc2 - structure of the cdc2 region. Mo!. Gen. Genet., 201, 543-545. 
Egel, R. and Egel-Mitani, M. (1974) Premeiotic DNA synthesis in fission yeast. Exp. 
Cell Res., 88, 127-134. 
Ellis, R.J. (ed.) (1996) The chaperonins. Academic Press, San Diego, CA. 
Enoch. (1990) Mutation of fission yeast cell cycle control genes abolishes 
dependence of mitosis on DNA replication. Cell, 60, 665-673. 
Evans, T., Rosenthal, E.T., Youngblom, J., Distel, D. and Hunt, T. (1983) Cyclin: a 
protein specified by maternal mRNA in sea urchin eggs that is destroyed at each 
cleavage division. Cell, 33, 389-396. 
Fantes, P. (1979) Epistatic gene interactions in the control of division in fission 
yeast. Nature, 279, 428. 
176 
Fantes, P. (1989) Yeast cell cycle. Curr. Opin. Cell Biol., 1, 250-255. 
Fantes, P.A. (198 1) Isolation of cell size mutants of a fission yeast by a new 
selective method: characterisation of mutants and implications for division control 
mechanisms. J Bacteriol., 146, 746-754. 
Farrell, A. and Morgan, D.O. (2000) Cdc37 promotes the stability of protein kinases 
Cdc28 and Caki. Mol. Cell. Biol., 20, 749-754. 
Featherstone, C. and Russell, P. (199 1) Fission yeast p 107wee1  mitotic inhibitor is a 
tyrosine/serine kinase. Nature, 349, 808-811. 
Feder, M.E. and Hofmann, G.E. (1999) Heat shock proteins, molecular chaperones 
and the stress response. Annu. Rev. Physiol., 61, 243-282. 
Fenton, W.A., Kashi, Y., Furtak, K. and Horwich, A.L. (1997) GroEL-mediated 
protein folding. Protein Sci., 6, 743-760. 
Ferguson, J., Ho, J.Y., Peterson, T.A. and Reed, S.I. (1986) Nucleotide-sequence of 
the yeast-cell division cycle start genes CDC28, CDC36, CDC37, and CDC39, and a 
structural-analysis of the predicted products. Nucleic Acids Res., 14, 6681-6697. 
Fikes, J.D., Becker, D.M., Winston, F. and Guarante, L. (1990) Striking conservation 
of TFIID in Schizosacccharomycespombe and Saccharomyces cerevisiae. Nature, 
346. 
Fink, G.R. (1987) Pseudogenes in yeast? Cell, 49, 5-6. 
Fuss, A.E., Fang, Y.F., Boschelli, F. and Caplan, A.J. (1997) Differential in vivo 
regulation of steroid hormone receptor activation by Cdc37p. Mol. Biol. Cell, 8, 
2501-2509. 
Forsburg, S.L. and Nurse, P. (199 1) Cell-cycle regulation in the yeasts Saccharomyces 
cerevisiae and Schizosaccharomyces pombe. Annu. Rev. Cell Biol., 7, 227-256. 
Fujimura, H.A. (1994) Yeast homolog of mammalian mitogen-activated protein-
kinase, FUS31DAC2 kinase, is required both for cell-fusion and for GI arrest of the 
cell cycle and morphological-changes by the cdc37 mutation. J. Cell Science, 107, 
2617-2622. 
Fumari, B., Blasina, A., Boddy, M.N., McGowan, C.H. and Russell, P. (1999) 
Cdc25 inhibited in vivo and in vitro by checkpoint kinases Cdsl and Chkl. Mol. Biol. 
Cell, 10, 833-845. 
177 
Gerber, M.R., Farrell, A., Deshaies, R.J., Herskowitz, I. and Morgan, D.O. (1995) 
Cdc37 is required for association of the protein-kinase Cdc28 with GI and mitotic 
cyclins. Proc. Nat. Acad. Sci. USA, 92,4651-4655. 
Gething, M.J. (ed.) (1997) Guidebook to molecular chaperones and protein folding 
catalysts. Oxford Univ. Press, Oxford, UK. 
Gething, M.J. and Sambrook, J. (1992) Protein folding in the cell. Nature, 355, 33-45. 
Gietz, D., St. Jean, A., Woods, R.A. and Schiestl, R.H. (1992) Improved method for 
high efficiency transformation of intact yeast cells. Nucleic Acids Res., 20, 1425. 
Gould, K.L., Moreno, S., Owen, D.J., Sazer, S. and Nurse, P. (199 1) 
Phosphorylation at Thr167 is required for Schizosaccharomycespombe p34cdc2 
function. EMBOJ., 10, 3297-3309. 
Gould, K.L., Moreno, S., Tonks, N.K. and Nurse, P. (1990) Complementation of the 
mitotic activator, p80cdc25,  by a human protein-tyrosine phosphatase. Science, 250, 
1573-1576. 
Gould, K.L. and Nurse, P. (1989) Tyrosine phosphorylation of the fission yeast 
cdc2+ protein kinase regulates entry into mitosis. Nature, 342, 39-45. 
Grammatikakis, N., Lin, J.-H., Grammatikakis, A., Tsichlis, P.N. and Cochran, B.H. 
(1999) p5Ocdc37  acting in concert with Hsp90 is required for Raf-1 function. Mol. 
Cell. Biol., 19,1661-1672. 
Gussow, D. and Clackson, T. (1989) Direct clone characterisation from plaques and 
colonies by the polymerase chain reaction. Nucleic Acids Res., 17, 4000. 
Gutz, H., Heslot, H., Leupold, U. and Loprieno, N. (1974) Schizosaccharomyces 
pombe. In Handbook of Genetics, Vol. 1 (R. C. King, ed.). Plenum Publishing Corp., 
New York. 
Hall, M. and Peters, G. (1996) Genetic alterations of cyclins, cyclin-dependent 
kinases, and CDK inhibitors in human cancer. Adv. Cancer Res., 68, 67-108. 
Hamaguchi, J.R., Tobey, R.A., Pines, J., Crissman, H.A., Hunter, T. and Bradbury, 
E.M. (1992) Requirement for p34cdc2  kinase is restricted to mitosis in the 
mammalian cdc2 mutant FT210. J. Cell Biol., 117, 1041-1053. 
Hanahan, D. (1983) Studies on transformation of Eschericia coli with plasmids. J. 
Mol. Biol., 166,557-580. 
178 
Harti, F.U. (1996) Molecular chaperones in cellular protein folding. Nature, 381, 
571-580. 
Hartwell, L.H. (1974) Saccharomyces cerevisiae cell cycle. Bacteriol. Rev., 38, 164-
198. 
Hartwell, L.H. and Unger, M.W. (1977) Unequal division in Saccharomyces 
cerevisiae and its implication for the control of cell division. .1 Cell Biol., 75, 422-
435. 
Hereford, L.M. and Hartwell, L.H. (1974) Sequential gene function in the initiataion 
of Saccharomyces cerevisiae DNA synthesis. .1. Mol. Biol., 84, 445-461. 
Hill, J., Donald, K.A. and Griffiths, D.E. (199 1) DMSO-enhanced whole cell yeast 
transformation. Nucleic Acids Res., 19, 5791. 
Huang, L., Grammatikakis, N. and Toole, B.P. (1998) Organization of the chick 
cdc37 gene. J Biol. Chem., 273, 3598-3603. 
Hunter, T. and Poon, R.Y.C. (1997) Cdc37: A protein kinase chaperone? Trends Cell 
Biol., 7,157-161. 
Ito, H., Fukada, Y., Murata, K. and Kimura, A. (1983) Transformation of intact 
yeast cells treated with alkali cations. I Bacteriol., 153, 163-168. 
Jakob, U. and Buchner, J. (1994) Assisting spontaneity - the role of Hsp90 and small 
Hsps as molecular chaperones. Trends Biochem. Sc., 19, 205-211. 
Johnston, G.C., Pringle, J.R. and Hartwell, L.H. (1977) Coordination of growth with 
cell division in the yeast Saccharomyces cerevisiae. Exp. Cell Res., 105, 79-98. 
Kato, J.Y., Matsuoka, M., Strom, D.K. and Sherr, C.J. (1994) Regulation of cyclin D 
dependent kinase 4 (Cdk4) by Cdk4 activating kinase. Mol. Cell. Biol., 14, 2713-2721. 
Kaufer, N., Simanis, V. and Nurse, P. (1985) Fission yeast Schizosaccharomyces 
pombe correctly excises a mammalian RNA transcript interveneing sequence. Nature, 
318,78-80. 
Kimura, Y., Rutherford, S.L., Miyata, Y., Yahara, I., Freeman, B.C., Yue, L., 
Morimoto, R.I. and Lindquist, S. (1997) Cdc37 is a molecular chaperone with 
specific functions in signal transduction. Genes Develop., 11, 1775-1785. 
179 
Kinoshita, N., Yamano, H., Niwa, H., Yoshida, T. and Yanagida, M. (1993) Negative 
regulation of mitosis by the fission yeast protein phosphatase Ppa2. Genes & Dev., 
7, 1059-1065. 
Kohli, J., Hottinger, H., Munz, P., Strauss, A. and Thuriaux, P. (1977) Genetic 
mapping in Schizosaccharomyces pombe by mititic and meiotic analysis and induced 
haploidisation. Genetics, 87, 423-471. 
Krek, W. and Nigg, E.A. (1991) Mutations of p34cdC2  phosphorylation sites induce 
premature mitotic events in HeLa cells: evidence for a double block to p34cdc 2 
kinase activation in vertebrates. EMBO J., 10, 3331-3341. 
Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the 
head of bacteriophage T4. Nature, 227, 680-685. 
Lamphere, L., Fiore, F., Xu, X., Brizuela, L., Keezer, S., Sardet, C., Draetta, G.F. and 
Gyuris, J. (1997) Interaction between Cdc37 and Cdk4 in human cells. Oncogene, 14, 
1999-2004. 
Lee, K.M., Saiz, J.E., Barton, W.A. and Fisher, R.P. (1999) Cdc2 activation in 
fission yeast depends on Mcs6 and Cskl, two partially redundant CDK-activating 
kinases (CAK5). Curr. Biol., 9, 441-444. 
Lee, M.G. and Nurse, P. (1987) Complementation used to clone a human homolog of 
the fission yeast cell cycle control gene cdc2. Nature, 327, 3 1-35. 
Lindquist, S. (1986) The heat-shock response. Annu. Rev. Biochem., 55, 1151-1191. 
Lipsich, L.A., Cutt, J.R. and Brugge, J.S. (1982) Association of the transforming 
proteins of Rous, Fujinami, and Y73 avian-sarcoma viruses with the same 2 cellular 
proteins. Mol. Cell. Biol., 2, 875-880. 
Lollier, M., Jaquet, L., Nedeva, T., Lacroute, F., Potier, S. and Souciet, J.-L. (1995) 
As in Saccharomyces cerevisiae, aspartate transcarbamyolase is asssembled on a 
multifuctional protein including a dihydroorotase-like cryptic domain in 
Schizosaccharomycespombe. Curr. Genet., 28, 138-149. 
Louvion, J.F., Warth, R. and Picard, D. (1996) Two eukaryote-specific regions of 
Hsp82 are dispensable for its viability and signal transduction functions in yeast. 
Proc. Nat!. Acad. Sci. USA, 93,13937-13942. 
Lundgren, K., Walworth, N., Booher, R., Dembski, M., Kirschner, M. and Beach, D. 
(1991) Miki and Weel cooperate in the inhibitory tyrosine phosphorylation of 
Cdc2. Cell, 64,1111-1122. 
WE 
Macneill, S.A. and Fantes, P. (1993) Methods for analysis of the fission yeast cell 
cycle. In Fantes, P. and R., B. (eds.), The Cell Cycle: A Practical Approach. IRL 
Press. 
Macneill, S.A. and Fantes, P.A. (1994) Controlling entry into mitosis in fission 
yeast. Frontiers in molecular biology: The cell cycle. IRL Press. 
Mahony, D., Parry, D.A. and Lees, E. (1998) Active Cdk6 complexes are 
predominantly nuclear and represent only a minority of the Cdk6 in T cells. 
Oncogene, 16, 603-611. 
Matsuoka, M., Kato, J.Y., Fisher, R.P., Morgan, D.O. and Sherr, C.J. (1994) 
Activation of cyclin dependent kinase 4 (Cdk4) by mouse Mo15-associated kinase. 
Mol. Cell. Biol., 14, 7265-7275. 
Matsushime, H., Quelle, D.E., Shurtleff, S.A., Shibuya, M., Sherr, C.J. and Kata, J. 
(1994) D-type cyc!in dependent kinase activity in mammalian cells. Mol. Cell. Biol., 
14, 2066-2076. 
Maundrell, K. (1990) nmtl of fission yeast. .1. Biol. Chem., 265, 10857-10864. 
Millar, J.B., Lenaers, G. and Russell, P. (1992) Pyp3 PTPase acts as a mitotic 
inducer in fission yeast. EMBOJ, 11, 4933-4941. 
Millar, J.B., McGowan, C.H., Lenaers, G., Jones, R. and Russell, P. (1991) 
p80c25 mitotic inducer is the tyrosine phosphatase that activates p34cdc 2  kinase 
in fission yeast. EMBO J., 10, 4301-4309. 
Minami, Y., Kimura, Y., Kawasaki, H., Suzuki, K. and Yahara, I. (1994) The carboxy 
terminal region of mamma!ain Hsp90 is required for its dimerisation and function in 
vivo. Mol. Cell. Biol., 14,1459-1464. 
Mitchison, J.M. (1957) The growth of single cells. I. Schizosaccharomycespombe. 
Exp. Cell Res., 13, 244. 
Mitchison, J.M. (1970) Physiological and cytological methods for 
Schizosaccharomycespombe. Met/i. Cell Physiol., 4, 131-165. 
Mitchison, J.M. (1990) The fission yeast Schizosaccharomyces pombe. BioEssays, 
12, 189-191. 
Mitchison, J.M. and Nurse, P. (1985) Growth in cell length in the fission yeast 
Schizosaccharomyces pombe. I Cell Sci., 75, 357-376. 
181 
Moreno, S., Kiar, A. and Nurse, P. (199 1) Molecular genetic analysis of fission yeast 
Schizosaccharomyces pombe. Meth. Enzym., 94, 795-823. 
Moreno, S. and Nurse, P. (1994) Regulation of progression through the G  phase of 
the cell cycle by the rum]i gene. Nature, 367, 236-242. 
Moreno, S., Nurse, P. and Russell, P. (1990) Regulation of mitosis by cyclic 
accumulation of p80c25 mitotic inducer in fission yeast. Nature, 344, 549-552. 
Morgan, D.O. (1995) Principles of CDK regulation. Nature, 374, 131-134. 
Morimoto, R.I., Tissieres, A. and Georgopoulos, C. (eds.) (1994) The biology of 
heat-shock proteins and molecular chaperones. Cold Spring Harbor Lab. Press, Cold 
Spring Harbor, N.Y. 
Mullis, K., Faloona, F., Scharf, S., Saiki, R., Horn, G. and Erlich, H. (1986) Specific 
enzymatic ampilification of DNA in vitro - the polymerase chain reaction. Cold 
Spring Harbor Sympos. Quant. Biol., 51, 263-273. 
Munoz, M.J., Bejarano, E.R., Daga, R.R. and Jimenez, J. (1999) The identification of 
Wos2, a p23 homologue that interacts with Wee I. Genetics. 
Munoz, M.J. and Jimenez, J. (1999) Genetic interactions between Hsp90 and the 
Cdc2 mitotic machinery in the fission yeast Schizosaccharomyces pombe. Mo!. Gen. 
Genet., 261, 242-250. 
Murray, A.W. (1992) Creative blocks: cell-cycle checkpoints and feedback controls. 
Nature, 359, 599-604. 
Murray, A.W. and Kirschner, M.W. (199 1) What controls the cell cycle? Sci. Amer., 
264,34-41. 
Nasmyth, K. (1993) Control of the yeast cell cycle by the Cdc28 protein kinase. 
Curr. Opin. Cell Biol., 5, 166-179. 
Nasmyth, K. and Nurse, P. (1979) A control acting over the initiation of DNA 
replication in the yeast Schizosaccharomyces pombe. I Cell Sci., 36, 155-168. 
Neiman, A.M., Chang, F., Komachi, K. and Herskowitz, I. (1990) CDC36 and 
CDC39 are negative elements in the signal transduction pathway of yeast. Cell 
Regul., 1, 391-401. 
Nigg, E.A. (1995) Cyclin dependent protein kinases - key regulators of the cell cycle. 
BioEssays, 17,471-480. 
182 
Norbury, C., Blow, J. and Nurse, P. (1991) Regulatory phosphorylation of the 
p34cdc2 protein kinase in vertebrates. EMBO J., 10, 3321-3329. 
Nurse, P. (1975) Genetic control of cell size at cell division in yeast. Nature, 256, 
547-55 1. 
Nurse, P. (1985) Cell cycle control in yeast. Trends Genet., 1, 5 1-55. 
Nurse, P. (1990) Universal control mechanism regulating onset of M-phase. Nature, 
344, 503-508. 
Nurse, P. and Fantes, P. (1981) Cell cycle controls in fission yeast: a genetic 
analysis. In John, P.C.L. (ed.) The cell cycle. Cambridge University press, pp. 85-98. 
Nurse, P. and Thuriaux, P. (1980) Regulatory genes controlling mitosis in the fission 
yeast Schizosaccharomycespombe. Genetics, 96, 627-637. 
Nurse, P., Thuriaux, P. and Nasmyth, K. (1976) Genetic control of the cell division 
cycle in the the fission yeast Schizosaccharomyces pombe. Mo!. Gen. Gen., 146, 
167-178. 
Oppermann, H., Levison, W. and Bishop, J.M. (198 1) A cellular protein that 
associates with the transforming protein of Rous-sarcoma virus is also a heat-shock 
protein. Proc. Nat!. Acad. Sci. USA, 78, 1067-1071. 
OwensGrillo, J.K., Czar, M.J., Hutchison, K.A., Hoffman, K., Perdew, G.H. and 
Pratt, W.B. (1996) A model of protein targeting mediated by immunophilins and 
other proteins that bind to Hsp90 via tetratricopeptide repeat domains. J. Rio!. 
Chem., 271, 13468-13475. 
Ozaki, T., Irie, K. and Sakiyama, S. (1995) Molecular cloning and cell cycle-
dependent expression of a novel gene that is homologous to cdc3 7. DNA Cell Biol., 
14, 1017-1023. 
Pardee, A.B. (1974) A restriction point for control of normal animal cell 
proliferation. Proc. Nat!. Acad Sci. USA, 71, 1286-1290. 
Parker, L.L., Walter, S.A., Young, P.G. and Piwnica-Worms, H. (1993) 
Phosphorylation and inactivation of the mitotic inhibitor Weel by the Niml/Cdrl 
kinase. Nature, 363, 736-738. 
Parker, L.L.A.-F., S. and Piwnica-Worms, H. (1992) plO7Weel is a dual-specificity 
kinase that phosphorylates p34cdc2  on tyrosine 15. Proc. Nat!. Acad. Sd. USA, 89, 
2917-2921. 
183 
Parsell, D.A. and Lindquist, S. (1993) The function of heat shock proteins in stress 
tolerance: degradation and reactivation of damaged proteins. Annu. Rev. Genet., 27, 
437-496. 
Patra, D., Wang, S.X., Kumagai, A. and Dunphy, W.G. (1999) The Xenopus 
Sucl/Cks protein promotes the phosphorylation of G2-M regulators. I Biol. Chem., 
274, 36839-36842. 
Pauli, D. and Mahowald, A.P. (1990) Germ-line sex determination in Drosophila 
melanogaster. Trends Genet., 6, 259-264. 
Perdew, G.H. and Whitelaw, M.L. (199 1) Evidence that the 90 kDa heat-shock 
protein (Hsp90) exists in cytosol in heteromeric complexes containing Hsp70 and 3 
other proteins with Mr of 63,000, 56,000 and 50,000. 1 Biol. Chem., 266, 6708-
6713. 
Perdew, G.H., Wiegand, H., VandenHeuvel, J.P., Mitchell, C. and Singh, S.S. (1997) 
A 50 kilodalton protein associated with raf and pp6ov -src protein kinases is a 
mammalian homolog of the cell cycle control protein Cdc37. Biochemistry, 36, 3600- 
3607. 
Peter, M., Gartner, A., Horecka, J., Ammerer, G. and Herskowitz, I. (1993) FAR  
links the signal transduction pathway to the cell cycle machinery in yeast. Cell, 73, 
747-760. 
Pratt, W.B. and Toft, D.O. (1997) Steroid receptor interactions with heat shock 
protein and immunophilin chaperones. Endocr. Rev., 18, 306-360. 
Prentice, H.L. (1991) High efficiency transformation of Schizosaccharomyces pombe 
by electroporation. Nucleic Acids Res., 20, 621. 
Reed, S.I. (198 Oa) The selection of amber mutations in genes required for completion 
of start, the controlling event of the cell division cycle of S.cerevisiae. Genetics, 95, 
579-588. 
Reed, S.I. (1 980b) The selection of S. cerevisiae mutants defective in the start event 
of cell division. Genetics, 95, 561-577. 
Reed, S.I. (1992) The role of p34 kinases in the G  to S phase transition. Annu. Rev. 
Cell Biol., 8, 529-661. 
Ritossa, F. (1996) Discovery of the heat shock response. Cell Stress Chaperones, 1, 
97-98. 
184 
Rodriguez, C.R., Cho, E.J., Keogh, M.C., Moore, C.L., Greenleaf, A.L. and 
Buratowski, S. (2000) Kin28, the TFIIH-associated carboxy-terminal domain kinase, 
facilitates the recruitment of mRNA processing machinery to RNA polymerase II. 
Mol. Cell. Biol., 20, 104-112. 
Rothstein, R.J. (1983) One step gene disruption in yeast. In Wu, R., Grossman, L. 
and Moldave, K. (eds.), Met/i. Enzym. Academic Press, Vol. 101, pp.  202-211. 
Russell, P. (1989) Gene cloning and expression. In Nasim, A., Young, P. and 
Johnston, B.F. (eds.), Mol. Biol. Fission Yeast. Academic Press, pp.  224-267. 
Russell, P. (1998) Checkpoints on the road to mitosis. Trends Biochem. Sci., 23, 
399-402. 
Russell, P. and Nurse, P. (1986) cdc25 functions as an inducer in the mitotic control 
of fission yeast. Cell, 45, 145-153. 
Russell, P. and Nurse, P. (1 987a) The mitotic inducer nimF functions in a 
regulatory network of protein kinase homologs controlling the initiation of mitosis. 
Cell, 49, 569-576. 
Russell, P. and Nurse, P. (1987b) Negative regulation of mitosis by wee], a gene 
encoding a protein kinase homolog. Cell, 49, 559-567. 
Saiki, R.K., Scharf, S., Faloona, F., Mullis, K.B., Horn, G.T., Erlich, H.A. and 
Arnheim, N. (1985) Enzymatic amplification of beta-globin genomic sequences and 
restriction site analysis for diagnosis of sickle-cell anaemia. Science, 230, 1350-1354. 
Sambrook, J., Fritch, E.F. and Maniatis, T. (1989) Molecular cloning: a laboratory 
handbook. Cold Spring Harbour Press, Cold Spring Harbour, New York. 
Schiesti, R.H. and Gietz, R.D. (1989) High efficiency transformation of intact cells 
using single-stranded nucleic acids as a carrier. Curr. Genet., 16, 339-346. 
Schutz, A.R., Giddings, T.H., Steiner, E. and Winey, M. (1997) The yeast CDC37 
gene interacts with MPS1 and is required for proper execution of spindle pole body 
duplication. .1 Cell Biol., 136, 969-982. 
Sheldrick, K.S. and Can, A.M. (1993) Feedback controls and G2 checkpoints: fission 
yeast as a model system. BioEssays, 15, 775-782. 
Shiozaki and Russell, P. (1996) Conjugation, meiosis, and the osmotic stress 
response are regulated by Spcl kinase through Atfi transcription factor in fission 
yeast. Genes Dev., 10, 2276-2288. 
185 
Silverstein, A.M., Grammatikakis, N., Cochran, B.H., Chinkers, M. and Pratt, W.B. 
(1998) p5ocdc37 binds directly to the catalytic domain of Raf as well as to a site on 
Hsp90 that is topologically adjacent to the tetratricopeptide repeat binding site. J. 
Biol. Chem., 273,20090-20095. 
Somero, G.N. (1995) Proteins and temperature. Annu. Rev. Physiol., 57, 43-68. 
Stancato, L.F., Chow, Y.H., Hutchison, K.A., Perdew, G.H., Jove, R. and Pratt, 
W.B. (1993) Raf exists in a native heterocomplex with hsp90 and p50 that can be 
reconstituted in a cell-free system. J. Biol. Chem., 268, 21711-21716. 
Stepanova, L., Leng, X.H. and Harper, J.W. (1997) Analysis of mammalian Cdc37, a 
protein kinase targeting subunit of heat shock protein 90. Meth. Enzym., 283, 220-
229. 
Stepanova, L., Leng, X.H., Parker, S.B. and Harper, J.W. (1996) Mammalian 
p5ocdc37 is a protein kinase targeting subunit of Hsp90 that binds and stabilizes 
Cdk4. Genes & Dev., 10, 1491-1502. 
Szabo, A., Langer, T., Schroder, H., Flanagan, J., Bukau, B. and Hard, F.U. (1994) 
The ATP hydrolysis-dependent reaction cycle of the Eschericia coli Hsp70 system-
DnaK, DnaJ and GrpE. Proc. Nat!. Acad. Sci. USA, 91,10345-10349. 
Th'ng, J.P., Wright, P.S., Hamaguchi, J., Lee, M.G., Norbury, C.J., Nurse, P. and 
Bradbury, E.M. (1990) The FT2 10 cell line is a mouse G2 phase mutant With a 
temperature-sensitive CDC2 gene product. Cell, 63, 313-324. 
Timmerman, S., Hinds, P.W. and Munger, K. (1997) Elevated activity of cyclin 
dependent kinase 6 in human squamous cell carcinoma lines. Cell Growth D, 8, 
361-370. 
Toda, T., Yamamoto, M. and Yanagida, M. (198 1) Sequential alteration in the nuclear 
chromatin region during mitosis of the fission yeast Schizosaccharomycespombe: 
Video fluoresence microscopy of synchronously growing wild-type and cold-
sensitive cdc mutants by using a DNA-binding fluorescent probe. J. Cell Sci., 52, 
271-287. 
Towbin, H., Steahelin, T. and Gordon, J. (1979) Electrophoretic transfer of proteins 
from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 
Proc. Nat. Acad. Sci. USA, 76,4350-4354. 
Tyers, M. and Futcher, B. (1993) Fan I and Fus3 link the mating pheromone signal 
transduction pathway to 3 GI-phase Cdc28 kinase complexes. Mol. Cell. Biol., 13, 
5659-5669. 
Valay, J.G., Simon, M., Dubois, M.F., Bensaude, 0., Facca, C. and Faye, G. (1995) 
The K1N28 gene is required both for RNA-polymerase II mediated transcription and 
phosphorylation of the Rpblp ctd. I Mol. Biol., 249, 535-544. 
Wartmann, M. and Davis, R.J. (1994) The native structure of the activated Raf 
protein-kinase is a membrane-bound multisubunit complex. .1. Biol. Chem., 269, 
6695-6701. 
Welch, W.J. and Feramisco, J.R. (1982) Purification of the major mammalian heat 
shock proteins. J. Biol. Chem., 257, 14949-14959. 
Whitelaw, M.L., Hutchison, K. and Perdew, G.H. (199 1) A 50-kda cytosolic protein 
complexed with the 90-kda heat-shock protein (Hsp90) is the same protein 
complexed with pp60VHsp90 in cells transformed by the Rous-sarcoma virus. J. 
Biol. Chem., 266, 16436-16440. 
Woollard, A. and Nurse, P. (1995) G  regulation and checkpoints operating around 
START in fission yeast. Bioessays, 17, 481-490. 
Wu, L. and Russell, P. (1993) Nimi kinase promotes mitosis by inactivating Wee  
tyrosine kinase. Nature, 363, 738-741. 
Xu, Y. and Lindquist, S. (1993) Heat-shock protein Hsp90 governs the activity of 
pp6ov-src kinase. Proc. Natl. Acad. Sci. USA, 90, 7074-7078. 
Yanagida, M. (1998) Fission yeast cut mutations revisited: control of anaphase. 
Trends Cell Biol., 8, 144-149. 
Young, J.C., Obermann, W.M.J. and Hart!, F.U. (1998) Specific binding of 
tetratricopeptide repeat proteins to the C-terminal 12 kDa domain of Hsp90. I Biol. 
Chem., 273,.18007-18010. 
Young, P.G. and Fantes, P.A. (1987) Schizosaccharomycespombe mutants affected 
in their division response to starvation. J. Cell Sci., 88, 295-3 04. 
Zhang, M.Q. and Marr, T.G. (1994) Fission yeast gene structure and recognition. 
Nucleic Acids Res., 22, 1750-1759. 
Ziemiecki, A. (1986) Characterization of the monomeric and complex-associated 
forms of the gag-onc fusion proteins of 3 isolates of feline sarcoma virus - 
phosphorylation, kinase-activity, acylation, and kinetics of complex formation. 
Virology, 151, 265-273. 
187 
